###begin article-title 0
###xml 115 120 <span type="species:ncbi:9606">human</span>
Identification of pregnane-X receptor target genes and coactivator and corepressor binding to promoter elements in human hepatocytes
###end article-title 0
###begin p 1
###xml 0 16 0 16 <!--CREATIVE COMMONS-->
CREATIVE COMMONSThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License () which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 63 68 <span type="species:ncbi:9606">human</span>
Chromatin immunoprecipitation (ChIP) studies were conducted in human hepatocytes treated with rifampicin in order to identify new pregnane-X receptor (PXR) target genes. Genes, both previously known to be involved and not known to be involved in drug disposition, with PXR response elements (PXREs) located upstream, within or downstream from their potentially associated genes, were identified. Validation experiments identified several new drug disposition genes with PXR binding sites. Of these, only CYP4F12 demonstrated increased binding in the presence of rifampicin. The role of PXR in the basal and inductive response of CYP4F12 was confirmed in hepatocytes in which PXR was silenced. We also assessed the association of PXR-coactivators and -corepressors with known and newly identified PXREs. Both PXR and the steroid receptor coactivator (SRC-1) were found to bind to PXREs in the absence of rifampicin, although binding was stronger after rifampicin treatment. We observed promoter-dependent patterns with respect to the binding of various coactivators and corepressors involved in the regulation of CYP4F12, CYP3A4, CYP2B6, UGT1A1 and P-glycoprotein. In conclusion, our findings indicate that PXR is involved in the regulation of CYP4F12 and that PXR along with SRC1 binds to a broad range of promoters but that many of these are not inducible by rifampicin.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 401 402 401 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 608 611 608 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1 B2 B3 B4 B5">1&#8211;5</xref>
###xml 689 690 689 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 1211 1214 1211 1214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7 B8 B9">7&#8211;9</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 1178 1186 <span type="species:ncbi:9606">patients</span>
The human pregnane-X receptor (PXR, NR1I2) is an essential regulator of a large and growing array of drug disposition genes which correspond to all phases of drug metabolism. These include phase I enzymes such as cytochrome P450 (CYP), phase II enzymes such as uridine-5'-diphosphate glucuronosyltransferases (UGTs) and transporters such as the multidrug resistance protein MDR1 P-glycoprotein (Pgp) (1). A large body of literature has revealed that PXR activation by xenobiotics, in the liver and intestine, results in a significant increase in the expression of drug metabolizing enzymes and transporters (1-5). In addition to increased gene expression, PXR can repress gene expression (6), indicating that gene regulation via PXR is complex. Although PXR functions as a defense mechanism against toxic insults, it also represents the molecular basis for pharmacokinetic drug-drug interactions. For example, if one drug activates PXR, administration of this drug can promote its own elimination (autoinduction) or the elimination of other coadministered drugs that are metabolized and eliminated by PXR-target gene products, thereby reducing the efficacy of drug therapies in patients on combination therapy (7-9).
###end p 4
###begin p 5
###xml 387 389 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 766 767 766 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 768 770 768 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
As a prototypical nuclear receptor, PXR has a DNA-binding domain (DBD) at the N-terminus and a ligand-binding domain (LBD) at the C-terminus. The DBD is responsible for binding to regulatory DNA sequences such as the AGGTCA-like direct repeats spaced by 3, 4 or 5 bases (DR3, DR4 and DR5), and the everted repeats separated by 6 or 8 bases (ER6 and ER8) located in the PXR target genes (10). The LBD is multifunctional in that it is capable of ligand binding, dimerization, transcriptional activation, and interactions with transcriptional co-factors. The C-terminal helix termed AF-2 is responsible for transcriptional activation by recruiting coactivators through conformational rearrangement, or gene repression by interactions with transcriptional corepressors (7,11).
###end p 5
###begin p 6
###xml 127 133 127 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
Understanding of coactivators and corepressors of PXR in the expression of target genes is relatively limited. Recently, Moore et al. (12) reviewed some of the key coactivators and corepressors involved in the PXR regulation of drug metabolizing enzymes and transporters. Small heterodimer partner (SHP/NC0B2) and nuclear receptor corepressor 2 (NCoR2/SMRT) were identified as corepressors, while steroid receptor coactivators 1 (SRC1/NCOA1) and 2 (SRC2/GRIP1), nuclear receptor interacting protein 1 (NRIP1/RIP140), peroxisome proliferator-activated receptor-gamma coactivator (PGC-1), and Forkhead transcription factor FKHR (FOXO1) were reported as coactivators.
###end p 6
###begin p 7
###xml 248 253 248 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13 B14 B15 B16">13&#8211;16</xref>
###xml 263 269 263 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 153 158 <span type="species:ncbi:4932">yeast</span>
While NCoR, SHP and SMRT are known to be corepressors of genes, studies undertaken by several groups using transfection assays in CV1, HepG2, HEK293 and yeast cells indicate that only SHP and SMRT are involved in transcriptional repression of PXR (13-16). Ourlin et al. (13) demonstrated in HepG2 cells that SHP blocks PXR binding to DNA in a ligand-dependent manner. In addition, their studies using transient transfection assays proved that increased expression of SHP resulted in a decrease in PXR activation in the presence of rifampicin.
###end p 7
###begin p 8
###xml 7 13 7 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 15 17 15 17 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 201 203 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 442 443 426 427 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
Tirona et al. (17) highlighted the critical involvement of hepatocyte nuclear factor 4alpha (HNF4alpha), together with PXR in the regulation of CYP3A4. Using mammalian two-hybrid assays Li and Chiang (18) showed that HNF4alpha and SHP compete to interact with PXR. These studies also revealed that SHP only partially blocked the PXR/SRC1 interaction and was unable to block the PXR/PGC-1alpha interaction. Using chromatin immunoprecipitation (ChIP) analysis, they observed that rifampicin increased the recruitment of HNF4alpha and SRC1 to the CYP3A4 chromatin but reduced PGC1alpha recruitment.
###end p 8
###begin p 9
###xml 574 576 574 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
In most studies referenced above, cell lines in which proteins were overexpressed were not of hepatic origin and promoter elements were outside of their natural chromatin environment. In addition, to assess DNA-protein and protein-protein interactions researchers used electro mobility shift assays that make use of 'naked' DNA as a probe, whereas in living cells much of the DNA is covered by nucleosomes. Thus, many binding sites for a protein in living cells could be masked by the presence of nucleosomes, but they would be scored as positive by the biochemical assays (19).
###end p 9
###begin p 10
###xml 152 157 <span type="species:ncbi:9606">human</span>
The goals of the experiments presented in this manuscript were 3-fold: First, using ChIP, we searched for new PXR target genes in cryopreserved primary human hepatocytes treated with rifampicin. Second, using ChIP-based assays, we studied binding of PXR, as well as PXR-corepressors and -coactivators to newly identified and established PXR response elements (PXREs) before and after treatment with rifampicin. Third, we investigated whether newly identified genes in the ChIP experiments were bona fide PXR target genes by measuring mRNA levels after small interfering RNA (siRNA)-mediated knockdown of PXR.
###end p 10
###begin title 11
MATERIALS AND METHODS
###end title 11
###begin title 12
Materials
###end title 12
###begin p 13
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 1101 1106 <span type="species:ncbi:9606">human</span>
Cryopreserved human hepatocytes, antibiotic/antimycotic Torpedo Mix, In VitroGRO-CP Media and In VitroGRO-HI Incubation Media were purchased from In Vitro Technologies (Baltimore, MD, USA). Rifampicin, glycine, Igepal, phenylmethanesulfonyl fluoride (PMSF) and formaldehyde were purchased from Sigma-Aldrich (St Louis, MO, USA). RNeasy 96 Kit was purchased from Qiagen (Valencia, CA, USA). Anti-PXR (sc-25381), -SRC-1 (sc-8995), -SRC-3 (sc-7216), -N-CoR (sc-8994), -HNF4alpha (sc-8987), -GRIP-1 (sc-8996), -PGC-1alpha (sc-13067), -SMRT (sc-1610), -FKHR (sc-11350), -RIP140 (sc-8997) and -SHP (sc-15283) antibodies were purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). Anti-RNA pol II (CTD phospho Ser-2, ab5095) antibody was purchased from Abcam Inc. (Cambridge, MA, USA). TaqMan(R) Universal PCR Master Mix was purchased from Applied Biosystems (Foster City, CA, USA). Collagen-coated 6-well plates were purchased from BD Biosciences (San Jose, CA, USA). ON-TARGETplus GAPDH Control Pool siRNA (D-001830), ON-TARGETplus Non-Targeting Pool siRNA (D-001810), ON-TARGETplus SMARTpool human NR1I2 siRNA (L-003415) and DharmaFECT-1 transfection reagent were purchased from Dharmacon Inc. (Lafayette, CO, USA). All other reagents and chemicals were of the highest grade and purchased from Fisher Scientific (Pittsburg, PA, USA).
###end p 13
###begin title 14
Cell culture and drug treatment
###end title 14
###begin p 15
###xml 300 301 300 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 430 431 424 425 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 951 952 941 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 1094 1095 1084 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 1233 1234 1219 1220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 22 27 <span type="species:ncbi:9606">human</span>
Cryopreserved primary human hepatocytes from three different donors (LHO: 68-year-old female Caucasian; 455: 37-year-old female Caucasian; and DMQ: 59-year-old African-American female) were used in our studies. Hepatocytes were plated in 6-well collagen-coated plates at a seeding density of 1.5 x 106 cells per well in In VitroGRO-CP Media and 2.2% antibiotic/antimycotic Torpedo Mix and placed in an incubator (37degreesC, 5% CO2). After 24 h the plating medium was discarded and hepatocytes were treated for 3 h with either DMSO (0.1%) or rifampicin 10 microM, prepared in In VitroGRO-HI incubation Media and 2.2% antibiotic/antimycotic Torpedo Mix. Following the 3 h incubation period, hepatocytes were fixed with 1/10 formaldehyde solution (11% formaldehyde, 0.1 M NaCl, 1 M EDTA, 50 mM HEPES pH 7.9). Fixation was stopped by adding 1/20 volume of glycine solution (2.5 M glycine, water) to the existing media. Cells were washed, centrifuged (800g for 10 min.) and resuspended in phosphate buffered saline (PBS)-Igepal solution (0.5% Igepal in PBS). Thereafter, cells were centrifuged (800g for 10 min.) and again resuspended in PBS-Igepal to which 100 microl PMSF (100 mM in ethanol) was added. Cells were then centrifuged (800g for 10 min.), pelleted and snap-frozen on dry ice and stored at -80degreesC for further analysis.
###end p 15
###begin title 16
ChIP-based assays
###end title 16
###begin p 17
###xml 448 450 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 709 711 705 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 58 63 <span type="species:ncbi:9606">human</span>
In order to identify PXREs present on genes in the entire human genome, cross-linked chromatin from hepatocytes treated with DMSO (0.1%) or 10 microM rifampicin were immunoprecipitated against a validated-PXR antibody. Cloning, sequencing, analysis of tags and confirmation of the PXR-binding sites using polymerase chain reaction (PCR) primers () targeting a region within 200 bp of each selected alignment were conducted as previously described (20). Assays to confirm that increased PXR-binding resulted in increased transcription were undertaken by immunoprecipitating cross-linked chromatin against RNA polymerase II (Pol II) antibody and the enrichment of Pol II was determined by quantitative (q)-PCR (20). To assess the involvement of coactivators and corepressors in the PXR-regulation of CYP3A4, CYP2B6, CYP4F12, UGT1A1 and MDR1 cross-linked chromatin was immunoprecipitated against the aforementioned coactivators and corepressors and the enrichment of SRC-1, SRC-3, GRIP1, NCOR, PGC1alpha, HNF4alpha, FKHR, RIP140, SMRT and SHP were determined by q-PCR.
###end p 17
###begin title 18
RNA interference
###end title 18
###begin p 19
###xml 1024 1027 1004 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18S</italic>
###xml 1287 1293 1263 1269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP3A4</italic>
###xml 1295 1301 1271 1277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2B6</italic>
###xml 1303 1306 1279 1282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pgp</italic>
###xml 1311 1317 1287 1293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UGT1A1</italic>
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 188 193 <span type="species:ncbi:9606">human</span>
Cryopreserved human hepatocytes (120 000 cells/well) were cultured in antibiotic-free In VitroGRO-HI plating medium in collagen-I coated 48-well plates. After 24 h ON-TARGETplus SMARTpool human NR1I2 siRNA (L-003415) was used to knockdown PXR. ON-TARGETplus GAPDH Control Pool siRNA (D-001830) and ON-TARGETplus Non-Targeting Pool siRNA (D-001810) were used as internal controls. Briefly, siRNA duplexes (100 nmol/well) and DharmaFect-1 (3 microl/well) were diluted in 50 microl antibiotic- and serum-free In VitroGRO-HI incubation medium separately and mixed gently and incubated for 5 min at room temperature. Afterward, PXR-siRNA and DharmaFect-1 were mixed (total volume 100 microl) and incubated at room temperature for 20 min. Then, 100 microl siRNA-DharmaFect-1 complex was diluted with 100 microl antibiotic-free medium and added to the well. Under these conditions, the transfected cells looked morphologically normal after 72 h, and they did not differ from untransfected cells in cell viability and levels of the 18S mRNA housekeeping gene (data not shown). Thereafter, hepatocytes were treated with 10 microM rifampicin or 0.1% DMSO (vehicle control) for 48 h. To ensure that functional and specific silencing was obtained, the mRNA levels of PXR and known PXR target genes (CYP3A4, CYP2B6, Pgp and UGT1A1) were compared between PXR-siRNA and SCR (scrambled) siRNA groups before and after treatments in all experiments.
###end p 19
###begin title 20
Reverse-transcription Q-PCR
###end title 20
###begin p 21
###xml 710 711 692 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 711 712 693 694 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 758 761 740 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18S</italic>
Total RNA was isolated using the RNeasy 96 Kit. A two-step reverse transcriptase (RT)-PCR reaction was conducted by reverse transcribing 50 ng of total RNA to cDNA using TaqMan(R) Reverse Transcription Reagents, according to the TaqMan(R) Universal PCR Master Mix protocol. PCR reactions were then prepared by adding an aliquot of cDNA (3 microl) to a reaction mixture containing the TaqMan(R) Fast Universal PXR Master Mix solution, primers (), and probes for the specific gene targets. PCR-amplified cDNAs were detected by real-time fluorescence on an ABI PRISM 7900 Fast Sequence Detection System (Perkin Elmer, Wellesley, MA, USA). Gene expression values were calculated based on the comparative DeltaDeltaCt method and normalized to values obtained for 18S ribosomal RNA.
###end p 21
###begin title 22
Statistical analysis
###end title 22
###begin p 23
###xml 247 248 235 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 358 359 342 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 359 360 343 344 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 386 387 370 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
The differences in PXR-, Pol II-, SRC-1-, SRC-3-, GRIP1-, NCOR-, PGC1alpha-, HNF4alpha-, FKHR-, RIP140-, SMRT- and SHP binding, between hepatocytes treated with 10 microM rifampicin or 0.1% DMSO (vehicle control) were analyzed using the Student's t-test. Statistical analysis of the differences in mRNA gene expression was based upon differences in the DeltaCt values. Differences with P-values <0.05 were considered significant.
###end p 23
###begin title 24
RESULTS
###end title 24
###begin title 25
Identification of new PXR target genes
###end title 25
###begin p 26
###xml 523 525 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 542 564 540 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP3A4, CYP2B6, UGT1A1</italic>
###xml 569 573 567 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1</italic>
###xml 693 701 691 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 793 801 791 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1340 1342 1338 1340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 1744 1753 1742 1751 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1.</label>
###xml 1758 1759 1756 1757 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1772 1773 1770 1771 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2247 2248 2244 2245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 2255 2256 2252 2253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1753 2264 1751 2261 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="27">PXR (<bold>A</bold>) and SRC-1 (<bold>B</bold>) binding to several known PXRE-containing promoters including CYP3A4, CYP2B6, UGT1A1, MDR1 and Untr 5 and 20. Cryopreserved human hepatocytes were treated with vehicle (Control; 0.1% DMSO) or rifampicin (10 &#956;M) for 3 h and processed for ChIP assays as described in Materials and methods section. Studies repeated with different batches of hepatocytes yielded similar results. The error bars represent the SD from the mean of triplicate assays of an individual experiment, <italic>n</italic> = 3, *<italic>P</italic> &lt; 0.05.</p>
###xml 1753 2264 1751 2261 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="27">PXR (<bold>A</bold>) and SRC-1 (<bold>B</bold>) binding to several known PXRE-containing promoters including CYP3A4, CYP2B6, UGT1A1, MDR1 and Untr 5 and 20. Cryopreserved human hepatocytes were treated with vehicle (Control; 0.1% DMSO) or rifampicin (10 &#956;M) for 3 h and processed for ChIP assays as described in Materials and methods section. Studies repeated with different batches of hepatocytes yielded similar results. The error bars represent the SD from the mean of triplicate assays of an individual experiment, <italic>n</italic> = 3, *<italic>P</italic> &lt; 0.05.</p></caption>
###xml 2264 2264 2261 2261 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn1047f1"/>
###xml 1744 2264 1742 2261 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F1" position="float"><label>Figure 1.</label><caption><p textid="27">PXR (<bold>A</bold>) and SRC-1 (<bold>B</bold>) binding to several known PXRE-containing promoters including CYP3A4, CYP2B6, UGT1A1, MDR1 and Untr 5 and 20. Cryopreserved human hepatocytes were treated with vehicle (Control; 0.1% DMSO) or rifampicin (10 &#956;M) for 3 h and processed for ChIP assays as described in Materials and methods section. Studies repeated with different batches of hepatocytes yielded similar results. The error bars represent the SD from the mean of triplicate assays of an individual experiment, <italic>n</italic> = 3, *<italic>P</italic> &lt; 0.05.</p></caption><graphic xlink:href="gkn1047f1"/></fig>
###xml 107 112 <span type="species:ncbi:9606">human</span>
###xml 1898 1903 <span type="species:ncbi:9606">human</span>
In order to identify new genes containing PXR binding sites, we performed ChIP analyses with cryopreserved human hepatocytes treated with the prototypical inducer rifampicin (10 muM, 3 h). The batches of hepatocytes used in these studies were selected for high inducibility of CYP3A4 mRNA (45- to 75-fold relative to vehicle control) after treatment with rifampicin (10 muM) for 48 h (data not shown). To validate the polyclonal anti-PXR antibody used for ChIP, the ability to detect known PXR target genes was determined (21): Enrichment of CYP3A4, CYP2B6, UGT1A1 and MDR1 PXRE were 3.9-, 4.2-, 2.2- and 1.5-fold higher in rifampicin as opposed to vehicle (control; 0.1% DMSO)-treated cells (Figure 1A). Remarkably, binding of PXR to all PXREs was also detected in the absence of rifampicin (Figure 1A), although binding was significantly lower than that after treatment with rifampicin. Measuring of PXR interaction to two untranscribed regions (Untr) served as negative controls. While ChIPs with a control IgG are often conducted as a negative control, our findings (data not shown) suggested that the values obtained using this approach provided a less reliable baseline than assaying negative control regions (Untr) with the experimental antibody. Also, we have observed that different antibodies have different levels of background (20). Our unpublished data also suggest that antibody titration experiments do not necessarily show the expected concentration-dependent increase and then plateau, but one continues to see some increase (but not linear or proportional with the antibody amount) upon increasing the antibody amount. In our studies, we could not utilize much higher antibody amounts which we believe were already in excess. Figure 1.PXR (A) and SRC-1 (B) binding to several known PXRE-containing promoters including CYP3A4, CYP2B6, UGT1A1, MDR1 and Untr 5 and 20. Cryopreserved human hepatocytes were treated with vehicle (Control; 0.1% DMSO) or rifampicin (10 muM) for 3 h and processed for ChIP assays as described in Materials and methods section. Studies repeated with different batches of hepatocytes yielded similar results. The error bars represent the SD from the mean of triplicate assays of an individual experiment, n = 3, *P < 0.05.
###end p 26
###begin p 27
###xml 5 6 5 6 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 19 20 19 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 494 495 493 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 502 503 501 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 145 150 <span type="species:ncbi:9606">human</span>
PXR (A) and SRC-1 (B) binding to several known PXRE-containing promoters including CYP3A4, CYP2B6, UGT1A1, MDR1 and Untr 5 and 20. Cryopreserved human hepatocytes were treated with vehicle (Control; 0.1% DMSO) or rifampicin (10 muM) for 3 h and processed for ChIP assays as described in Materials and methods section. Studies repeated with different batches of hepatocytes yielded similar results. The error bars represent the SD from the mean of triplicate assays of an individual experiment, n = 3, *P < 0.05.
###end p 27
###begin p 28
###xml 328 336 316 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1317 1323 1291 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP3A4</italic>
###xml 1328 1332 1302 1306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1</italic>
###xml 1465 1474 1439 1448 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2.</label>
###xml 2132 2133 2106 2107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 1474 2135 1448 2109 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="29">Construction of the PXR-binding site library. Outline of the strategy for ChIP-cloning and filtering of sequences. &#8216;Filter&#8217;: short sequences (&lt;40 bp), highly repetitive sequences and those with &lt;90% identity to the genome were eliminated. &#8216;Selection&#8217;: 12 clusters with strong PXR binding (&gt;5-fold binding relative to the negative control region) were selected for further testing. In addition, 29 tags were selected which were in the proximity of genes known to be involved in different metabolic processes including drug metabolism, or recently identified as PXR target genes by gene profiling in studies with the colon carcinoma cell line LS180 (Table 1) (<xref ref-type="bibr" rid="B2">2</xref>).</p>
###xml 1474 2135 1448 2109 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="29">Construction of the PXR-binding site library. Outline of the strategy for ChIP-cloning and filtering of sequences. &#8216;Filter&#8217;: short sequences (&lt;40 bp), highly repetitive sequences and those with &lt;90% identity to the genome were eliminated. &#8216;Selection&#8217;: 12 clusters with strong PXR binding (&gt;5-fold binding relative to the negative control region) were selected for further testing. In addition, 29 tags were selected which were in the proximity of genes known to be involved in different metabolic processes including drug metabolism, or recently identified as PXR target genes by gene profiling in studies with the colon carcinoma cell line LS180 (Table 1) (<xref ref-type="bibr" rid="B2">2</xref>).</p></caption>
###xml 2135 2135 2109 2109 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn1047f2"/>
###xml 1465 2135 1439 2109 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F2" position="float"><label>Figure 2.</label><caption><p textid="29">Construction of the PXR-binding site library. Outline of the strategy for ChIP-cloning and filtering of sequences. &#8216;Filter&#8217;: short sequences (&lt;40 bp), highly repetitive sequences and those with &lt;90% identity to the genome were eliminated. &#8216;Selection&#8217;: 12 clusters with strong PXR binding (&gt;5-fold binding relative to the negative control region) were selected for further testing. In addition, 29 tags were selected which were in the proximity of genes known to be involved in different metabolic processes including drug metabolism, or recently identified as PXR target genes by gene profiling in studies with the colon carcinoma cell line LS180 (Table 1) (<xref ref-type="bibr" rid="B2">2</xref>).</p></caption><graphic xlink:href="gkn1047f2"/></fig>
###xml 72 77 <span type="species:ncbi:9606">human</span>
A discovery approach for the identification of PXR binding sites in the human genome was initiated (see Materials and methods section). After chromatin precipitation with the anti-PXR antibody, approximately7300 tags representing anti-PXR immunoprecipitated DNA, which were derived from rifampicin-treated cells, was sequenced (Figure 2). Approximately 5000 of these sequences produced acceptable genomic alignments from which 32.7% (or about 1/3) did not map within 10 kb of any gene. The number of genes that had at least one tag alignment within 10 kb was 3745 (using the NCBI gene database). Of these 3745 genes, 500 had two or more tag alignments (). For these 500 genes, there were a total of 1244 aligns (within +/-10 kb), of which 877 (70.5%) mapped inside genes, 190 (15.3%) upstream and 177 (14.2%) downstream. Our analysis included all of these tags since PXRE sites may be important wherever they lie within the gene and do not necessarily need to be located in the 5' UTR. Because ChIP fragments were <600 bp, 1200 was set as the maximal distance between two tags representing the same binding site, such that approximately500 tags generated 182 clusters consisting of two or more distinct alignments within 1200 bp). Genes identified as known to contain PXR binding sites in their promoter regions were CYP3A4 and MDR1. As expected, the lack of identification of additional known PXR target genes indicated that the screen had not reached saturation. Figure 2.Construction of the PXR-binding site library. Outline of the strategy for ChIP-cloning and filtering of sequences. 'Filter': short sequences (<40 bp), highly repetitive sequences and those with <90% identity to the genome were eliminated. 'Selection': 12 clusters with strong PXR binding (>5-fold binding relative to the negative control region) were selected for further testing. In addition, 29 tags were selected which were in the proximity of genes known to be involved in different metabolic processes including drug metabolism, or recently identified as PXR target genes by gene profiling in studies with the colon carcinoma cell line LS180 (Table 1) (2).
###end p 28
###begin p 29
###xml 658 659 658 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
Construction of the PXR-binding site library. Outline of the strategy for ChIP-cloning and filtering of sequences. 'Filter': short sequences (<40 bp), highly repetitive sequences and those with <90% identity to the genome were eliminated. 'Selection': 12 clusters with strong PXR binding (>5-fold binding relative to the negative control region) were selected for further testing. In addition, 29 tags were selected which were in the proximity of genes known to be involved in different metabolic processes including drug metabolism, or recently identified as PXR target genes by gene profiling in studies with the colon carcinoma cell line LS180 (Table 1) (2).
###end p 29
###begin p 30
###xml 384 391 372 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 987 994 975 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 997 998 985 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 1136 1143 1124 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 1308 1315 1296 1303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 1320 1328 1308 1316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1421 1430 1409 1418 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3.</label>
###xml 1435 1436 1423 1424 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1449 1450 1437 1438 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1878 1879 1862 1863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1886 1887 1870 1871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1985 1986 1969 1970 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1430 1991 1418 1975 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="31">PXR (<bold>A</bold>) and SRC-1 (<bold>B</bold>) binding to 11 of 23 genes identified as PXRE-containing promoters with a trend towards increased binding in the presence of rifampicin. Cryopreserved human hepatocytes were treated with vehicle (Control; 0.1% DMSO) or rifampicin (10 &#181;M) for 3 h and processed for ChIP assays as described in the Materials and methods section. The error bars represent the SD from the mean of triplicate assays of an individual experiment, <italic>n</italic> = 3, *<italic>P</italic> &lt; 0.05. PXR-binding to CLG and SRC-1-binding to ABCB4 in rifampicin-treated cells are based upon <italic>n</italic> = 2.</p>
###xml 1430 1991 1418 1975 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="31">PXR (<bold>A</bold>) and SRC-1 (<bold>B</bold>) binding to 11 of 23 genes identified as PXRE-containing promoters with a trend towards increased binding in the presence of rifampicin. Cryopreserved human hepatocytes were treated with vehicle (Control; 0.1% DMSO) or rifampicin (10 &#181;M) for 3 h and processed for ChIP assays as described in the Materials and methods section. The error bars represent the SD from the mean of triplicate assays of an individual experiment, <italic>n</italic> = 3, *<italic>P</italic> &lt; 0.05. PXR-binding to CLG and SRC-1-binding to ABCB4 in rifampicin-treated cells are based upon <italic>n</italic> = 2.</p></caption>
###xml 1991 1991 1975 1975 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn1047f3"/>
###xml 1421 1991 1409 1975 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F3" position="float"><label>Figure 3.</label><caption><p textid="31">PXR (<bold>A</bold>) and SRC-1 (<bold>B</bold>) binding to 11 of 23 genes identified as PXRE-containing promoters with a trend towards increased binding in the presence of rifampicin. Cryopreserved human hepatocytes were treated with vehicle (Control; 0.1% DMSO) or rifampicin (10 &#181;M) for 3 h and processed for ChIP assays as described in the Materials and methods section. The error bars represent the SD from the mean of triplicate assays of an individual experiment, <italic>n</italic> = 3, *<italic>P</italic> &lt; 0.05. PXR-binding to CLG and SRC-1-binding to ABCB4 in rifampicin-treated cells are based upon <italic>n</italic> = 2.</p></caption><graphic xlink:href="gkn1047f3"/></fig>
###xml 1991 1999 1975 1983 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1.</label>
###xml 1999 2066 1983 2050 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="32">Tags/Clusters from discovery approach selected for further analysis</p>
###xml 1999 2066 1983 2050 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="32">Tags/Clusters from discovery approach selected for further analysis</p></caption>
###xml 2066 2080 2050 2064 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Genomic region</th>
###xml 2080 2096 2064 2080 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Tag/Cluster name</th>
###xml 2096 2121 2080 2105 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Gene/Proteome description</th>
###xml 2066 2121 2050 2105 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><th rowspan="1" colspan="1">Genomic region</th><th rowspan="1" colspan="1">Tag/Cluster name</th><th rowspan="1" colspan="1">Gene/Proteome description</th></tr>
###xml 2066 2121 2050 2105 <thead xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><th rowspan="1" colspan="1">Genomic region</th><th rowspan="1" colspan="1">Tag/Cluster name</th><th rowspan="1" colspan="1">Gene/Proteome description</th></tr></thead>
###xml 2121 2134 2105 2118 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CYP3A4 (PXRE)</td>
###xml 2134 2154 2118 2138 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Control (literature)</td>
###xml 2154 2154 2138 2138 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2121 2154 2105 2138 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CYP3A4 (PXRE)</td><td rowspan="1" colspan="1">Control (literature)</td><td rowspan="1" colspan="1"/></tr>
###xml 2154 2160 2138 2144 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CYP2B6</td>
###xml 2160 2180 2144 2164 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Control (literature)</td>
###xml 2180 2180 2164 2164 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2154 2180 2138 2164 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CYP2B6</td><td rowspan="1" colspan="1">Control (literature)</td><td rowspan="1" colspan="1"/></tr>
###xml 2180 2186 2164 2170 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">UGT1A1</td>
###xml 2186 2206 2170 2190 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Control (literature)</td>
###xml 2206 2206 2190 2190 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2180 2206 2164 2190 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">UGT1A1</td><td rowspan="1" colspan="1">Control (literature)</td><td rowspan="1" colspan="1"/></tr>
###xml 2206 2210 2190 2194 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">MDR1</td>
###xml 2210 2230 2194 2214 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Control (literature)</td>
###xml 2230 2230 2214 2214 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2206 2230 2190 2214 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">MDR1</td><td rowspan="1" colspan="1">Control (literature)</td><td rowspan="1" colspan="1"/></tr>
###xml 2230 2234 2214 2218 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CARS</td>
###xml 2234 2255 2218 2239 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GP0059_02_B04-frag008</td>
###xml 2255 2653 2239 2637 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Encodes a class 1 aminoacyl-tRNA synthetase, cysteinyl-tRNA synthetase. Each of the 20 aminoacyl-tRNA synthetases catalyzes the aminoacylation of a specific tRNA or tRNA isoaccepting family with the cognate amino acid. Alterations in this region have been associated with the Beckwith&#8211;Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and lung, ovarian and breast cancer.</td>
###xml 2230 2653 2214 2637 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CARS</td><td rowspan="1" colspan="1">GP0059_02_B04-frag008</td><td rowspan="1" colspan="1">Encodes a class 1 aminoacyl-tRNA synthetase, cysteinyl-tRNA synthetase. Each of the 20 aminoacyl-tRNA synthetases catalyzes the aminoacylation of a specific tRNA or tRNA isoaccepting family with the cognate amino acid. Alterations in this region have been associated with the Beckwith&#8211;Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and lung, ovarian and breast cancer.</td></tr>
###xml 2653 2658 2637 2642 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">OSBP2</td>
###xml 2658 2679 2642 2663 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GP0059_06_B06-frag009</td>
###xml 2679 2972 2663 2956 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Oxysterols are byproducts of cholesterol that can have cytotoxic effects on many cell types. The membrane-bound protein encoded by this gene contains a pleckstrin homology domain and an oxysterol-binding region. It binds oxysterols such as 7-ketocholesterol and may inhibit their cytotoxicity.</td>
###xml 2653 2972 2637 2956 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">OSBP2</td><td rowspan="1" colspan="1">GP0059_06_B06-frag009</td><td rowspan="1" colspan="1">Oxysterols are byproducts of cholesterol that can have cytotoxic effects on many cell types. The membrane-bound protein encoded by this gene contains a pleckstrin homology domain and an oxysterol-binding region. It binds oxysterols such as 7-ketocholesterol and may inhibit their cytotoxicity.</td></tr>
###xml 2972 2976 2956 2960 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">PFAS</td>
###xml 2976 2997 2960 2981 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GP0059_03_A11-frag004</td>
###xml 2997 3093 2981 3077 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">The enzyme encoded by this gene catalyzes the fourth step of inosine monophosphate biosynthesis.</td>
###xml 2972 3093 2956 3077 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">PFAS</td><td rowspan="1" colspan="1">GP0059_03_A11-frag004</td><td rowspan="1" colspan="1">The enzyme encoded by this gene catalyzes the fourth step of inosine monophosphate biosynthesis.</td></tr>
###xml 3093 3097 3077 3081 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CD59</td>
###xml 3097 3118 3081 3102 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GP0059_06_C01-frag008</td>
###xml 3118 3782 3102 3766 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This gene encodes a cell surface glycoprotein that regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. This protein also plays a role in signal transduction pathways in the activation of T cells. Mutations in this gene cause CD59 deficiency, a disease resulting in hemolytic anemia and thrombosis, and which causes cerebral infarction.</td>
###xml 3093 3782 3077 3766 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CD59</td><td rowspan="1" colspan="1">GP0059_06_C01-frag008</td><td rowspan="1" colspan="1">This gene encodes a cell surface glycoprotein that regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. This protein also plays a role in signal transduction pathways in the activation of T cells. Mutations in this gene cause CD59 deficiency, a disease resulting in hemolytic anemia and thrombosis, and which causes cerebral infarction.</td></tr>
###xml 3782 3789 3766 3773 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CEACAM6</td>
###xml 3789 3810 3773 3794 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GP0059_05_C06-frag011</td>
###xml 3810 4137 3794 4121 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Carcinoembryonic antigen is one of the most widely used tumor markers in serum immunoassay determinations of carcinoma. An apparent lack of absolute cancer specificity for CEA probably results in part from the presence in normal and neoplastic tissues of antigens that share antigenic determinants with the 180 kDa form of CEA.</td>
###xml 3782 4137 3766 4121 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CEACAM6</td><td rowspan="1" colspan="1">GP0059_05_C06-frag011</td><td rowspan="1" colspan="1">Carcinoembryonic antigen is one of the most widely used tumor markers in serum immunoassay determinations of carcinoma. An apparent lack of absolute cancer specificity for CEA probably results in part from the presence in normal and neoplastic tissues of antigens that share antigenic determinants with the 180 kDa form of CEA.</td></tr>
###xml 4137 4142 4121 4126 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">DOCK1</td>
###xml 4142 4163 4126 4147 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GP0059_08_D04-frag004</td>
###xml 4163 4413 4147 4397 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Dedicator of cytokinesis 1, member of the CDM family, contains an SH3 domain, binds phosphatidylinositol-3,4,5-triphosphate, integrin receptor-mediated complex formation with BCAR1 and CRK leads to RAC1 activation and phagocytosis of apoptotic cells.</td>
###xml 4137 4413 4121 4397 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">DOCK1</td><td rowspan="1" colspan="1">GP0059_08_D04-frag004</td><td rowspan="1" colspan="1">Dedicator of cytokinesis 1, member of the CDM family, contains an SH3 domain, binds phosphatidylinositol-3,4,5-triphosphate, integrin receptor-mediated complex formation with BCAR1 and CRK leads to RAC1 activation and phagocytosis of apoptotic cells.</td></tr>
###xml 4413 4421 4397 4405 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">FLJ10986</td>
###xml 4421 4442 4405 4426 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GP0059_06_D06-frag004</td>
###xml 4442 4442 4426 4426 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 4413 4442 4397 4426 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">FLJ10986</td><td rowspan="1" colspan="1">GP0059_06_D06-frag004</td><td rowspan="1" colspan="1"/></tr>
###xml 4442 4449 4426 4433 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CYP4F12</td>
###xml 4449 4510 4433 4494 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Cluster 19 153 (GP0059_07_F05-frag007; GP0059_06_D09-frag005)</td>
###xml 4510 4723 4494 4707 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Cytochrome P450 family 4 subfamily F polypeptide 12, metabolizes arachidonic acid by omega 3-hydroxylation, metabolizes docosahexanoic acid, docosapentaenoic acid, leukotrienes and the antihistamine drug ebastine.</td>
###xml 4442 4723 4426 4707 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CYP4F12</td><td rowspan="1" colspan="1">Cluster 19 153 (GP0059_07_F05-frag007; GP0059_06_D09-frag005)</td><td rowspan="1" colspan="1">Cytochrome P450 family 4 subfamily F polypeptide 12, metabolizes arachidonic acid by omega 3-hydroxylation, metabolizes docosahexanoic acid, docosapentaenoic acid, leukotrienes and the antihistamine drug ebastine.</td></tr>
###xml 4723 4729 4707 4713 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CYP3A5</td>
###xml 4729 4750 4713 4734 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GP0059_02_H05-frag007</td>
###xml 4750 5306 4734 5290 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. The enzyme metabolizes drugs such as nifedipine and cyclosporine as well as the steroid hormones testosterone, progesterone and androstenedione. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. This cluster includes a pseudogene, CYP3A5P1, which is very similar to CYP3A5. This similarity has caused some difficulty in determining whether cloned sequences represent the gene or the pseudogene.</td>
###xml 4723 5306 4707 5290 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CYP3A5</td><td rowspan="1" colspan="1">GP0059_02_H05-frag007</td><td rowspan="1" colspan="1">This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. The enzyme metabolizes drugs such as nifedipine and cyclosporine as well as the steroid hormones testosterone, progesterone and androstenedione. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. This cluster includes a pseudogene, CYP3A5P1, which is very similar to CYP3A5. This similarity has caused some difficulty in determining whether cloned sequences represent the gene or the pseudogene.</td></tr>
###xml 5306 5321 5290 5305 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CYP3A5P2/CYP3A4</td>
###xml 5321 5381 5305 5365 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Cluster 7 170 (GP0059_04_A01-frag006; GP0059_01_D05-frag007)</td>
###xml 5381 5381 5365 5365 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 5306 5381 5290 5365 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CYP3A5P2/CYP3A4</td><td rowspan="1" colspan="1">Cluster 7 170 (GP0059_04_A01-frag006; GP0059_01_D05-frag007)</td><td rowspan="1" colspan="1"/></tr>
###xml 5381 5386 5365 5370 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">ABCC4</td>
###xml 5386 5407 5370 5391 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GP0059_10_C11-frag004</td>
###xml 5407 5781 5391 5765 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. This protein is a member of the MRP subfamily which is involved in multi-drug resistance. The specific function of this protein has not yet been determined; however, this protein may play a role in cellular detoxification as a pump for its substrate, organic anions.</td>
###xml 5381 5781 5365 5765 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">ABCC4</td><td rowspan="1" colspan="1">GP0059_10_C11-frag004</td><td rowspan="1" colspan="1">The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. This protein is a member of the MRP subfamily which is involved in multi-drug resistance. The specific function of this protein has not yet been determined; however, this protein may play a role in cellular detoxification as a pump for its substrate, organic anions.</td></tr>
###xml 5781 5788 5765 5772 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">SULT1B1</td>
###xml 5788 5809 5772 5793 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GP0059_01_B02-frag007</td>
###xml 5809 6113 5793 6097 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Sulfotransferase enzymes catalyze the sulfate conjugation of many hormones, neurotransmitters, drugs and xenobiotic compounds. These cytosolic enzymes are different in their tissue distributions and substrate specificities. The gene structure (number and length of exons) is similar among family members.</td>
###xml 5781 6113 5765 6097 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">SULT1B1</td><td rowspan="1" colspan="1">GP0059_01_B02-frag007</td><td rowspan="1" colspan="1">Sulfotransferase enzymes catalyze the sulfate conjugation of many hormones, neurotransmitters, drugs and xenobiotic compounds. These cytosolic enzymes are different in their tissue distributions and substrate specificities. The gene structure (number and length of exons) is similar among family members.</td></tr>
###xml 6113 6120 6097 6104 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">SLC40A1</td>
###xml 6120 6180 6104 6164 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Cluster 2 215 (GP0059_10_F11-frag006; GP0059_01_C04-frag005)</td>
###xml 6180 6434 6164 6418 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Solute carrier family 40 (iron-regulated transporter) member 1, an iron transporter involved in iron homeostasis and regulation of translation initiation, possibly involved in development; gene mutations are a cause of autosomal dominant hemochromatosis.</td>
###xml 6113 6434 6097 6418 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">SLC40A1</td><td rowspan="1" colspan="1">Cluster 2 215 (GP0059_10_F11-frag006; GP0059_01_C04-frag005)</td><td rowspan="1" colspan="1">Solute carrier family 40 (iron-regulated transporter) member 1, an iron transporter involved in iron homeostasis and regulation of translation initiation, possibly involved in development; gene mutations are a cause of autosomal dominant hemochromatosis.</td></tr>
###xml 6434 6439 6418 6423 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">KCNK5</td>
###xml 6439 6499 6423 6483 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Cluster 6 129 (GP0059_03_F09-frag006; GP0059_10_A04-frag005)</td>
###xml 6612 6613 6596 6597 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 6499 6695 6483 6679 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Potassium channel subfamily K member 5, mediates a pH and acid sensitive, noninactivating, outwardly rectifying K<sup>+</sup> conductance, involved in potassium ion transport, inhibited by amide anesthetics.</td>
###xml 6434 6695 6418 6679 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">KCNK5</td><td rowspan="1" colspan="1">Cluster 6 129 (GP0059_03_F09-frag006; GP0059_10_A04-frag005)</td><td rowspan="1" colspan="1">Potassium channel subfamily K member 5, mediates a pH and acid sensitive, noninactivating, outwardly rectifying K<sup>+</sup> conductance, involved in potassium ion transport, inhibited by amide anesthetics.</td></tr>
###xml 6695 6701 6679 6685 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">UGT1A5</td>
###xml 6701 6722 6685 6706 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GP0059_07_C01-frag002</td>
###xml 6722 6938 6706 6922 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones and drugs, into water-soluble, excretable metabolites.</td>
###xml 6695 6938 6679 6922 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">UGT1A5</td><td rowspan="1" colspan="1">GP0059_07_C01-frag002</td><td rowspan="1" colspan="1">Encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones and drugs, into water-soluble, excretable metabolites.</td></tr>
###xml 6938 6944 6922 6928 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">AKR1C1</td>
###xml 6944 6965 6928 6949 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GP0059_01_B10-frag003</td>
###xml 6965 7140 6949 7124 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Aldo-keto reductase family 1 member C1 acts in xenobiotic and progesterone metabolism, increased expression is observed in lung cancer, glaucoma and polycystic ovary syndrome.</td>
###xml 6938 7140 6922 7124 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">AKR1C1</td><td rowspan="1" colspan="1">GP0059_01_B10-frag003</td><td rowspan="1" colspan="1">Aldo-keto reductase family 1 member C1 acts in xenobiotic and progesterone metabolism, increased expression is observed in lung cancer, glaucoma and polycystic ovary syndrome.</td></tr>
###xml 7140 7146 7124 7130 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">AKR1C2</td>
###xml 7146 7167 7130 7151 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GP0059_02_C12-frag007</td>
###xml 7167 7418 7151 7402 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Aldo-keto reductase family 1 member C2 (dihydrodiol dehydrogenase), functions in bile transport, steroid metabolism and xenobiotic metabolism, expression is decreased in prostate and breast cancer but upregulated in esophageal squamous cell carcinoma.</td>
###xml 7140 7418 7124 7402 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">AKR1C2</td><td rowspan="1" colspan="1">GP0059_02_C12-frag007</td><td rowspan="1" colspan="1">Aldo-keto reductase family 1 member C2 (dihydrodiol dehydrogenase), functions in bile transport, steroid metabolism and xenobiotic metabolism, expression is decreased in prostate and breast cancer but upregulated in esophageal squamous cell carcinoma.</td></tr>
###xml 7418 7431 7402 7415 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CYP2C8 (gene)</td>
###xml 7431 7452 7415 7436 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GP0059_03_D11-frag004</td>
###xml 7452 7670 7436 7654 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Cytochrome P450 family 2 subfamily C polypeptide 8, a member of heme-binding mono-oxygenase superfamily, metabolizes steroids, fatty acids and xenobiotics, altered expression may contribute to colon cancer development.</td>
###xml 7418 7670 7402 7654 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CYP2C8 (gene)</td><td rowspan="1" colspan="1">GP0059_03_D11-frag004</td><td rowspan="1" colspan="1">Cytochrome P450 family 2 subfamily C polypeptide 8, a member of heme-binding mono-oxygenase superfamily, metabolizes steroids, fatty acids and xenobiotics, altered expression may contribute to colon cancer development.</td></tr>
###xml 7670 7689 7654 7673 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CYP2C8 (downstream)</td>
###xml 7689 7710 7673 7694 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GP0059_05_C04-frag010</td>
###xml 7710 7710 7694 7694 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 7670 7710 7654 7694 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CYP2C8 (downstream)</td><td rowspan="1" colspan="1">GP0059_05_C04-frag010</td><td rowspan="1" colspan="1"/></tr>
###xml 7710 7716 7694 7700 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">PAPSS2</td>
###xml 7716 7737 7700 7721 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GP0059_01_A08-frag002</td>
###xml 7737 7958 7721 7942 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">3&#8242;-phosphoadenosine 5&#8242;-phosphosulfate synthase 2, involved in skeletal development; mutation in the corresponding gene correlates with spondyloepimetaphyseal dysplasia, mouse Papss2 gene is associated with brachymorphism.</td>
###xml 7710 7958 7694 7942 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">PAPSS2</td><td rowspan="1" colspan="1">GP0059_01_A08-frag002</td><td rowspan="1" colspan="1">3&#8242;-phosphoadenosine 5&#8242;-phosphosulfate synthase 2, involved in skeletal development; mutation in the corresponding gene correlates with spondyloepimetaphyseal dysplasia, mouse Papss2 gene is associated with brachymorphism.</td></tr>
###xml 7958 7964 7942 7948 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">HDAC7A</td>
###xml 7964 7985 7948 7969 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GP0059_06_H02-frag002</td>
###xml 7985 8325 7969 8309 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Histone acetylation/deacetylation alters chromosome structure and affects transcription factor access to DNA. The protein encoded by this gene has sequence homology to members of the histone deacetylase family. This gene is orthologous to mouse HDAC7 gene whose protein promotes repression mediated via the transcriptional corepressor SMRT.</td>
###xml 7958 8325 7942 8309 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">HDAC7A</td><td rowspan="1" colspan="1">GP0059_06_H02-frag002</td><td rowspan="1" colspan="1">Histone acetylation/deacetylation alters chromosome structure and affects transcription factor access to DNA. The protein encoded by this gene has sequence homology to members of the histone deacetylase family. This gene is orthologous to mouse HDAC7 gene whose protein promotes repression mediated via the transcriptional corepressor SMRT.</td></tr>
###xml 8325 8330 8309 8314 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">TEAD2</td>
###xml 8330 8351 8314 8335 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GP0059_01_B06-frag007</td>
###xml 8351 8554 8335 8538 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">TEA domain family member 2, a member of the TEA DNA-binding domain family of transcription factors, regulates transcription, may be involved in organ morphogenesis and central nervous system development.</td>
###xml 8325 8554 8309 8538 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">TEAD2</td><td rowspan="1" colspan="1">GP0059_01_B06-frag007</td><td rowspan="1" colspan="1">TEA domain family member 2, a member of the TEA DNA-binding domain family of transcription factors, regulates transcription, may be involved in organ morphogenesis and central nervous system development.</td></tr>
###xml 8554 8562 8538 8546 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">HIST1H1E</td>
###xml 8562 8583 8546 8567 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GP0059_06_E12-frag008</td>
###xml 8583 8967 8567 8951 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">The linker histone, H1, interacts with linker DNA between nucleosomes and functions in the compaction of chromatin into higher order structures. This gene is intronless and encodes a member of the histone H1 family. Transcripts from this gene lack polyA tails but instead contain a palindromic termination element. This gene is found in the large histone gene cluster on chromosome 6.</td>
###xml 8554 8967 8538 8951 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">HIST1H1E</td><td rowspan="1" colspan="1">GP0059_06_E12-frag008</td><td rowspan="1" colspan="1">The linker histone, H1, interacts with linker DNA between nucleosomes and functions in the compaction of chromatin into higher order structures. This gene is intronless and encodes a member of the histone H1 family. Transcripts from this gene lack polyA tails but instead contain a palindromic termination element. This gene is found in the large histone gene cluster on chromosome 6.</td></tr>
###xml 8967 8971 8951 8955 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">BMP1</td>
###xml 8971 8992 8955 8976 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GP0059_06_G08-frag002</td>
###xml 9061 9068 9045 9052 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 8992 9240 8976 9221 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Encodes a protein that is capable of inducing formation of cartilage <italic>in vivo</italic>. Although other bone morphogenetic proteins are members of the TGF-&#946; superfamily, this gene encodes a protein that is not closely related to other known growth factors.</td>
###xml 8967 9240 8951 9221 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">BMP1</td><td rowspan="1" colspan="1">GP0059_06_G08-frag002</td><td rowspan="1" colspan="1">Encodes a protein that is capable of inducing formation of cartilage <italic>in vivo</italic>. Although other bone morphogenetic proteins are members of the TGF-&#946; superfamily, this gene encodes a protein that is not closely related to other known growth factors.</td></tr>
###xml 9240 9244 9221 9225 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CFL1</td>
###xml 9244 9266 9225 9247 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GP0059_09_F09-frag0005</td>
###xml 9266 9451 9247 9432 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Cofilin 1 (non-muscle), plays a role in actin filament depolymerization and lymphocyte chemotaxis, involved in the G protein-coupled receptor protein and Rho protein signaling pathways.</td>
###xml 9240 9451 9221 9432 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CFL1</td><td rowspan="1" colspan="1">GP0059_09_F09-frag0005</td><td rowspan="1" colspan="1">Cofilin 1 (non-muscle), plays a role in actin filament depolymerization and lymphocyte chemotaxis, involved in the G protein-coupled receptor protein and Rho protein signaling pathways.</td></tr>
###xml 9451 9455 9432 9436 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">EIF5</td>
###xml 9455 9476 9436 9457 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GP0059_05_G08-frag003</td>
###xml 9476 9476 9457 9457 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 9451 9476 9432 9457 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">EIF5</td><td rowspan="1" colspan="1">GP0059_05_G08-frag003</td><td rowspan="1" colspan="1"/></tr>
###xml 9476 9481 9457 9462 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">TGIF2</td>
###xml 9481 9502 9462 9483 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GP0059_03_G06-frag003</td>
###xml 9502 9818 9483 9796 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This gene is a DNA-binding homeobox protein and a transcriptional repressor. The encoded protein appears to repress transcription by recruiting histone deacetylases to TGF-&#946;-responsive genes. This gene is amplified and overexpressed in some ovarian cancers, and mutations in this gene can cause holoprosencephaly.</td>
###xml 9476 9818 9457 9796 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">TGIF2</td><td rowspan="1" colspan="1">GP0059_03_G06-frag003</td><td rowspan="1" colspan="1">This gene is a DNA-binding homeobox protein and a transcriptional repressor. The encoded protein appears to repress transcription by recruiting histone deacetylases to TGF-&#946;-responsive genes. This gene is amplified and overexpressed in some ovarian cancers, and mutations in this gene can cause holoprosencephaly.</td></tr>
###xml 9818 9822 9796 9800 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">BBC3</td>
###xml 9822 9835 9800 9813 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Cluster 19-76</td>
###xml 9835 10077 9813 10055 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Bcl-2 binding component 3, regulates p53 (TP53)-dependent and independent apoptosis, increased expression of BBC3 plays a role in chronic lymphocytic leukemia and lung neoplasms and is used in the treatment of glioma and colorectal neoplasms.</td>
###xml 9818 10077 9796 10055 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">BBC3</td><td rowspan="1" colspan="1">Cluster 19-76</td><td rowspan="1" colspan="1">Bcl-2 binding component 3, regulates p53 (TP53)-dependent and independent apoptosis, increased expression of BBC3 plays a role in chronic lymphocytic leukemia and lung neoplasms and is used in the treatment of glioma and colorectal neoplasms.</td></tr>
###xml 10077 10080 10055 10058 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CLG</td>
###xml 10080 10094 10058 10072 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Cluster 19-185</td>
###xml 10094 10094 10072 10072 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 10077 10094 10055 10072 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CLG</td><td rowspan="1" colspan="1">Cluster 19-185</td><td rowspan="1" colspan="1"/></tr>
###xml 10094 10098 10072 10076 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GLDC</td>
###xml 10098 10111 10076 10089 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Cluster 9-228</td>
###xml 10111 10321 10089 10299 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Glycine decarboxylase (glycine dehydrogenase, P-protein), part of the glycine cleavage system that catalyzes the decarboxylation of glycine; mutation of the corresponding gene causes nonketotic hyperglycinemia.</td>
###xml 10094 10321 10072 10299 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">GLDC</td><td rowspan="1" colspan="1">Cluster 9-228</td><td rowspan="1" colspan="1">Glycine decarboxylase (glycine dehydrogenase, P-protein), part of the glycine cleavage system that catalyzes the decarboxylation of glycine; mutation of the corresponding gene causes nonketotic hyperglycinemia.</td></tr>
###xml 10321 10326 10299 10304 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">ABCB4</td>
###xml 10326 10347 10304 10325 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GP0059_06_D02-frag005</td>
###xml 10347 10784 10325 10762 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance as well as antigen presentation. This gene encodes a full transporter and member of the P-glycoprotein family of membrane proteins with phosphatidylcholine as its substrate. The function of this protein has not yet been determined; however, it may involve transport of phospholipids from liver hepatocytes into bile.</td>
###xml 10321 10784 10299 10762 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">ABCB4</td><td rowspan="1" colspan="1">GP0059_06_D02-frag005</td><td rowspan="1" colspan="1">This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance as well as antigen presentation. This gene encodes a full transporter and member of the P-glycoprotein family of membrane proteins with phosphatidylcholine as its substrate. The function of this protein has not yet been determined; however, it may involve transport of phospholipids from liver hepatocytes into bile.</td></tr>
###xml 10784 10790 10762 10768 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CENTD2</td>
###xml 10790 10804 10768 10782 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Cluster 11-186</td>
###xml 10804 11022 10782 11000 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Centaurin delta 2, functions as a GTPase activating protein (GAP) for both Arf and Rho family proteins, mediates PIP3 phosphoinositide-dependent Golgi apparatus membrane changes, filopodia formation and cell spreading.</td>
###xml 10784 11022 10762 11000 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CENTD2</td><td rowspan="1" colspan="1">Cluster 11-186</td><td rowspan="1" colspan="1">Centaurin delta 2, functions as a GTPase activating protein (GAP) for both Arf and Rho family proteins, mediates PIP3 phosphoinositide-dependent Golgi apparatus membrane changes, filopodia formation and cell spreading.</td></tr>
###xml 11022 11028 11000 11006 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">ZNF281</td>
###xml 11028 11040 11006 11018 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Cluster 1-52</td>
###xml 11040 11160 11018 11138 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Zinc finger protein 281, a transcriptional repressor, member of the ZBP family, contains four Kruppel-type zinc fingers.</td>
###xml 11022 11160 11000 11138 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">ZNF281</td><td rowspan="1" colspan="1">Cluster 1-52</td><td rowspan="1" colspan="1">Zinc finger protein 281, a transcriptional repressor, member of the ZBP family, contains four Kruppel-type zinc fingers.</td></tr>
###xml 11160 11165 11138 11143 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">BCL9L</td>
###xml 11165 11179 11143 11157 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Cluster 11-267</td>
###xml 11179 11434 11157 11409 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">B-cell CLL/lymphoma 9-like, a BCL9-related protein that acts as a transcriptional regulator, induces &#946;-catenin (CTNNB1) nuclear translocation epithelial to mesenchymal transition, enhances cell migration, expression is upregulated in colorectal tumors.</td>
###xml 11160 11434 11138 11409 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">BCL9L</td><td rowspan="1" colspan="1">Cluster 11-267</td><td rowspan="1" colspan="1">B-cell CLL/lymphoma 9-like, a BCL9-related protein that acts as a transcriptional regulator, induces &#946;-catenin (CTNNB1) nuclear translocation epithelial to mesenchymal transition, enhances cell migration, expression is upregulated in colorectal tumors.</td></tr>
###xml 11434 11439 11409 11414 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">ARNT2</td>
###xml 11439 11453 11414 11428 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Cluster 15-179</td>
###xml 11453 11625 11428 11600 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Aryl-hydrocarbon receptor nuclear translocator 2, a protein that heterodimerizes with HIF-1alpha (HIF1A) and is involved in hypoxia-induced erythropoietin (EPO) expression.</td>
###xml 11434 11625 11409 11600 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">ARNT2</td><td rowspan="1" colspan="1">Cluster 15-179</td><td rowspan="1" colspan="1">Aryl-hydrocarbon receptor nuclear translocator 2, a protein that heterodimerizes with HIF-1alpha (HIF1A) and is involved in hypoxia-induced erythropoietin (EPO) expression.</td></tr>
###xml 11625 11629 11600 11604 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">ASS1</td>
###xml 11629 11641 11604 11616 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Cluster 9-86</td>
###xml 11641 12114 11616 12089 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">The protein encoded by this gene catalyzes the penultimate step of the arginine biosynthetic pathway. There are approximately 10&#8211;14 copies of this gene including the pseudogenes scattered across the human genome, among which the one located on chromosome 9 appears to be the only functional gene for argininosuccinate synthetase. Mutations in the chromosome 9 copy of ASS cause citrullinemia. Two transcript variants encoding the same protein have been found for this gene.</td>
###xml 11625 12114 11600 12089 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">ASS1</td><td rowspan="1" colspan="1">Cluster 9-86</td><td rowspan="1" colspan="1">The protein encoded by this gene catalyzes the penultimate step of the arginine biosynthetic pathway. There are approximately 10&#8211;14 copies of this gene including the pseudogenes scattered across the human genome, among which the one located on chromosome 9 appears to be the only functional gene for argininosuccinate synthetase. Mutations in the chromosome 9 copy of ASS cause citrullinemia. Two transcript variants encoding the same protein have been found for this gene.</td></tr>
###xml 12114 12120 12089 12095 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CTNNA1</td>
###xml 12120 12141 12095 12116 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GF0059_10_B02-frag003</td>
###xml 12141 12141 12116 12116 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 12114 12141 12089 12116 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CTNNA1</td><td rowspan="1" colspan="1">GF0059_10_B02-frag003</td><td rowspan="1" colspan="1"/></tr>
###xml 12141 12145 12116 12120 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">ELK1</td>
###xml 12145 12166 12120 12141 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GP0059_02_G12-frag003</td>
###xml 12166 12546 12141 12521 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This gene is a member of the Ets family of transcription factors and of the ternary complex factor (TCF) subfamily. Proteins of the TCF subfamily form a ternary complex by binding to the the serum response factor and the serum reponse element in the promoter of the c-fos proto-oncogene. The protein encoded by this gene is a nuclear target for the ras-raf-MAPK signaling cascade.</td>
###xml 12141 12546 12116 12521 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">ELK1</td><td rowspan="1" colspan="1">GP0059_02_G12-frag003</td><td rowspan="1" colspan="1">This gene is a member of the Ets family of transcription factors and of the ternary complex factor (TCF) subfamily. Proteins of the TCF subfamily form a ternary complex by binding to the the serum response factor and the serum reponse element in the promoter of the c-fos proto-oncogene. The protein encoded by this gene is a nuclear target for the ras-raf-MAPK signaling cascade.</td></tr>
###xml 12546 12550 12521 12525 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">MTL5</td>
###xml 12550 12571 12525 12546 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GP0059_04_G12-frag010</td>
###xml 12571 12988 12546 12963 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Metallothionein proteins are highly conserved low-molecular-weight cysteine-rich proteins that are induced by and bind to heavy metal ions and have no enzymatic activity. They may play a central role in the regulation of cell growth and differentiation and are involved in spermatogenesis. This gene encodes a metallothionein-like protein which has been shown to be expressed differentially in mouse testes and ovary.</td>
###xml 12546 12988 12521 12963 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">MTL5</td><td rowspan="1" colspan="1">GP0059_04_G12-frag010</td><td rowspan="1" colspan="1">Metallothionein proteins are highly conserved low-molecular-weight cysteine-rich proteins that are induced by and bind to heavy metal ions and have no enzymatic activity. They may play a central role in the regulation of cell growth and differentiation and are involved in spermatogenesis. This gene encodes a metallothionein-like protein which has been shown to be expressed differentially in mouse testes and ovary.</td></tr>
###xml 12988 12990 12963 12965 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">WT</td>
###xml 12990 13011 12965 12986 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GP0059_05_B10-frag005</td>
###xml 13011 13011 12986 12986 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 12988 13011 12963 12986 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">WT</td><td rowspan="1" colspan="1">GP0059_05_B10-frag005</td><td rowspan="1" colspan="1"/></tr>
###xml 13011 13016 12986 12991 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">XRCC5</td>
###xml 13016 13037 12991 13012 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GP0059_01_D07-frag005</td>
###xml 13037 13456 13012 13431 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">The protein encoded by this gene is the 80 kDa subunit of the Ku heterodimer protein which is also known as ATP-dependant DNA helicase II or DNA repair protein XRCC5. Ku is the DNA-binding component of the DNA-dependent protein kinase, and it functions together with the DNA ligase IV-XRCC4 complex in the repair of DNA double-strand break by non-homologous end joining and the completion of V(D)J recombination events.</td>
###xml 13011 13456 12986 13431 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">XRCC5</td><td rowspan="1" colspan="1">GP0059_01_D07-frag005</td><td rowspan="1" colspan="1">The protein encoded by this gene is the 80 kDa subunit of the Ku heterodimer protein which is also known as ATP-dependant DNA helicase II or DNA repair protein XRCC5. Ku is the DNA-binding component of the DNA-dependent protein kinase, and it functions together with the DNA ligase IV-XRCC4 complex in the repair of DNA double-strand break by non-homologous end joining and the completion of V(D)J recombination events.</td></tr>
###xml 2121 13456 2105 13431 <tbody xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><td rowspan="1" colspan="1">CYP3A4 (PXRE)</td><td rowspan="1" colspan="1">Control (literature)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">CYP2B6</td><td rowspan="1" colspan="1">Control (literature)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">UGT1A1</td><td rowspan="1" colspan="1">Control (literature)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">MDR1</td><td rowspan="1" colspan="1">Control (literature)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">CARS</td><td rowspan="1" colspan="1">GP0059_02_B04-frag008</td><td rowspan="1" colspan="1">Encodes a class 1 aminoacyl-tRNA synthetase, cysteinyl-tRNA synthetase. Each of the 20 aminoacyl-tRNA synthetases catalyzes the aminoacylation of a specific tRNA or tRNA isoaccepting family with the cognate amino acid. Alterations in this region have been associated with the Beckwith&#8211;Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and lung, ovarian and breast cancer.</td></tr><tr><td rowspan="1" colspan="1">OSBP2</td><td rowspan="1" colspan="1">GP0059_06_B06-frag009</td><td rowspan="1" colspan="1">Oxysterols are byproducts of cholesterol that can have cytotoxic effects on many cell types. The membrane-bound protein encoded by this gene contains a pleckstrin homology domain and an oxysterol-binding region. It binds oxysterols such as 7-ketocholesterol and may inhibit their cytotoxicity.</td></tr><tr><td rowspan="1" colspan="1">PFAS</td><td rowspan="1" colspan="1">GP0059_03_A11-frag004</td><td rowspan="1" colspan="1">The enzyme encoded by this gene catalyzes the fourth step of inosine monophosphate biosynthesis.</td></tr><tr><td rowspan="1" colspan="1">CD59</td><td rowspan="1" colspan="1">GP0059_06_C01-frag008</td><td rowspan="1" colspan="1">This gene encodes a cell surface glycoprotein that regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. This protein also plays a role in signal transduction pathways in the activation of T cells. Mutations in this gene cause CD59 deficiency, a disease resulting in hemolytic anemia and thrombosis, and which causes cerebral infarction.</td></tr><tr><td rowspan="1" colspan="1">CEACAM6</td><td rowspan="1" colspan="1">GP0059_05_C06-frag011</td><td rowspan="1" colspan="1">Carcinoembryonic antigen is one of the most widely used tumor markers in serum immunoassay determinations of carcinoma. An apparent lack of absolute cancer specificity for CEA probably results in part from the presence in normal and neoplastic tissues of antigens that share antigenic determinants with the 180 kDa form of CEA.</td></tr><tr><td rowspan="1" colspan="1">DOCK1</td><td rowspan="1" colspan="1">GP0059_08_D04-frag004</td><td rowspan="1" colspan="1">Dedicator of cytokinesis 1, member of the CDM family, contains an SH3 domain, binds phosphatidylinositol-3,4,5-triphosphate, integrin receptor-mediated complex formation with BCAR1 and CRK leads to RAC1 activation and phagocytosis of apoptotic cells.</td></tr><tr><td rowspan="1" colspan="1">FLJ10986</td><td rowspan="1" colspan="1">GP0059_06_D06-frag004</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">CYP4F12</td><td rowspan="1" colspan="1">Cluster 19 153 (GP0059_07_F05-frag007; GP0059_06_D09-frag005)</td><td rowspan="1" colspan="1">Cytochrome P450 family 4 subfamily F polypeptide 12, metabolizes arachidonic acid by omega 3-hydroxylation, metabolizes docosahexanoic acid, docosapentaenoic acid, leukotrienes and the antihistamine drug ebastine.</td></tr><tr><td rowspan="1" colspan="1">CYP3A5</td><td rowspan="1" colspan="1">GP0059_02_H05-frag007</td><td rowspan="1" colspan="1">This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. The enzyme metabolizes drugs such as nifedipine and cyclosporine as well as the steroid hormones testosterone, progesterone and androstenedione. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. This cluster includes a pseudogene, CYP3A5P1, which is very similar to CYP3A5. This similarity has caused some difficulty in determining whether cloned sequences represent the gene or the pseudogene.</td></tr><tr><td rowspan="1" colspan="1">CYP3A5P2/CYP3A4</td><td rowspan="1" colspan="1">Cluster 7 170 (GP0059_04_A01-frag006; GP0059_01_D05-frag007)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">ABCC4</td><td rowspan="1" colspan="1">GP0059_10_C11-frag004</td><td rowspan="1" colspan="1">The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. This protein is a member of the MRP subfamily which is involved in multi-drug resistance. The specific function of this protein has not yet been determined; however, this protein may play a role in cellular detoxification as a pump for its substrate, organic anions.</td></tr><tr><td rowspan="1" colspan="1">SULT1B1</td><td rowspan="1" colspan="1">GP0059_01_B02-frag007</td><td rowspan="1" colspan="1">Sulfotransferase enzymes catalyze the sulfate conjugation of many hormones, neurotransmitters, drugs and xenobiotic compounds. These cytosolic enzymes are different in their tissue distributions and substrate specificities. The gene structure (number and length of exons) is similar among family members.</td></tr><tr><td rowspan="1" colspan="1">SLC40A1</td><td rowspan="1" colspan="1">Cluster 2 215 (GP0059_10_F11-frag006; GP0059_01_C04-frag005)</td><td rowspan="1" colspan="1">Solute carrier family 40 (iron-regulated transporter) member 1, an iron transporter involved in iron homeostasis and regulation of translation initiation, possibly involved in development; gene mutations are a cause of autosomal dominant hemochromatosis.</td></tr><tr><td rowspan="1" colspan="1">KCNK5</td><td rowspan="1" colspan="1">Cluster 6 129 (GP0059_03_F09-frag006; GP0059_10_A04-frag005)</td><td rowspan="1" colspan="1">Potassium channel subfamily K member 5, mediates a pH and acid sensitive, noninactivating, outwardly rectifying K<sup>+</sup> conductance, involved in potassium ion transport, inhibited by amide anesthetics.</td></tr><tr><td rowspan="1" colspan="1">UGT1A5</td><td rowspan="1" colspan="1">GP0059_07_C01-frag002</td><td rowspan="1" colspan="1">Encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones and drugs, into water-soluble, excretable metabolites.</td></tr><tr><td rowspan="1" colspan="1">AKR1C1</td><td rowspan="1" colspan="1">GP0059_01_B10-frag003</td><td rowspan="1" colspan="1">Aldo-keto reductase family 1 member C1 acts in xenobiotic and progesterone metabolism, increased expression is observed in lung cancer, glaucoma and polycystic ovary syndrome.</td></tr><tr><td rowspan="1" colspan="1">AKR1C2</td><td rowspan="1" colspan="1">GP0059_02_C12-frag007</td><td rowspan="1" colspan="1">Aldo-keto reductase family 1 member C2 (dihydrodiol dehydrogenase), functions in bile transport, steroid metabolism and xenobiotic metabolism, expression is decreased in prostate and breast cancer but upregulated in esophageal squamous cell carcinoma.</td></tr><tr><td rowspan="1" colspan="1">CYP2C8 (gene)</td><td rowspan="1" colspan="1">GP0059_03_D11-frag004</td><td rowspan="1" colspan="1">Cytochrome P450 family 2 subfamily C polypeptide 8, a member of heme-binding mono-oxygenase superfamily, metabolizes steroids, fatty acids and xenobiotics, altered expression may contribute to colon cancer development.</td></tr><tr><td rowspan="1" colspan="1">CYP2C8 (downstream)</td><td rowspan="1" colspan="1">GP0059_05_C04-frag010</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">PAPSS2</td><td rowspan="1" colspan="1">GP0059_01_A08-frag002</td><td rowspan="1" colspan="1">3&#8242;-phosphoadenosine 5&#8242;-phosphosulfate synthase 2, involved in skeletal development; mutation in the corresponding gene correlates with spondyloepimetaphyseal dysplasia, mouse Papss2 gene is associated with brachymorphism.</td></tr><tr><td rowspan="1" colspan="1">HDAC7A</td><td rowspan="1" colspan="1">GP0059_06_H02-frag002</td><td rowspan="1" colspan="1">Histone acetylation/deacetylation alters chromosome structure and affects transcription factor access to DNA. The protein encoded by this gene has sequence homology to members of the histone deacetylase family. This gene is orthologous to mouse HDAC7 gene whose protein promotes repression mediated via the transcriptional corepressor SMRT.</td></tr><tr><td rowspan="1" colspan="1">TEAD2</td><td rowspan="1" colspan="1">GP0059_01_B06-frag007</td><td rowspan="1" colspan="1">TEA domain family member 2, a member of the TEA DNA-binding domain family of transcription factors, regulates transcription, may be involved in organ morphogenesis and central nervous system development.</td></tr><tr><td rowspan="1" colspan="1">HIST1H1E</td><td rowspan="1" colspan="1">GP0059_06_E12-frag008</td><td rowspan="1" colspan="1">The linker histone, H1, interacts with linker DNA between nucleosomes and functions in the compaction of chromatin into higher order structures. This gene is intronless and encodes a member of the histone H1 family. Transcripts from this gene lack polyA tails but instead contain a palindromic termination element. This gene is found in the large histone gene cluster on chromosome 6.</td></tr><tr><td rowspan="1" colspan="1">BMP1</td><td rowspan="1" colspan="1">GP0059_06_G08-frag002</td><td rowspan="1" colspan="1">Encodes a protein that is capable of inducing formation of cartilage <italic>in vivo</italic>. Although other bone morphogenetic proteins are members of the TGF-&#946; superfamily, this gene encodes a protein that is not closely related to other known growth factors.</td></tr><tr><td rowspan="1" colspan="1">CFL1</td><td rowspan="1" colspan="1">GP0059_09_F09-frag0005</td><td rowspan="1" colspan="1">Cofilin 1 (non-muscle), plays a role in actin filament depolymerization and lymphocyte chemotaxis, involved in the G protein-coupled receptor protein and Rho protein signaling pathways.</td></tr><tr><td rowspan="1" colspan="1">EIF5</td><td rowspan="1" colspan="1">GP0059_05_G08-frag003</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">TGIF2</td><td rowspan="1" colspan="1">GP0059_03_G06-frag003</td><td rowspan="1" colspan="1">This gene is a DNA-binding homeobox protein and a transcriptional repressor. The encoded protein appears to repress transcription by recruiting histone deacetylases to TGF-&#946;-responsive genes. This gene is amplified and overexpressed in some ovarian cancers, and mutations in this gene can cause holoprosencephaly.</td></tr><tr><td rowspan="1" colspan="1">BBC3</td><td rowspan="1" colspan="1">Cluster 19-76</td><td rowspan="1" colspan="1">Bcl-2 binding component 3, regulates p53 (TP53)-dependent and independent apoptosis, increased expression of BBC3 plays a role in chronic lymphocytic leukemia and lung neoplasms and is used in the treatment of glioma and colorectal neoplasms.</td></tr><tr><td rowspan="1" colspan="1">CLG</td><td rowspan="1" colspan="1">Cluster 19-185</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">GLDC</td><td rowspan="1" colspan="1">Cluster 9-228</td><td rowspan="1" colspan="1">Glycine decarboxylase (glycine dehydrogenase, P-protein), part of the glycine cleavage system that catalyzes the decarboxylation of glycine; mutation of the corresponding gene causes nonketotic hyperglycinemia.</td></tr><tr><td rowspan="1" colspan="1">ABCB4</td><td rowspan="1" colspan="1">GP0059_06_D02-frag005</td><td rowspan="1" colspan="1">This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance as well as antigen presentation. This gene encodes a full transporter and member of the P-glycoprotein family of membrane proteins with phosphatidylcholine as its substrate. The function of this protein has not yet been determined; however, it may involve transport of phospholipids from liver hepatocytes into bile.</td></tr><tr><td rowspan="1" colspan="1">CENTD2</td><td rowspan="1" colspan="1">Cluster 11-186</td><td rowspan="1" colspan="1">Centaurin delta 2, functions as a GTPase activating protein (GAP) for both Arf and Rho family proteins, mediates PIP3 phosphoinositide-dependent Golgi apparatus membrane changes, filopodia formation and cell spreading.</td></tr><tr><td rowspan="1" colspan="1">ZNF281</td><td rowspan="1" colspan="1">Cluster 1-52</td><td rowspan="1" colspan="1">Zinc finger protein 281, a transcriptional repressor, member of the ZBP family, contains four Kruppel-type zinc fingers.</td></tr><tr><td rowspan="1" colspan="1">BCL9L</td><td rowspan="1" colspan="1">Cluster 11-267</td><td rowspan="1" colspan="1">B-cell CLL/lymphoma 9-like, a BCL9-related protein that acts as a transcriptional regulator, induces &#946;-catenin (CTNNB1) nuclear translocation epithelial to mesenchymal transition, enhances cell migration, expression is upregulated in colorectal tumors.</td></tr><tr><td rowspan="1" colspan="1">ARNT2</td><td rowspan="1" colspan="1">Cluster 15-179</td><td rowspan="1" colspan="1">Aryl-hydrocarbon receptor nuclear translocator 2, a protein that heterodimerizes with HIF-1alpha (HIF1A) and is involved in hypoxia-induced erythropoietin (EPO) expression.</td></tr><tr><td rowspan="1" colspan="1">ASS1</td><td rowspan="1" colspan="1">Cluster 9-86</td><td rowspan="1" colspan="1">The protein encoded by this gene catalyzes the penultimate step of the arginine biosynthetic pathway. There are approximately 10&#8211;14 copies of this gene including the pseudogenes scattered across the human genome, among which the one located on chromosome 9 appears to be the only functional gene for argininosuccinate synthetase. Mutations in the chromosome 9 copy of ASS cause citrullinemia. Two transcript variants encoding the same protein have been found for this gene.</td></tr><tr><td rowspan="1" colspan="1">CTNNA1</td><td rowspan="1" colspan="1">GF0059_10_B02-frag003</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">ELK1</td><td rowspan="1" colspan="1">GP0059_02_G12-frag003</td><td rowspan="1" colspan="1">This gene is a member of the Ets family of transcription factors and of the ternary complex factor (TCF) subfamily. Proteins of the TCF subfamily form a ternary complex by binding to the the serum response factor and the serum reponse element in the promoter of the c-fos proto-oncogene. The protein encoded by this gene is a nuclear target for the ras-raf-MAPK signaling cascade.</td></tr><tr><td rowspan="1" colspan="1">MTL5</td><td rowspan="1" colspan="1">GP0059_04_G12-frag010</td><td rowspan="1" colspan="1">Metallothionein proteins are highly conserved low-molecular-weight cysteine-rich proteins that are induced by and bind to heavy metal ions and have no enzymatic activity. They may play a central role in the regulation of cell growth and differentiation and are involved in spermatogenesis. This gene encodes a metallothionein-like protein which has been shown to be expressed differentially in mouse testes and ovary.</td></tr><tr><td rowspan="1" colspan="1">WT</td><td rowspan="1" colspan="1">GP0059_05_B10-frag005</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">XRCC5</td><td rowspan="1" colspan="1">GP0059_01_D07-frag005</td><td rowspan="1" colspan="1">The protein encoded by this gene is the 80 kDa subunit of the Ku heterodimer protein which is also known as ATP-dependant DNA helicase II or DNA repair protein XRCC5. Ku is the DNA-binding component of the DNA-dependent protein kinase, and it functions together with the DNA ligase IV-XRCC4 complex in the repair of DNA double-strand break by non-homologous end joining and the completion of V(D)J recombination events.</td></tr></tbody>
###xml 2066 13456 2050 13431 <table xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Genomic region</th><th rowspan="1" colspan="1">Tag/Cluster name</th><th rowspan="1" colspan="1">Gene/Proteome description</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">CYP3A4 (PXRE)</td><td rowspan="1" colspan="1">Control (literature)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">CYP2B6</td><td rowspan="1" colspan="1">Control (literature)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">UGT1A1</td><td rowspan="1" colspan="1">Control (literature)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">MDR1</td><td rowspan="1" colspan="1">Control (literature)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">CARS</td><td rowspan="1" colspan="1">GP0059_02_B04-frag008</td><td rowspan="1" colspan="1">Encodes a class 1 aminoacyl-tRNA synthetase, cysteinyl-tRNA synthetase. Each of the 20 aminoacyl-tRNA synthetases catalyzes the aminoacylation of a specific tRNA or tRNA isoaccepting family with the cognate amino acid. Alterations in this region have been associated with the Beckwith&#8211;Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and lung, ovarian and breast cancer.</td></tr><tr><td rowspan="1" colspan="1">OSBP2</td><td rowspan="1" colspan="1">GP0059_06_B06-frag009</td><td rowspan="1" colspan="1">Oxysterols are byproducts of cholesterol that can have cytotoxic effects on many cell types. The membrane-bound protein encoded by this gene contains a pleckstrin homology domain and an oxysterol-binding region. It binds oxysterols such as 7-ketocholesterol and may inhibit their cytotoxicity.</td></tr><tr><td rowspan="1" colspan="1">PFAS</td><td rowspan="1" colspan="1">GP0059_03_A11-frag004</td><td rowspan="1" colspan="1">The enzyme encoded by this gene catalyzes the fourth step of inosine monophosphate biosynthesis.</td></tr><tr><td rowspan="1" colspan="1">CD59</td><td rowspan="1" colspan="1">GP0059_06_C01-frag008</td><td rowspan="1" colspan="1">This gene encodes a cell surface glycoprotein that regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. This protein also plays a role in signal transduction pathways in the activation of T cells. Mutations in this gene cause CD59 deficiency, a disease resulting in hemolytic anemia and thrombosis, and which causes cerebral infarction.</td></tr><tr><td rowspan="1" colspan="1">CEACAM6</td><td rowspan="1" colspan="1">GP0059_05_C06-frag011</td><td rowspan="1" colspan="1">Carcinoembryonic antigen is one of the most widely used tumor markers in serum immunoassay determinations of carcinoma. An apparent lack of absolute cancer specificity for CEA probably results in part from the presence in normal and neoplastic tissues of antigens that share antigenic determinants with the 180 kDa form of CEA.</td></tr><tr><td rowspan="1" colspan="1">DOCK1</td><td rowspan="1" colspan="1">GP0059_08_D04-frag004</td><td rowspan="1" colspan="1">Dedicator of cytokinesis 1, member of the CDM family, contains an SH3 domain, binds phosphatidylinositol-3,4,5-triphosphate, integrin receptor-mediated complex formation with BCAR1 and CRK leads to RAC1 activation and phagocytosis of apoptotic cells.</td></tr><tr><td rowspan="1" colspan="1">FLJ10986</td><td rowspan="1" colspan="1">GP0059_06_D06-frag004</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">CYP4F12</td><td rowspan="1" colspan="1">Cluster 19 153 (GP0059_07_F05-frag007; GP0059_06_D09-frag005)</td><td rowspan="1" colspan="1">Cytochrome P450 family 4 subfamily F polypeptide 12, metabolizes arachidonic acid by omega 3-hydroxylation, metabolizes docosahexanoic acid, docosapentaenoic acid, leukotrienes and the antihistamine drug ebastine.</td></tr><tr><td rowspan="1" colspan="1">CYP3A5</td><td rowspan="1" colspan="1">GP0059_02_H05-frag007</td><td rowspan="1" colspan="1">This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. The enzyme metabolizes drugs such as nifedipine and cyclosporine as well as the steroid hormones testosterone, progesterone and androstenedione. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. This cluster includes a pseudogene, CYP3A5P1, which is very similar to CYP3A5. This similarity has caused some difficulty in determining whether cloned sequences represent the gene or the pseudogene.</td></tr><tr><td rowspan="1" colspan="1">CYP3A5P2/CYP3A4</td><td rowspan="1" colspan="1">Cluster 7 170 (GP0059_04_A01-frag006; GP0059_01_D05-frag007)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">ABCC4</td><td rowspan="1" colspan="1">GP0059_10_C11-frag004</td><td rowspan="1" colspan="1">The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. This protein is a member of the MRP subfamily which is involved in multi-drug resistance. The specific function of this protein has not yet been determined; however, this protein may play a role in cellular detoxification as a pump for its substrate, organic anions.</td></tr><tr><td rowspan="1" colspan="1">SULT1B1</td><td rowspan="1" colspan="1">GP0059_01_B02-frag007</td><td rowspan="1" colspan="1">Sulfotransferase enzymes catalyze the sulfate conjugation of many hormones, neurotransmitters, drugs and xenobiotic compounds. These cytosolic enzymes are different in their tissue distributions and substrate specificities. The gene structure (number and length of exons) is similar among family members.</td></tr><tr><td rowspan="1" colspan="1">SLC40A1</td><td rowspan="1" colspan="1">Cluster 2 215 (GP0059_10_F11-frag006; GP0059_01_C04-frag005)</td><td rowspan="1" colspan="1">Solute carrier family 40 (iron-regulated transporter) member 1, an iron transporter involved in iron homeostasis and regulation of translation initiation, possibly involved in development; gene mutations are a cause of autosomal dominant hemochromatosis.</td></tr><tr><td rowspan="1" colspan="1">KCNK5</td><td rowspan="1" colspan="1">Cluster 6 129 (GP0059_03_F09-frag006; GP0059_10_A04-frag005)</td><td rowspan="1" colspan="1">Potassium channel subfamily K member 5, mediates a pH and acid sensitive, noninactivating, outwardly rectifying K<sup>+</sup> conductance, involved in potassium ion transport, inhibited by amide anesthetics.</td></tr><tr><td rowspan="1" colspan="1">UGT1A5</td><td rowspan="1" colspan="1">GP0059_07_C01-frag002</td><td rowspan="1" colspan="1">Encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones and drugs, into water-soluble, excretable metabolites.</td></tr><tr><td rowspan="1" colspan="1">AKR1C1</td><td rowspan="1" colspan="1">GP0059_01_B10-frag003</td><td rowspan="1" colspan="1">Aldo-keto reductase family 1 member C1 acts in xenobiotic and progesterone metabolism, increased expression is observed in lung cancer, glaucoma and polycystic ovary syndrome.</td></tr><tr><td rowspan="1" colspan="1">AKR1C2</td><td rowspan="1" colspan="1">GP0059_02_C12-frag007</td><td rowspan="1" colspan="1">Aldo-keto reductase family 1 member C2 (dihydrodiol dehydrogenase), functions in bile transport, steroid metabolism and xenobiotic metabolism, expression is decreased in prostate and breast cancer but upregulated in esophageal squamous cell carcinoma.</td></tr><tr><td rowspan="1" colspan="1">CYP2C8 (gene)</td><td rowspan="1" colspan="1">GP0059_03_D11-frag004</td><td rowspan="1" colspan="1">Cytochrome P450 family 2 subfamily C polypeptide 8, a member of heme-binding mono-oxygenase superfamily, metabolizes steroids, fatty acids and xenobiotics, altered expression may contribute to colon cancer development.</td></tr><tr><td rowspan="1" colspan="1">CYP2C8 (downstream)</td><td rowspan="1" colspan="1">GP0059_05_C04-frag010</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">PAPSS2</td><td rowspan="1" colspan="1">GP0059_01_A08-frag002</td><td rowspan="1" colspan="1">3&#8242;-phosphoadenosine 5&#8242;-phosphosulfate synthase 2, involved in skeletal development; mutation in the corresponding gene correlates with spondyloepimetaphyseal dysplasia, mouse Papss2 gene is associated with brachymorphism.</td></tr><tr><td rowspan="1" colspan="1">HDAC7A</td><td rowspan="1" colspan="1">GP0059_06_H02-frag002</td><td rowspan="1" colspan="1">Histone acetylation/deacetylation alters chromosome structure and affects transcription factor access to DNA. The protein encoded by this gene has sequence homology to members of the histone deacetylase family. This gene is orthologous to mouse HDAC7 gene whose protein promotes repression mediated via the transcriptional corepressor SMRT.</td></tr><tr><td rowspan="1" colspan="1">TEAD2</td><td rowspan="1" colspan="1">GP0059_01_B06-frag007</td><td rowspan="1" colspan="1">TEA domain family member 2, a member of the TEA DNA-binding domain family of transcription factors, regulates transcription, may be involved in organ morphogenesis and central nervous system development.</td></tr><tr><td rowspan="1" colspan="1">HIST1H1E</td><td rowspan="1" colspan="1">GP0059_06_E12-frag008</td><td rowspan="1" colspan="1">The linker histone, H1, interacts with linker DNA between nucleosomes and functions in the compaction of chromatin into higher order structures. This gene is intronless and encodes a member of the histone H1 family. Transcripts from this gene lack polyA tails but instead contain a palindromic termination element. This gene is found in the large histone gene cluster on chromosome 6.</td></tr><tr><td rowspan="1" colspan="1">BMP1</td><td rowspan="1" colspan="1">GP0059_06_G08-frag002</td><td rowspan="1" colspan="1">Encodes a protein that is capable of inducing formation of cartilage <italic>in vivo</italic>. Although other bone morphogenetic proteins are members of the TGF-&#946; superfamily, this gene encodes a protein that is not closely related to other known growth factors.</td></tr><tr><td rowspan="1" colspan="1">CFL1</td><td rowspan="1" colspan="1">GP0059_09_F09-frag0005</td><td rowspan="1" colspan="1">Cofilin 1 (non-muscle), plays a role in actin filament depolymerization and lymphocyte chemotaxis, involved in the G protein-coupled receptor protein and Rho protein signaling pathways.</td></tr><tr><td rowspan="1" colspan="1">EIF5</td><td rowspan="1" colspan="1">GP0059_05_G08-frag003</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">TGIF2</td><td rowspan="1" colspan="1">GP0059_03_G06-frag003</td><td rowspan="1" colspan="1">This gene is a DNA-binding homeobox protein and a transcriptional repressor. The encoded protein appears to repress transcription by recruiting histone deacetylases to TGF-&#946;-responsive genes. This gene is amplified and overexpressed in some ovarian cancers, and mutations in this gene can cause holoprosencephaly.</td></tr><tr><td rowspan="1" colspan="1">BBC3</td><td rowspan="1" colspan="1">Cluster 19-76</td><td rowspan="1" colspan="1">Bcl-2 binding component 3, regulates p53 (TP53)-dependent and independent apoptosis, increased expression of BBC3 plays a role in chronic lymphocytic leukemia and lung neoplasms and is used in the treatment of glioma and colorectal neoplasms.</td></tr><tr><td rowspan="1" colspan="1">CLG</td><td rowspan="1" colspan="1">Cluster 19-185</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">GLDC</td><td rowspan="1" colspan="1">Cluster 9-228</td><td rowspan="1" colspan="1">Glycine decarboxylase (glycine dehydrogenase, P-protein), part of the glycine cleavage system that catalyzes the decarboxylation of glycine; mutation of the corresponding gene causes nonketotic hyperglycinemia.</td></tr><tr><td rowspan="1" colspan="1">ABCB4</td><td rowspan="1" colspan="1">GP0059_06_D02-frag005</td><td rowspan="1" colspan="1">This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance as well as antigen presentation. This gene encodes a full transporter and member of the P-glycoprotein family of membrane proteins with phosphatidylcholine as its substrate. The function of this protein has not yet been determined; however, it may involve transport of phospholipids from liver hepatocytes into bile.</td></tr><tr><td rowspan="1" colspan="1">CENTD2</td><td rowspan="1" colspan="1">Cluster 11-186</td><td rowspan="1" colspan="1">Centaurin delta 2, functions as a GTPase activating protein (GAP) for both Arf and Rho family proteins, mediates PIP3 phosphoinositide-dependent Golgi apparatus membrane changes, filopodia formation and cell spreading.</td></tr><tr><td rowspan="1" colspan="1">ZNF281</td><td rowspan="1" colspan="1">Cluster 1-52</td><td rowspan="1" colspan="1">Zinc finger protein 281, a transcriptional repressor, member of the ZBP family, contains four Kruppel-type zinc fingers.</td></tr><tr><td rowspan="1" colspan="1">BCL9L</td><td rowspan="1" colspan="1">Cluster 11-267</td><td rowspan="1" colspan="1">B-cell CLL/lymphoma 9-like, a BCL9-related protein that acts as a transcriptional regulator, induces &#946;-catenin (CTNNB1) nuclear translocation epithelial to mesenchymal transition, enhances cell migration, expression is upregulated in colorectal tumors.</td></tr><tr><td rowspan="1" colspan="1">ARNT2</td><td rowspan="1" colspan="1">Cluster 15-179</td><td rowspan="1" colspan="1">Aryl-hydrocarbon receptor nuclear translocator 2, a protein that heterodimerizes with HIF-1alpha (HIF1A) and is involved in hypoxia-induced erythropoietin (EPO) expression.</td></tr><tr><td rowspan="1" colspan="1">ASS1</td><td rowspan="1" colspan="1">Cluster 9-86</td><td rowspan="1" colspan="1">The protein encoded by this gene catalyzes the penultimate step of the arginine biosynthetic pathway. There are approximately 10&#8211;14 copies of this gene including the pseudogenes scattered across the human genome, among which the one located on chromosome 9 appears to be the only functional gene for argininosuccinate synthetase. Mutations in the chromosome 9 copy of ASS cause citrullinemia. Two transcript variants encoding the same protein have been found for this gene.</td></tr><tr><td rowspan="1" colspan="1">CTNNA1</td><td rowspan="1" colspan="1">GF0059_10_B02-frag003</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">ELK1</td><td rowspan="1" colspan="1">GP0059_02_G12-frag003</td><td rowspan="1" colspan="1">This gene is a member of the Ets family of transcription factors and of the ternary complex factor (TCF) subfamily. Proteins of the TCF subfamily form a ternary complex by binding to the the serum response factor and the serum reponse element in the promoter of the c-fos proto-oncogene. The protein encoded by this gene is a nuclear target for the ras-raf-MAPK signaling cascade.</td></tr><tr><td rowspan="1" colspan="1">MTL5</td><td rowspan="1" colspan="1">GP0059_04_G12-frag010</td><td rowspan="1" colspan="1">Metallothionein proteins are highly conserved low-molecular-weight cysteine-rich proteins that are induced by and bind to heavy metal ions and have no enzymatic activity. They may play a central role in the regulation of cell growth and differentiation and are involved in spermatogenesis. This gene encodes a metallothionein-like protein which has been shown to be expressed differentially in mouse testes and ovary.</td></tr><tr><td rowspan="1" colspan="1">WT</td><td rowspan="1" colspan="1">GP0059_05_B10-frag005</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">XRCC5</td><td rowspan="1" colspan="1">GP0059_01_D07-frag005</td><td rowspan="1" colspan="1">The protein encoded by this gene is the 80 kDa subunit of the Ku heterodimer protein which is also known as ATP-dependant DNA helicase II or DNA repair protein XRCC5. Ku is the DNA-binding component of the DNA-dependent protein kinase, and it functions together with the DNA ligase IV-XRCC4 complex in the repair of DNA double-strand break by non-homologous end joining and the completion of V(D)J recombination events.</td></tr></tbody></table>
###xml 1991 13456 1975 13431 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T1" position="float"><label>Table 1.</label><caption><p textid="32">Tags/Clusters from discovery approach selected for further analysis</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Genomic region</th><th rowspan="1" colspan="1">Tag/Cluster name</th><th rowspan="1" colspan="1">Gene/Proteome description</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">CYP3A4 (PXRE)</td><td rowspan="1" colspan="1">Control (literature)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">CYP2B6</td><td rowspan="1" colspan="1">Control (literature)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">UGT1A1</td><td rowspan="1" colspan="1">Control (literature)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">MDR1</td><td rowspan="1" colspan="1">Control (literature)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">CARS</td><td rowspan="1" colspan="1">GP0059_02_B04-frag008</td><td rowspan="1" colspan="1">Encodes a class 1 aminoacyl-tRNA synthetase, cysteinyl-tRNA synthetase. Each of the 20 aminoacyl-tRNA synthetases catalyzes the aminoacylation of a specific tRNA or tRNA isoaccepting family with the cognate amino acid. Alterations in this region have been associated with the Beckwith&#8211;Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and lung, ovarian and breast cancer.</td></tr><tr><td rowspan="1" colspan="1">OSBP2</td><td rowspan="1" colspan="1">GP0059_06_B06-frag009</td><td rowspan="1" colspan="1">Oxysterols are byproducts of cholesterol that can have cytotoxic effects on many cell types. The membrane-bound protein encoded by this gene contains a pleckstrin homology domain and an oxysterol-binding region. It binds oxysterols such as 7-ketocholesterol and may inhibit their cytotoxicity.</td></tr><tr><td rowspan="1" colspan="1">PFAS</td><td rowspan="1" colspan="1">GP0059_03_A11-frag004</td><td rowspan="1" colspan="1">The enzyme encoded by this gene catalyzes the fourth step of inosine monophosphate biosynthesis.</td></tr><tr><td rowspan="1" colspan="1">CD59</td><td rowspan="1" colspan="1">GP0059_06_C01-frag008</td><td rowspan="1" colspan="1">This gene encodes a cell surface glycoprotein that regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. This protein also plays a role in signal transduction pathways in the activation of T cells. Mutations in this gene cause CD59 deficiency, a disease resulting in hemolytic anemia and thrombosis, and which causes cerebral infarction.</td></tr><tr><td rowspan="1" colspan="1">CEACAM6</td><td rowspan="1" colspan="1">GP0059_05_C06-frag011</td><td rowspan="1" colspan="1">Carcinoembryonic antigen is one of the most widely used tumor markers in serum immunoassay determinations of carcinoma. An apparent lack of absolute cancer specificity for CEA probably results in part from the presence in normal and neoplastic tissues of antigens that share antigenic determinants with the 180 kDa form of CEA.</td></tr><tr><td rowspan="1" colspan="1">DOCK1</td><td rowspan="1" colspan="1">GP0059_08_D04-frag004</td><td rowspan="1" colspan="1">Dedicator of cytokinesis 1, member of the CDM family, contains an SH3 domain, binds phosphatidylinositol-3,4,5-triphosphate, integrin receptor-mediated complex formation with BCAR1 and CRK leads to RAC1 activation and phagocytosis of apoptotic cells.</td></tr><tr><td rowspan="1" colspan="1">FLJ10986</td><td rowspan="1" colspan="1">GP0059_06_D06-frag004</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">CYP4F12</td><td rowspan="1" colspan="1">Cluster 19 153 (GP0059_07_F05-frag007; GP0059_06_D09-frag005)</td><td rowspan="1" colspan="1">Cytochrome P450 family 4 subfamily F polypeptide 12, metabolizes arachidonic acid by omega 3-hydroxylation, metabolizes docosahexanoic acid, docosapentaenoic acid, leukotrienes and the antihistamine drug ebastine.</td></tr><tr><td rowspan="1" colspan="1">CYP3A5</td><td rowspan="1" colspan="1">GP0059_02_H05-frag007</td><td rowspan="1" colspan="1">This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. The enzyme metabolizes drugs such as nifedipine and cyclosporine as well as the steroid hormones testosterone, progesterone and androstenedione. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. This cluster includes a pseudogene, CYP3A5P1, which is very similar to CYP3A5. This similarity has caused some difficulty in determining whether cloned sequences represent the gene or the pseudogene.</td></tr><tr><td rowspan="1" colspan="1">CYP3A5P2/CYP3A4</td><td rowspan="1" colspan="1">Cluster 7 170 (GP0059_04_A01-frag006; GP0059_01_D05-frag007)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">ABCC4</td><td rowspan="1" colspan="1">GP0059_10_C11-frag004</td><td rowspan="1" colspan="1">The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. This protein is a member of the MRP subfamily which is involved in multi-drug resistance. The specific function of this protein has not yet been determined; however, this protein may play a role in cellular detoxification as a pump for its substrate, organic anions.</td></tr><tr><td rowspan="1" colspan="1">SULT1B1</td><td rowspan="1" colspan="1">GP0059_01_B02-frag007</td><td rowspan="1" colspan="1">Sulfotransferase enzymes catalyze the sulfate conjugation of many hormones, neurotransmitters, drugs and xenobiotic compounds. These cytosolic enzymes are different in their tissue distributions and substrate specificities. The gene structure (number and length of exons) is similar among family members.</td></tr><tr><td rowspan="1" colspan="1">SLC40A1</td><td rowspan="1" colspan="1">Cluster 2 215 (GP0059_10_F11-frag006; GP0059_01_C04-frag005)</td><td rowspan="1" colspan="1">Solute carrier family 40 (iron-regulated transporter) member 1, an iron transporter involved in iron homeostasis and regulation of translation initiation, possibly involved in development; gene mutations are a cause of autosomal dominant hemochromatosis.</td></tr><tr><td rowspan="1" colspan="1">KCNK5</td><td rowspan="1" colspan="1">Cluster 6 129 (GP0059_03_F09-frag006; GP0059_10_A04-frag005)</td><td rowspan="1" colspan="1">Potassium channel subfamily K member 5, mediates a pH and acid sensitive, noninactivating, outwardly rectifying K<sup>+</sup> conductance, involved in potassium ion transport, inhibited by amide anesthetics.</td></tr><tr><td rowspan="1" colspan="1">UGT1A5</td><td rowspan="1" colspan="1">GP0059_07_C01-frag002</td><td rowspan="1" colspan="1">Encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones and drugs, into water-soluble, excretable metabolites.</td></tr><tr><td rowspan="1" colspan="1">AKR1C1</td><td rowspan="1" colspan="1">GP0059_01_B10-frag003</td><td rowspan="1" colspan="1">Aldo-keto reductase family 1 member C1 acts in xenobiotic and progesterone metabolism, increased expression is observed in lung cancer, glaucoma and polycystic ovary syndrome.</td></tr><tr><td rowspan="1" colspan="1">AKR1C2</td><td rowspan="1" colspan="1">GP0059_02_C12-frag007</td><td rowspan="1" colspan="1">Aldo-keto reductase family 1 member C2 (dihydrodiol dehydrogenase), functions in bile transport, steroid metabolism and xenobiotic metabolism, expression is decreased in prostate and breast cancer but upregulated in esophageal squamous cell carcinoma.</td></tr><tr><td rowspan="1" colspan="1">CYP2C8 (gene)</td><td rowspan="1" colspan="1">GP0059_03_D11-frag004</td><td rowspan="1" colspan="1">Cytochrome P450 family 2 subfamily C polypeptide 8, a member of heme-binding mono-oxygenase superfamily, metabolizes steroids, fatty acids and xenobiotics, altered expression may contribute to colon cancer development.</td></tr><tr><td rowspan="1" colspan="1">CYP2C8 (downstream)</td><td rowspan="1" colspan="1">GP0059_05_C04-frag010</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">PAPSS2</td><td rowspan="1" colspan="1">GP0059_01_A08-frag002</td><td rowspan="1" colspan="1">3&#8242;-phosphoadenosine 5&#8242;-phosphosulfate synthase 2, involved in skeletal development; mutation in the corresponding gene correlates with spondyloepimetaphyseal dysplasia, mouse Papss2 gene is associated with brachymorphism.</td></tr><tr><td rowspan="1" colspan="1">HDAC7A</td><td rowspan="1" colspan="1">GP0059_06_H02-frag002</td><td rowspan="1" colspan="1">Histone acetylation/deacetylation alters chromosome structure and affects transcription factor access to DNA. The protein encoded by this gene has sequence homology to members of the histone deacetylase family. This gene is orthologous to mouse HDAC7 gene whose protein promotes repression mediated via the transcriptional corepressor SMRT.</td></tr><tr><td rowspan="1" colspan="1">TEAD2</td><td rowspan="1" colspan="1">GP0059_01_B06-frag007</td><td rowspan="1" colspan="1">TEA domain family member 2, a member of the TEA DNA-binding domain family of transcription factors, regulates transcription, may be involved in organ morphogenesis and central nervous system development.</td></tr><tr><td rowspan="1" colspan="1">HIST1H1E</td><td rowspan="1" colspan="1">GP0059_06_E12-frag008</td><td rowspan="1" colspan="1">The linker histone, H1, interacts with linker DNA between nucleosomes and functions in the compaction of chromatin into higher order structures. This gene is intronless and encodes a member of the histone H1 family. Transcripts from this gene lack polyA tails but instead contain a palindromic termination element. This gene is found in the large histone gene cluster on chromosome 6.</td></tr><tr><td rowspan="1" colspan="1">BMP1</td><td rowspan="1" colspan="1">GP0059_06_G08-frag002</td><td rowspan="1" colspan="1">Encodes a protein that is capable of inducing formation of cartilage <italic>in vivo</italic>. Although other bone morphogenetic proteins are members of the TGF-&#946; superfamily, this gene encodes a protein that is not closely related to other known growth factors.</td></tr><tr><td rowspan="1" colspan="1">CFL1</td><td rowspan="1" colspan="1">GP0059_09_F09-frag0005</td><td rowspan="1" colspan="1">Cofilin 1 (non-muscle), plays a role in actin filament depolymerization and lymphocyte chemotaxis, involved in the G protein-coupled receptor protein and Rho protein signaling pathways.</td></tr><tr><td rowspan="1" colspan="1">EIF5</td><td rowspan="1" colspan="1">GP0059_05_G08-frag003</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">TGIF2</td><td rowspan="1" colspan="1">GP0059_03_G06-frag003</td><td rowspan="1" colspan="1">This gene is a DNA-binding homeobox protein and a transcriptional repressor. The encoded protein appears to repress transcription by recruiting histone deacetylases to TGF-&#946;-responsive genes. This gene is amplified and overexpressed in some ovarian cancers, and mutations in this gene can cause holoprosencephaly.</td></tr><tr><td rowspan="1" colspan="1">BBC3</td><td rowspan="1" colspan="1">Cluster 19-76</td><td rowspan="1" colspan="1">Bcl-2 binding component 3, regulates p53 (TP53)-dependent and independent apoptosis, increased expression of BBC3 plays a role in chronic lymphocytic leukemia and lung neoplasms and is used in the treatment of glioma and colorectal neoplasms.</td></tr><tr><td rowspan="1" colspan="1">CLG</td><td rowspan="1" colspan="1">Cluster 19-185</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">GLDC</td><td rowspan="1" colspan="1">Cluster 9-228</td><td rowspan="1" colspan="1">Glycine decarboxylase (glycine dehydrogenase, P-protein), part of the glycine cleavage system that catalyzes the decarboxylation of glycine; mutation of the corresponding gene causes nonketotic hyperglycinemia.</td></tr><tr><td rowspan="1" colspan="1">ABCB4</td><td rowspan="1" colspan="1">GP0059_06_D02-frag005</td><td rowspan="1" colspan="1">This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance as well as antigen presentation. This gene encodes a full transporter and member of the P-glycoprotein family of membrane proteins with phosphatidylcholine as its substrate. The function of this protein has not yet been determined; however, it may involve transport of phospholipids from liver hepatocytes into bile.</td></tr><tr><td rowspan="1" colspan="1">CENTD2</td><td rowspan="1" colspan="1">Cluster 11-186</td><td rowspan="1" colspan="1">Centaurin delta 2, functions as a GTPase activating protein (GAP) for both Arf and Rho family proteins, mediates PIP3 phosphoinositide-dependent Golgi apparatus membrane changes, filopodia formation and cell spreading.</td></tr><tr><td rowspan="1" colspan="1">ZNF281</td><td rowspan="1" colspan="1">Cluster 1-52</td><td rowspan="1" colspan="1">Zinc finger protein 281, a transcriptional repressor, member of the ZBP family, contains four Kruppel-type zinc fingers.</td></tr><tr><td rowspan="1" colspan="1">BCL9L</td><td rowspan="1" colspan="1">Cluster 11-267</td><td rowspan="1" colspan="1">B-cell CLL/lymphoma 9-like, a BCL9-related protein that acts as a transcriptional regulator, induces &#946;-catenin (CTNNB1) nuclear translocation epithelial to mesenchymal transition, enhances cell migration, expression is upregulated in colorectal tumors.</td></tr><tr><td rowspan="1" colspan="1">ARNT2</td><td rowspan="1" colspan="1">Cluster 15-179</td><td rowspan="1" colspan="1">Aryl-hydrocarbon receptor nuclear translocator 2, a protein that heterodimerizes with HIF-1alpha (HIF1A) and is involved in hypoxia-induced erythropoietin (EPO) expression.</td></tr><tr><td rowspan="1" colspan="1">ASS1</td><td rowspan="1" colspan="1">Cluster 9-86</td><td rowspan="1" colspan="1">The protein encoded by this gene catalyzes the penultimate step of the arginine biosynthetic pathway. There are approximately 10&#8211;14 copies of this gene including the pseudogenes scattered across the human genome, among which the one located on chromosome 9 appears to be the only functional gene for argininosuccinate synthetase. Mutations in the chromosome 9 copy of ASS cause citrullinemia. Two transcript variants encoding the same protein have been found for this gene.</td></tr><tr><td rowspan="1" colspan="1">CTNNA1</td><td rowspan="1" colspan="1">GF0059_10_B02-frag003</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">ELK1</td><td rowspan="1" colspan="1">GP0059_02_G12-frag003</td><td rowspan="1" colspan="1">This gene is a member of the Ets family of transcription factors and of the ternary complex factor (TCF) subfamily. Proteins of the TCF subfamily form a ternary complex by binding to the the serum response factor and the serum reponse element in the promoter of the c-fos proto-oncogene. The protein encoded by this gene is a nuclear target for the ras-raf-MAPK signaling cascade.</td></tr><tr><td rowspan="1" colspan="1">MTL5</td><td rowspan="1" colspan="1">GP0059_04_G12-frag010</td><td rowspan="1" colspan="1">Metallothionein proteins are highly conserved low-molecular-weight cysteine-rich proteins that are induced by and bind to heavy metal ions and have no enzymatic activity. They may play a central role in the regulation of cell growth and differentiation and are involved in spermatogenesis. This gene encodes a metallothionein-like protein which has been shown to be expressed differentially in mouse testes and ovary.</td></tr><tr><td rowspan="1" colspan="1">WT</td><td rowspan="1" colspan="1">GP0059_05_B10-frag005</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">XRCC5</td><td rowspan="1" colspan="1">GP0059_01_D07-frag005</td><td rowspan="1" colspan="1">The protein encoded by this gene is the 80 kDa subunit of the Ku heterodimer protein which is also known as ATP-dependant DNA helicase II or DNA repair protein XRCC5. Ku is the DNA-binding component of the DNA-dependent protein kinase, and it functions together with the DNA ligase IV-XRCC4 complex in the repair of DNA double-strand break by non-homologous end joining and the completion of V(D)J recombination events.</td></tr></tbody></table></table-wrap>
###xml 13456 13464 13431 13439 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2.</label>
###xml 13464 13507 13439 13482 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="33">List of identified strong PXR binding sites</p>
###xml 13464 13507 13439 13482 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="33">List of identified strong PXR binding sites</p></caption>
###xml 13507 13522 13482 13497 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Binding site ID</th>
###xml 13522 13566 13497 13541 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Nearest gene, mRNA, EST, or genomic location</th>
###xml 13566 13576 13541 13551 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GenBank ID</th>
###xml 13576 13589 13551 13564 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Also known as</th>
###xml 13589 13614 13564 13589 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Distance to start of gene</th>
###xml 13633 13633 13608 13608 <hr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 13614 13633 13589 13608 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" colspan="2" align="center" rowspan="1">Cluster information<hr/></th>
###xml 13651 13651 13626 13626 <hr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 13633 13651 13608 13626 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" colspan="2" align="center" rowspan="1">Normalized binding<hr/></th>
###xml 13651 13665 13626 13640 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Binding ratios</th>
###xml 13507 13665 13482 13640 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><th rowspan="1" colspan="1">Binding site ID</th><th rowspan="1" colspan="1">Nearest gene, mRNA, EST, or genomic location</th><th rowspan="1" colspan="1">GenBank ID</th><th rowspan="1" colspan="1">Also known as</th><th rowspan="1" colspan="1">Distance to start of gene</th><th colspan="2" align="center" rowspan="1">Cluster information<hr/></th><th colspan="2" align="center" rowspan="1">Normalized binding<hr/></th><th rowspan="1" colspan="1">Binding ratios</th></tr>
###xml 13665 13665 13640 13640 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 13665 13665 13640 13640 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 13665 13665 13640 13640 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 13665 13665 13640 13640 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 13665 13665 13640 13640 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 13665 13676 13640 13651 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">No. of tags</th>
###xml 13676 13686 13651 13661 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Length, nt</th>
###xml 13686 13700 13661 13673 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Control &#177; SD</th>
###xml 13700 13717 13673 13688 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Rifampicin &#177; SD</th>
###xml 13717 13736 13688 13707 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Rifampicin/ control</th>
###xml 13665 13736 13640 13707 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">No. of tags</th><th rowspan="1" colspan="1">Length, nt</th><th rowspan="1" colspan="1">Control &#177; SD</th><th rowspan="1" colspan="1">Rifampicin &#177; SD</th><th rowspan="1" colspan="1">Rifampicin/ control</th></tr>
###xml 13507 13736 13482 13707 <thead xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><th rowspan="1" colspan="1">Binding site ID</th><th rowspan="1" colspan="1">Nearest gene, mRNA, EST, or genomic location</th><th rowspan="1" colspan="1">GenBank ID</th><th rowspan="1" colspan="1">Also known as</th><th rowspan="1" colspan="1">Distance to start of gene</th><th colspan="2" align="center" rowspan="1">Cluster information<hr/></th><th colspan="2" align="center" rowspan="1">Normalized binding<hr/></th><th rowspan="1" colspan="1">Binding ratios</th></tr><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">No. of tags</th><th rowspan="1" colspan="1">Length, nt</th><th rowspan="1" colspan="1">Control &#177; SD</th><th rowspan="1" colspan="1">Rifampicin &#177; SD</th><th rowspan="1" colspan="1">Rifampicin/ control</th></tr></thead>
###xml 13736 13743 13707 13714 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">SLC40A1</td>
###xml 13743 13806 13714 13777 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Solute carrier family 40 (iron-regulated transporter), member 1</td>
###xml 13806 13815 13777 13786 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NM_014585</td>
###xml 13815 13864 13786 13835 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">FPN1; HFE4; MTP1; IREG1; MST079; MSTP079; SLC11A3</td>
###xml 13864 13876 13835 13847 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;2914, &#8722;3986</td>
###xml 13876 13877 13847 13848 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">2</td>
###xml 13877 13881 13848 13852 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1113</td>
###xml 13881 13894 13852 13863 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.30 &#177; 0.10</td>
###xml 13894 13907 13863 13874 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.39 &#177; 0.17</td>
###xml 13907 13911 13874 13878 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1.29</td>
###xml 13736 13911 13707 13878 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">SLC40A1</td><td rowspan="1" colspan="1">Solute carrier family 40 (iron-regulated transporter), member 1</td><td rowspan="1" colspan="1">NM_014585</td><td rowspan="1" colspan="1">FPN1; HFE4; MTP1; IREG1; MST079; MSTP079; SLC11A3</td><td rowspan="1" colspan="1">&#8722;2914, &#8722;3986</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">1113</td><td rowspan="1" colspan="1">0.30 &#177; 0.10</td><td rowspan="1" colspan="1">0.39 &#177; 0.17</td><td rowspan="1" colspan="1">1.29</td></tr>
###xml 13911 13917 13878 13884 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">KCNK 5</td>
###xml 13917 13957 13884 13924 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Potassium channel, subfamily K, member 5</td>
###xml 13957 13966 13924 13933 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NM_003740</td>
###xml 13966 13997 13933 13964 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">FLJ11035, K2p5.1, TASK-2, TASK2</td>
###xml 13997 14011 13964 13978 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">18 682, 18 670</td>
###xml 14011 14012 13978 13979 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">2</td>
###xml 14012 14014 13979 13981 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">44</td>
###xml 14014 14027 13981 13992 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.66 &#177; 0.07</td>
###xml 14027 14040 13992 14003 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.85 &#177; 0.14</td>
###xml 14040 14044 14003 14007 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1.29</td>
###xml 13911 14044 13878 14007 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">KCNK 5</td><td rowspan="1" colspan="1">Potassium channel, subfamily K, member 5</td><td rowspan="1" colspan="1">NM_003740</td><td rowspan="1" colspan="1">FLJ11035, K2p5.1, TASK-2, TASK2</td><td rowspan="1" colspan="1">18 682, 18 670</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">44</td><td rowspan="1" colspan="1">0.66 &#177; 0.07</td><td rowspan="1" colspan="1">0.85 &#177; 0.14</td><td rowspan="1" colspan="1">1.29</td></tr>
###xml 14044 14052 14007 14015 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">SULT 1B1</td>
###xml 14052 14100 14015 14063 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Sulfotransferase family, cytosolic, 1B, member 1</td>
###xml 14100 14109 14063 14072 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NM_014465</td>
###xml 14109 14133 14072 14096 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">ST1B2; SULT1B2; MGC13356</td>
###xml 14133 14137 14096 14100 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;271</td>
###xml 14137 14137 14100 14100 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 14137 14137 14100 14100 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 14137 14150 14100 14111 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.41 &#177; 0.16</td>
###xml 14150 14163 14111 14122 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.34 &#177; 0.03</td>
###xml 14163 14167 14122 14126 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.82</td>
###xml 14044 14167 14007 14126 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">SULT 1B1</td><td rowspan="1" colspan="1">Sulfotransferase family, cytosolic, 1B, member 1</td><td rowspan="1" colspan="1">NM_014465</td><td rowspan="1" colspan="1">ST1B2; SULT1B2; MGC13356</td><td rowspan="1" colspan="1">&#8722;271</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.41 &#177; 0.16</td><td rowspan="1" colspan="1">0.34 &#177; 0.03</td><td rowspan="1" colspan="1">0.82</td></tr>
###xml 14167 14182 14126 14141 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">AKR1C1/2 (gene)</td>
###xml 14182 14221 14141 14180 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Aldo-keto reductase family 1, member C1</td>
###xml 14221 14230 14180 14189 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NM_001354</td>
###xml 14230 14303 14189 14262 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">2-ALPHA-HSD, 20-ALPHA-HSD, C9, DD1, DDH, DDH1, H-37, HAKRC, MBAB, MGC8954</td>
###xml 14303 14307 14262 14266 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">4088</td>
###xml 14307 14307 14266 14266 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 14307 14307 14266 14266 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 14307 14320 14266 14277 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.39 &#177; 0.13</td>
###xml 14320 14333 14277 14288 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.40 &#177; 0.22</td>
###xml 14333 14337 14288 14292 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1.03</td>
###xml 14167 14337 14126 14292 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">AKR1C1/2 (gene)</td><td rowspan="1" colspan="1">Aldo-keto reductase family 1, member C1</td><td rowspan="1" colspan="1">NM_001354</td><td rowspan="1" colspan="1">2-ALPHA-HSD, 20-ALPHA-HSD, C9, DD1, DDH, DDH1, H-37, HAKRC, MBAB, MGC8954</td><td rowspan="1" colspan="1">4088</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.39 &#177; 0.13</td><td rowspan="1" colspan="1">0.40 &#177; 0.22</td><td rowspan="1" colspan="1">1.03</td></tr>
###xml 14337 14358 14292 14313 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">AKR1C1/2 (downstream)</td>
###xml 14358 14358 14313 14313 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 14358 14367 14313 14322 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NM_001354</td>
###xml 14367 14367 14322 14322 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 14367 14373 14322 14328 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">18 979</td>
###xml 14373 14373 14328 14328 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 14373 14373 14328 14328 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 14373 14386 14328 14339 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.45 &#177; 0.13</td>
###xml 14386 14399 14339 14350 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.40 &#177; 0.07</td>
###xml 14399 14403 14350 14354 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.90</td>
###xml 14337 14403 14292 14354 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">AKR1C1/2 (downstream)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">NM_001354</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">18 979</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.45 &#177; 0.13</td><td rowspan="1" colspan="1">0.40 &#177; 0.07</td><td rowspan="1" colspan="1">0.90</td></tr>
###xml 14403 14407 14354 14358 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">EIF5</td>
###xml 14407 14449 14358 14400 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Eukaryotic translation initiation factor 5</td>
###xml 14449 14458 14400 14409 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NM_001969</td>
###xml 14458 14464 14409 14415 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">EIF-5A</td>
###xml 14464 14469 14415 14420 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;1198</td>
###xml 14469 14469 14420 14420 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 14469 14469 14420 14420 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 14469 14482 14420 14431 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.50 &#177; 0.05</td>
###xml 14482 14495 14431 14442 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.47 &#177; 0.01</td>
###xml 14495 14499 14442 14446 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.93</td>
###xml 14403 14499 14354 14446 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">EIF5</td><td rowspan="1" colspan="1">Eukaryotic translation initiation factor 5</td><td rowspan="1" colspan="1">NM_001969</td><td rowspan="1" colspan="1">EIF-5A</td><td rowspan="1" colspan="1">&#8722;1198</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.50 &#177; 0.05</td><td rowspan="1" colspan="1">0.47 &#177; 0.01</td><td rowspan="1" colspan="1">0.93</td></tr>
###xml 14499 14512 14446 14459 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CYP2C8 (gene)</td>
###xml 14512 14565 14459 14512 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Cytochrome P450, family 2, subfamily C, polypeptide 8</td>
###xml 14565 14574 14512 14521 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NM_000770</td>
###xml 14574 14596 14521 14543 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CPC8, P450 MP-12/MP-20</td>
###xml 14596 14602 14543 14549 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">18 489</td>
###xml 14602 14602 14549 14549 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 14602 14602 14549 14549 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 14602 14615 14549 14560 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.30 &#177; 0.10</td>
###xml 14615 14628 14560 14571 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.25 &#177; 0.01</td>
###xml 14628 14632 14571 14575 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.86</td>
###xml 14499 14632 14446 14575 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CYP2C8 (gene)</td><td rowspan="1" colspan="1">Cytochrome P450, family 2, subfamily C, polypeptide 8</td><td rowspan="1" colspan="1">NM_000770</td><td rowspan="1" colspan="1">CPC8, P450 MP-12/MP-20</td><td rowspan="1" colspan="1">18 489</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.30 &#177; 0.10</td><td rowspan="1" colspan="1">0.25 &#177; 0.01</td><td rowspan="1" colspan="1">0.86</td></tr>
###xml 14632 14636 14575 14579 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CD59</td>
###xml 14636 14680 14579 14623 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CD59 molecule, complement regulatory protein</td>
###xml 14680 14689 14623 14632 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NM_000611</td>
###xml 14689 14779 14632 14722 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">16.3A5, EJ16, EJ30, EL32, G344, MGC2354, MIC11, MIN1, MIN2, MIN3, MSK21, PROTECTIN, p18-20</td>
###xml 14779 14785 14722 14728 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">36 417</td>
###xml 14785 14785 14728 14728 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 14785 14785 14728 14728 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 14785 14798 14728 14739 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.89 &#177; 0.14</td>
###xml 14798 14811 14739 14750 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1.08 &#177; 0.30</td>
###xml 14811 14815 14750 14754 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1.21</td>
###xml 14632 14815 14575 14754 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CD59</td><td rowspan="1" colspan="1">CD59 molecule, complement regulatory protein</td><td rowspan="1" colspan="1">NM_000611</td><td rowspan="1" colspan="1">16.3A5, EJ16, EJ30, EL32, G344, MGC2354, MIC11, MIN1, MIN2, MIN3, MSK21, PROTECTIN, p18-20</td><td rowspan="1" colspan="1">36 417</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.89 &#177; 0.14</td><td rowspan="1" colspan="1">1.08 &#177; 0.30</td><td rowspan="1" colspan="1">1.21</td></tr>
###xml 14822 14823 14761 14762 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 14822 14823 14761 14762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF1"><sup>a</sup></xref>
###xml 14815 14823 14754 14762 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CYP4F12<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td>
###xml 14823 14877 14762 14816 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Cytochrome P450, family 4, subfamily F, polypeptide 12</td>
###xml 14877 14886 14816 14825 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NM_023944</td>
###xml 14886 14894 14825 14833 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">F22329_1</td>
###xml 14894 14904 14833 14843 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">8204, 8197</td>
###xml 14904 14905 14843 14844 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">2</td>
###xml 14905 14907 14844 14846 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">46</td>
###xml 14907 14920 14846 14857 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1.99 &#177; 0.29</td>
###xml 14920 14933 14857 14868 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">3.49 &#177; 0.41</td>
###xml 14933 14937 14868 14872 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1.75</td>
###xml 14815 14937 14754 14872 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CYP4F12<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">Cytochrome P450, family 4, subfamily F, polypeptide 12</td><td rowspan="1" colspan="1">NM_023944</td><td rowspan="1" colspan="1">F22329_1</td><td rowspan="1" colspan="1">8204, 8197</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">46</td><td rowspan="1" colspan="1">1.99 &#177; 0.29</td><td rowspan="1" colspan="1">3.49 &#177; 0.41</td><td rowspan="1" colspan="1">1.75</td></tr>
###xml 14942 14943 14877 14878 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 14942 14943 14877 14878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF1"><sup>a</sup></xref>
###xml 14937 14943 14872 14878 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">ABCC4<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td>
###xml 14943 14998 14878 14933 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">ATP-binding cassette, sub-family C (CFTR/MRP), member 4</td>
###xml 14998 15007 14933 14942 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NM_005845</td>
###xml 15007 15051 14942 14986 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">RP11-74A12.1, EST170205, MOAT-B, MOATB, MRP4</td>
###xml 15051 15057 14986 14992 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">90 518</td>
###xml 15057 15057 14992 14992 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 15057 15057 14992 14992 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 15057 15070 14992 15003 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.20 &#177; 0.06</td>
###xml 15070 15083 15003 15014 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.34 &#177; 0.02</td>
###xml 15083 15087 15014 15018 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1.69</td>
###xml 14937 15087 14872 15018 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">ABCC4<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">ATP-binding cassette, sub-family C (CFTR/MRP), member 4</td><td rowspan="1" colspan="1">NM_005845</td><td rowspan="1" colspan="1">RP11-74A12.1, EST170205, MOAT-B, MOATB, MRP4</td><td rowspan="1" colspan="1">90 518</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.20 &#177; 0.06</td><td rowspan="1" colspan="1">0.34 &#177; 0.02</td><td rowspan="1" colspan="1">1.69</td></tr>
###xml 15093 15094 15024 15025 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 15093 15094 15024 15025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF1"><sup>a</sup></xref>
###xml 15087 15094 15018 15025 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">UGT1A5<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td>
###xml 15094 15146 15025 15077 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">UDP glucuronosyltransferase 1 family, polypeptide A5</td>
###xml 15146 15155 15077 15086 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NM_019078</td>
###xml 15155 15175 15086 15106 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">UDPGT, UGT1*5, UGT1E</td>
###xml 15175 15180 15106 15111 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;3758</td>
###xml 15180 15180 15111 15111 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 15180 15180 15111 15111 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 15180 15193 15111 15122 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.41 &#177; 0.13</td>
###xml 15193 15206 15122 15133 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.75 &#177; 0.18</td>
###xml 15206 15210 15133 15137 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1.84</td>
###xml 15087 15210 15018 15137 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">UGT1A5<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">UDP glucuronosyltransferase 1 family, polypeptide A5</td><td rowspan="1" colspan="1">NM_019078</td><td rowspan="1" colspan="1">UDPGT, UGT1*5, UGT1E</td><td rowspan="1" colspan="1">&#8722;3758</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.41 &#177; 0.13</td><td rowspan="1" colspan="1">0.75 &#177; 0.18</td><td rowspan="1" colspan="1">1.84</td></tr>
###xml 15216 15217 15143 15144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 15216 15217 15143 15144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF1"><sup>a</sup></xref>
###xml 15210 15217 15137 15144 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CYP3A5<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td>
###xml 15217 15270 15144 15197 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Cytochrome P450, family 3, subfamily A, polypeptide 5</td>
###xml 15270 15279 15197 15206 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NM_000777</td>
###xml 15279 15299 15206 15226 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CP35, P450PCN3, PCN3</td>
###xml 15299 15303 15226 15230 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">7277</td>
###xml 15303 15303 15230 15230 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 15303 15303 15230 15230 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 15303 15316 15230 15241 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.47 &#177; 0.08</td>
###xml 15316 15329 15241 15252 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.79 &#177; 0.19</td>
###xml 15329 15333 15252 15256 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1.70</td>
###xml 15210 15333 15137 15256 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CYP3A5<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">Cytochrome P450, family 3, subfamily A, polypeptide 5</td><td rowspan="1" colspan="1">NM_000777</td><td rowspan="1" colspan="1">CP35, P450PCN3, PCN3</td><td rowspan="1" colspan="1">7277</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.47 &#177; 0.08</td><td rowspan="1" colspan="1">0.79 &#177; 0.19</td><td rowspan="1" colspan="1">1.70</td></tr>
###xml 15337 15338 15260 15261 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 15337 15338 15260 15261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF1"><sup>a</sup></xref>
###xml 15333 15338 15256 15261 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CARS<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td>
###xml 15338 15363 15261 15286 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Cysteinyl-tRNA synthetase</td>
###xml 15363 15372 15286 15295 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NM_001751</td>
###xml 15372 15395 15295 15318 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CARS1, CYSRS, MGC:11246</td>
###xml 15395 15401 15318 15324 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">15 820</td>
###xml 15401 15401 15324 15324 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 15401 15401 15324 15324 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 15401 15414 15324 15335 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.48 &#177; 0.19</td>
###xml 15414 15427 15335 15346 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.92 &#177; 0.23</td>
###xml 15427 15431 15346 15350 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1.92</td>
###xml 15333 15431 15256 15350 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CARS<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">Cysteinyl-tRNA synthetase</td><td rowspan="1" colspan="1">NM_001751</td><td rowspan="1" colspan="1">CARS1, CYSRS, MGC:11246</td><td rowspan="1" colspan="1">15 820</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.48 &#177; 0.19</td><td rowspan="1" colspan="1">0.92 &#177; 0.23</td><td rowspan="1" colspan="1">1.92</td></tr>
###xml 15435 15436 15354 15355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 15435 15436 15354 15355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF1"><sup>a</sup></xref>
###xml 15431 15436 15350 15355 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">BMP1<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td>
###xml 15436 15464 15355 15383 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Bone morphogenetic protein 1</td>
###xml 15464 15473 15383 15392 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NM_006131</td>
###xml 15473 15498 15392 15417 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">FLJ44432, PCOLC, PCP, TLD</td>
###xml 15498 15502 15417 15421 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">4711</td>
###xml 15502 15502 15421 15421 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 15502 15502 15421 15421 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 15502 15515 15421 15432 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.46 &#177; 0.08</td>
###xml 15515 15528 15432 15443 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.69 &#177; 0.14</td>
###xml 15528 15532 15443 15447 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1.48</td>
###xml 15431 15532 15350 15447 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">BMP1<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">Bone morphogenetic protein 1</td><td rowspan="1" colspan="1">NM_006131</td><td rowspan="1" colspan="1">FLJ44432, PCOLC, PCP, TLD</td><td rowspan="1" colspan="1">4711</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.46 &#177; 0.08</td><td rowspan="1" colspan="1">0.69 &#177; 0.14</td><td rowspan="1" colspan="1">1.48</td></tr>
###xml 15537 15538 15452 15453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 15537 15538 15452 15453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF1"><sup>a</sup></xref>
###xml 15532 15538 15447 15453 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">TGIF2<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td>
###xml 15538 15572 15453 15484 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">TGF-&#946;-induced factor homeobox 2</td>
###xml 15572 15580 15484 15492 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">AF055012</td>
###xml 15580 15775 15492 15678 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-TG-3&#8242; interacting factor 2; TGF-&#946;-induced transcription factor 2; TGF-&#946;-induced factor 2 (TALE family homeobox); homeobox protein TGIF2; transcription growth factor-&#946;-induced factor 2</td>
###xml 15775 15779 15678 15682 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1373</td>
###xml 15779 15779 15682 15682 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 15779 15779 15682 15682 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 15779 15792 15682 15693 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.72 &#177; 0.21</td>
###xml 15792 15805 15693 15704 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1.15 &#177; 0.41</td>
###xml 15805 15809 15704 15708 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1.61</td>
###xml 15532 15809 15447 15708 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">TGIF2<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">TGF-&#946;-induced factor homeobox 2</td><td rowspan="1" colspan="1">AF055012</td><td rowspan="1" colspan="1">5&#8242;-TG-3&#8242; interacting factor 2; TGF-&#946;-induced transcription factor 2; TGF-&#946;-induced factor 2 (TALE family homeobox); homeobox protein TGIF2; transcription growth factor-&#946;-induced factor 2</td><td rowspan="1" colspan="1">1373</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.72 &#177; 0.21</td><td rowspan="1" colspan="1">1.15 &#177; 0.41</td><td rowspan="1" colspan="1">1.61</td></tr>
###xml 15814 15815 15713 15714 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 15814 15815 15713 15714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF1"><sup>a</sup></xref>
###xml 15809 15815 15708 15714 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">BCL9L<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td>
###xml 15815 15841 15714 15740 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">B-cell CLL/lymphoma 9-like</td>
###xml 15841 15850 15740 15749 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NM_182557</td>
###xml 15850 15864 15749 15763 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">BCL9-2, DLNB11</td>
###xml 15864 15889 15763 15788 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;23 391, &#8722;23 240, &#8722;23 141</td>
###xml 15889 15890 15788 15789 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">3</td>
###xml 15890 15893 15789 15792 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">291</td>
###xml 15893 15906 15792 15803 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1.20 &#177; 0.33</td>
###xml 15906 15919 15803 15814 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">2.42 &#177; 1.14</td>
###xml 15919 15923 15814 15818 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">2.01</td>
###xml 15809 15923 15708 15818 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">BCL9L<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">B-cell CLL/lymphoma 9-like</td><td rowspan="1" colspan="1">NM_182557</td><td rowspan="1" colspan="1">BCL9-2, DLNB11</td><td rowspan="1" colspan="1">&#8722;23 391, &#8722;23 240, &#8722;23 141</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">291</td><td rowspan="1" colspan="1">1.20 &#177; 0.33</td><td rowspan="1" colspan="1">2.42 &#177; 1.14</td><td rowspan="1" colspan="1">2.01</td></tr>
###xml 15926 15927 15821 15822 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 15926 15927 15821 15822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF1"><sup>a</sup></xref>
###xml 15923 15927 15818 15822 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CLG<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td>
###xml 15927 16004 15822 15899 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Pleckstrin homology domain containing, family G (with RhoGef domain) member 2</td>
###xml 16004 16013 15899 15908 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NM_022835</td>
###xml 16013 16040 15908 15935 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">PLEKHG2, FLJ00018, FLJ22458</td>
###xml 16040 16065 15935 15960 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;14 177, &#8722;15 081, &#8722;15 054</td>
###xml 16065 16066 15960 15961 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">3</td>
###xml 16066 16069 15961 15964 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">933</td>
###xml 16069 16082 15964 15975 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.37 &#177; 0.11</td>
###xml 16082 16095 15975 15986 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.81 &#177; 0.27</td>
###xml 16095 16099 15986 15990 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">2.20</td>
###xml 15923 16099 15818 15990 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CLG<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">Pleckstrin homology domain containing, family G (with RhoGef domain) member 2</td><td rowspan="1" colspan="1">NM_022835</td><td rowspan="1" colspan="1">PLEKHG2, FLJ00018, FLJ22458</td><td rowspan="1" colspan="1">&#8722;14 177, &#8722;15 081, &#8722;15 054</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">933</td><td rowspan="1" colspan="1">0.37 &#177; 0.11</td><td rowspan="1" colspan="1">0.81 &#177; 0.27</td><td rowspan="1" colspan="1">2.20</td></tr>
###xml 16103 16104 15994 15995 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 16103 16104 15994 15995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF1"><sup>a</sup></xref>
###xml 16099 16104 15990 15995 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GLDC<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td>
###xml 16104 16143 15995 16034 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Glycine dehydrogenase (decarboxylating)</td>
###xml 16143 16152 16034 16043 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NM_000170</td>
###xml 16152 16195 16043 16086 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GCE, GCSP, HYGN1, MGC138198, MGC138200, NKH</td>
###xml 16195 16223 16086 16114 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;109 084, &#8722;109 083, &#8722;109 566</td>
###xml 16223 16224 16114 16115 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">3</td>
###xml 16224 16227 16115 16118 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">524</td>
###xml 16227 16240 16118 16129 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.37 &#177; 0.12</td>
###xml 16240 16253 16129 16140 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.66 &#177; 0.27</td>
###xml 16253 16257 16140 16144 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1.77</td>
###xml 16099 16257 15990 16144 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">GLDC<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">Glycine dehydrogenase (decarboxylating)</td><td rowspan="1" colspan="1">NM_000170</td><td rowspan="1" colspan="1">GCE, GCSP, HYGN1, MGC138198, MGC138200, NKH</td><td rowspan="1" colspan="1">&#8722;109 084, &#8722;109 083, &#8722;109 566</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">524</td><td rowspan="1" colspan="1">0.37 &#177; 0.12</td><td rowspan="1" colspan="1">0.66 &#177; 0.27</td><td rowspan="1" colspan="1">1.77</td></tr>
###xml 16262 16263 16149 16150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 16257 16263 16144 16150 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">ABCB4<sup>a</sup></td>
###xml 16263 16317 16150 16204 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">ATP-binding cassette, sub-family B (MDR/TAP), member 4</td>
###xml 16317 16326 16204 16213 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NM_018849</td>
###xml 16326 16359 16213 16246 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">MDR3; PGY3; ABC21; MDR2/3; PFIC-3</td>
###xml 16359 16364 16246 16251 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;3078</td>
###xml 16364 16364 16251 16251 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 16364 16364 16251 16251 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 16364 16377 16251 16262 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.74 &#177; 0.05</td>
###xml 16377 16390 16262 16273 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1.19 &#177; 0.39</td>
###xml 16390 16394 16273 16277 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1.60</td>
###xml 16257 16394 16144 16277 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">ABCB4<sup>a</sup></td><td rowspan="1" colspan="1">ATP-binding cassette, sub-family B (MDR/TAP), member 4</td><td rowspan="1" colspan="1">NM_018849</td><td rowspan="1" colspan="1">MDR3; PGY3; ABC21; MDR2/3; PFIC-3</td><td rowspan="1" colspan="1">&#8722;3078</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.74 &#177; 0.05</td><td rowspan="1" colspan="1">1.19 &#177; 0.39</td><td rowspan="1" colspan="1">1.60</td></tr>
###xml 16394 16398 16277 16281 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CFL1</td>
###xml 16398 16420 16281 16303 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Cofilin 1 (non-muscle)</td>
###xml 16420 16429 16303 16312 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NM_005507</td>
###xml 16429 16432 16312 16315 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CFL</td>
###xml 16432 16451 16315 16334 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;1874, &#8722;1879, &#8722;1882</td>
###xml 16451 16452 16334 16335 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">3</td>
###xml 16452 16454 16335 16337 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">47</td>
###xml 16454 16467 16337 16348 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.44 &#177; 0.13</td>
###xml 16467 16480 16348 16359 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.29 &#177; 0.16</td>
###xml 16480 16484 16359 16363 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.66</td>
###xml 16394 16484 16277 16363 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CFL1</td><td rowspan="1" colspan="1">Cofilin 1 (non-muscle)</td><td rowspan="1" colspan="1">NM_005507</td><td rowspan="1" colspan="1">CFL</td><td rowspan="1" colspan="1">&#8722;1874, &#8722;1879, &#8722;1882</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">47</td><td rowspan="1" colspan="1">0.44 &#177; 0.13</td><td rowspan="1" colspan="1">0.29 &#177; 0.16</td><td rowspan="1" colspan="1">0.66</td></tr>
###xml 16484 16503 16363 16382 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CYP2C8 (downstream)</td>
###xml 16503 16503 16382 16382 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 16503 16512 16382 16391 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NM_000770</td>
###xml 16512 16512 16391 16391 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 16512 16518 16391 16397 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">33 678</td>
###xml 16518 16518 16397 16397 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 16518 16518 16397 16397 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 16518 16531 16397 16408 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.51 &#177; 0.27</td>
###xml 16531 16544 16408 16419 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.36 &#177; 0.15</td>
###xml 16544 16548 16419 16423 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.71</td>
###xml 16484 16548 16363 16423 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CYP2C8 (downstream)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">NM_000770</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">33 678</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.51 &#177; 0.27</td><td rowspan="1" colspan="1">0.36 &#177; 0.15</td><td rowspan="1" colspan="1">0.71</td></tr>
###xml 16548 16552 16423 16427 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GCKR</td>
###xml 16552 16588 16427 16463 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Glucokinase (hexokinase 4) regulator</td>
###xml 16588 16597 16463 16472 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NM_001486</td>
###xml 16597 16601 16472 16476 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GKRP</td>
###xml 16601 16607 16476 16482 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">27 665</td>
###xml 16607 16607 16482 16482 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 16607 16607 16482 16482 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 16607 16620 16482 16493 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.32 &#177; 0.05</td>
###xml 16620 16633 16493 16504 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.19 &#177; 0.13</td>
###xml 16633 16637 16504 16508 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.60</td>
###xml 16548 16637 16423 16508 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">GCKR</td><td rowspan="1" colspan="1">Glucokinase (hexokinase 4) regulator</td><td rowspan="1" colspan="1">NM_001486</td><td rowspan="1" colspan="1">GKRP</td><td rowspan="1" colspan="1">27 665</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.32 &#177; 0.05</td><td rowspan="1" colspan="1">0.19 &#177; 0.13</td><td rowspan="1" colspan="1">0.60</td></tr>
###xml 16637 16642 16508 16513 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GSTT1</td>
###xml 16642 16675 16513 16546 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Glutathione S-transferase theta 1</td>
###xml 16675 16684 16546 16555 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NM_000853</td>
###xml 16684 16684 16555 16555 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 16684 16688 16555 16559 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;567</td>
###xml 16688 16688 16559 16559 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 16688 16688 16559 16559 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 16688 16701 16559 16570 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.40 &#177; 0.20</td>
###xml 16701 16714 16570 16581 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.25 &#177; 0.11</td>
###xml 16714 16718 16581 16585 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.63</td>
###xml 16637 16718 16508 16585 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">GSTT1</td><td rowspan="1" colspan="1">Glutathione S-transferase theta 1</td><td rowspan="1" colspan="1">NM_000853</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8722;567</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.40 &#177; 0.20</td><td rowspan="1" colspan="1">0.25 &#177; 0.11</td><td rowspan="1" colspan="1">0.63</td></tr>
###xml 13736 16718 13707 16585 <tbody xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><td rowspan="1" colspan="1">SLC40A1</td><td rowspan="1" colspan="1">Solute carrier family 40 (iron-regulated transporter), member 1</td><td rowspan="1" colspan="1">NM_014585</td><td rowspan="1" colspan="1">FPN1; HFE4; MTP1; IREG1; MST079; MSTP079; SLC11A3</td><td rowspan="1" colspan="1">&#8722;2914, &#8722;3986</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">1113</td><td rowspan="1" colspan="1">0.30 &#177; 0.10</td><td rowspan="1" colspan="1">0.39 &#177; 0.17</td><td rowspan="1" colspan="1">1.29</td></tr><tr><td rowspan="1" colspan="1">KCNK 5</td><td rowspan="1" colspan="1">Potassium channel, subfamily K, member 5</td><td rowspan="1" colspan="1">NM_003740</td><td rowspan="1" colspan="1">FLJ11035, K2p5.1, TASK-2, TASK2</td><td rowspan="1" colspan="1">18 682, 18 670</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">44</td><td rowspan="1" colspan="1">0.66 &#177; 0.07</td><td rowspan="1" colspan="1">0.85 &#177; 0.14</td><td rowspan="1" colspan="1">1.29</td></tr><tr><td rowspan="1" colspan="1">SULT 1B1</td><td rowspan="1" colspan="1">Sulfotransferase family, cytosolic, 1B, member 1</td><td rowspan="1" colspan="1">NM_014465</td><td rowspan="1" colspan="1">ST1B2; SULT1B2; MGC13356</td><td rowspan="1" colspan="1">&#8722;271</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.41 &#177; 0.16</td><td rowspan="1" colspan="1">0.34 &#177; 0.03</td><td rowspan="1" colspan="1">0.82</td></tr><tr><td rowspan="1" colspan="1">AKR1C1/2 (gene)</td><td rowspan="1" colspan="1">Aldo-keto reductase family 1, member C1</td><td rowspan="1" colspan="1">NM_001354</td><td rowspan="1" colspan="1">2-ALPHA-HSD, 20-ALPHA-HSD, C9, DD1, DDH, DDH1, H-37, HAKRC, MBAB, MGC8954</td><td rowspan="1" colspan="1">4088</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.39 &#177; 0.13</td><td rowspan="1" colspan="1">0.40 &#177; 0.22</td><td rowspan="1" colspan="1">1.03</td></tr><tr><td rowspan="1" colspan="1">AKR1C1/2 (downstream)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">NM_001354</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">18 979</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.45 &#177; 0.13</td><td rowspan="1" colspan="1">0.40 &#177; 0.07</td><td rowspan="1" colspan="1">0.90</td></tr><tr><td rowspan="1" colspan="1">EIF5</td><td rowspan="1" colspan="1">Eukaryotic translation initiation factor 5</td><td rowspan="1" colspan="1">NM_001969</td><td rowspan="1" colspan="1">EIF-5A</td><td rowspan="1" colspan="1">&#8722;1198</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.50 &#177; 0.05</td><td rowspan="1" colspan="1">0.47 &#177; 0.01</td><td rowspan="1" colspan="1">0.93</td></tr><tr><td rowspan="1" colspan="1">CYP2C8 (gene)</td><td rowspan="1" colspan="1">Cytochrome P450, family 2, subfamily C, polypeptide 8</td><td rowspan="1" colspan="1">NM_000770</td><td rowspan="1" colspan="1">CPC8, P450 MP-12/MP-20</td><td rowspan="1" colspan="1">18 489</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.30 &#177; 0.10</td><td rowspan="1" colspan="1">0.25 &#177; 0.01</td><td rowspan="1" colspan="1">0.86</td></tr><tr><td rowspan="1" colspan="1">CD59</td><td rowspan="1" colspan="1">CD59 molecule, complement regulatory protein</td><td rowspan="1" colspan="1">NM_000611</td><td rowspan="1" colspan="1">16.3A5, EJ16, EJ30, EL32, G344, MGC2354, MIC11, MIN1, MIN2, MIN3, MSK21, PROTECTIN, p18-20</td><td rowspan="1" colspan="1">36 417</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.89 &#177; 0.14</td><td rowspan="1" colspan="1">1.08 &#177; 0.30</td><td rowspan="1" colspan="1">1.21</td></tr><tr><td rowspan="1" colspan="1">CYP4F12<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">Cytochrome P450, family 4, subfamily F, polypeptide 12</td><td rowspan="1" colspan="1">NM_023944</td><td rowspan="1" colspan="1">F22329_1</td><td rowspan="1" colspan="1">8204, 8197</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">46</td><td rowspan="1" colspan="1">1.99 &#177; 0.29</td><td rowspan="1" colspan="1">3.49 &#177; 0.41</td><td rowspan="1" colspan="1">1.75</td></tr><tr><td rowspan="1" colspan="1">ABCC4<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">ATP-binding cassette, sub-family C (CFTR/MRP), member 4</td><td rowspan="1" colspan="1">NM_005845</td><td rowspan="1" colspan="1">RP11-74A12.1, EST170205, MOAT-B, MOATB, MRP4</td><td rowspan="1" colspan="1">90 518</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.20 &#177; 0.06</td><td rowspan="1" colspan="1">0.34 &#177; 0.02</td><td rowspan="1" colspan="1">1.69</td></tr><tr><td rowspan="1" colspan="1">UGT1A5<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">UDP glucuronosyltransferase 1 family, polypeptide A5</td><td rowspan="1" colspan="1">NM_019078</td><td rowspan="1" colspan="1">UDPGT, UGT1*5, UGT1E</td><td rowspan="1" colspan="1">&#8722;3758</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.41 &#177; 0.13</td><td rowspan="1" colspan="1">0.75 &#177; 0.18</td><td rowspan="1" colspan="1">1.84</td></tr><tr><td rowspan="1" colspan="1">CYP3A5<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">Cytochrome P450, family 3, subfamily A, polypeptide 5</td><td rowspan="1" colspan="1">NM_000777</td><td rowspan="1" colspan="1">CP35, P450PCN3, PCN3</td><td rowspan="1" colspan="1">7277</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.47 &#177; 0.08</td><td rowspan="1" colspan="1">0.79 &#177; 0.19</td><td rowspan="1" colspan="1">1.70</td></tr><tr><td rowspan="1" colspan="1">CARS<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">Cysteinyl-tRNA synthetase</td><td rowspan="1" colspan="1">NM_001751</td><td rowspan="1" colspan="1">CARS1, CYSRS, MGC:11246</td><td rowspan="1" colspan="1">15 820</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.48 &#177; 0.19</td><td rowspan="1" colspan="1">0.92 &#177; 0.23</td><td rowspan="1" colspan="1">1.92</td></tr><tr><td rowspan="1" colspan="1">BMP1<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">Bone morphogenetic protein 1</td><td rowspan="1" colspan="1">NM_006131</td><td rowspan="1" colspan="1">FLJ44432, PCOLC, PCP, TLD</td><td rowspan="1" colspan="1">4711</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.46 &#177; 0.08</td><td rowspan="1" colspan="1">0.69 &#177; 0.14</td><td rowspan="1" colspan="1">1.48</td></tr><tr><td rowspan="1" colspan="1">TGIF2<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">TGF-&#946;-induced factor homeobox 2</td><td rowspan="1" colspan="1">AF055012</td><td rowspan="1" colspan="1">5&#8242;-TG-3&#8242; interacting factor 2; TGF-&#946;-induced transcription factor 2; TGF-&#946;-induced factor 2 (TALE family homeobox); homeobox protein TGIF2; transcription growth factor-&#946;-induced factor 2</td><td rowspan="1" colspan="1">1373</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.72 &#177; 0.21</td><td rowspan="1" colspan="1">1.15 &#177; 0.41</td><td rowspan="1" colspan="1">1.61</td></tr><tr><td rowspan="1" colspan="1">BCL9L<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">B-cell CLL/lymphoma 9-like</td><td rowspan="1" colspan="1">NM_182557</td><td rowspan="1" colspan="1">BCL9-2, DLNB11</td><td rowspan="1" colspan="1">&#8722;23 391, &#8722;23 240, &#8722;23 141</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">291</td><td rowspan="1" colspan="1">1.20 &#177; 0.33</td><td rowspan="1" colspan="1">2.42 &#177; 1.14</td><td rowspan="1" colspan="1">2.01</td></tr><tr><td rowspan="1" colspan="1">CLG<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">Pleckstrin homology domain containing, family G (with RhoGef domain) member 2</td><td rowspan="1" colspan="1">NM_022835</td><td rowspan="1" colspan="1">PLEKHG2, FLJ00018, FLJ22458</td><td rowspan="1" colspan="1">&#8722;14 177, &#8722;15 081, &#8722;15 054</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">933</td><td rowspan="1" colspan="1">0.37 &#177; 0.11</td><td rowspan="1" colspan="1">0.81 &#177; 0.27</td><td rowspan="1" colspan="1">2.20</td></tr><tr><td rowspan="1" colspan="1">GLDC<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">Glycine dehydrogenase (decarboxylating)</td><td rowspan="1" colspan="1">NM_000170</td><td rowspan="1" colspan="1">GCE, GCSP, HYGN1, MGC138198, MGC138200, NKH</td><td rowspan="1" colspan="1">&#8722;109 084, &#8722;109 083, &#8722;109 566</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">524</td><td rowspan="1" colspan="1">0.37 &#177; 0.12</td><td rowspan="1" colspan="1">0.66 &#177; 0.27</td><td rowspan="1" colspan="1">1.77</td></tr><tr><td rowspan="1" colspan="1">ABCB4<sup>a</sup></td><td rowspan="1" colspan="1">ATP-binding cassette, sub-family B (MDR/TAP), member 4</td><td rowspan="1" colspan="1">NM_018849</td><td rowspan="1" colspan="1">MDR3; PGY3; ABC21; MDR2/3; PFIC-3</td><td rowspan="1" colspan="1">&#8722;3078</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.74 &#177; 0.05</td><td rowspan="1" colspan="1">1.19 &#177; 0.39</td><td rowspan="1" colspan="1">1.60</td></tr><tr><td rowspan="1" colspan="1">CFL1</td><td rowspan="1" colspan="1">Cofilin 1 (non-muscle)</td><td rowspan="1" colspan="1">NM_005507</td><td rowspan="1" colspan="1">CFL</td><td rowspan="1" colspan="1">&#8722;1874, &#8722;1879, &#8722;1882</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">47</td><td rowspan="1" colspan="1">0.44 &#177; 0.13</td><td rowspan="1" colspan="1">0.29 &#177; 0.16</td><td rowspan="1" colspan="1">0.66</td></tr><tr><td rowspan="1" colspan="1">CYP2C8 (downstream)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">NM_000770</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">33 678</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.51 &#177; 0.27</td><td rowspan="1" colspan="1">0.36 &#177; 0.15</td><td rowspan="1" colspan="1">0.71</td></tr><tr><td rowspan="1" colspan="1">GCKR</td><td rowspan="1" colspan="1">Glucokinase (hexokinase 4) regulator</td><td rowspan="1" colspan="1">NM_001486</td><td rowspan="1" colspan="1">GKRP</td><td rowspan="1" colspan="1">27 665</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.32 &#177; 0.05</td><td rowspan="1" colspan="1">0.19 &#177; 0.13</td><td rowspan="1" colspan="1">0.60</td></tr><tr><td rowspan="1" colspan="1">GSTT1</td><td rowspan="1" colspan="1">Glutathione S-transferase theta 1</td><td rowspan="1" colspan="1">NM_000853</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8722;567</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.40 &#177; 0.20</td><td rowspan="1" colspan="1">0.25 &#177; 0.11</td><td rowspan="1" colspan="1">0.63</td></tr></tbody>
###xml 13507 16718 13482 16585 <table xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Binding site ID</th><th rowspan="1" colspan="1">Nearest gene, mRNA, EST, or genomic location</th><th rowspan="1" colspan="1">GenBank ID</th><th rowspan="1" colspan="1">Also known as</th><th rowspan="1" colspan="1">Distance to start of gene</th><th colspan="2" align="center" rowspan="1">Cluster information<hr/></th><th colspan="2" align="center" rowspan="1">Normalized binding<hr/></th><th rowspan="1" colspan="1">Binding ratios</th></tr><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">No. of tags</th><th rowspan="1" colspan="1">Length, nt</th><th rowspan="1" colspan="1">Control &#177; SD</th><th rowspan="1" colspan="1">Rifampicin &#177; SD</th><th rowspan="1" colspan="1">Rifampicin/ control</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">SLC40A1</td><td rowspan="1" colspan="1">Solute carrier family 40 (iron-regulated transporter), member 1</td><td rowspan="1" colspan="1">NM_014585</td><td rowspan="1" colspan="1">FPN1; HFE4; MTP1; IREG1; MST079; MSTP079; SLC11A3</td><td rowspan="1" colspan="1">&#8722;2914, &#8722;3986</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">1113</td><td rowspan="1" colspan="1">0.30 &#177; 0.10</td><td rowspan="1" colspan="1">0.39 &#177; 0.17</td><td rowspan="1" colspan="1">1.29</td></tr><tr><td rowspan="1" colspan="1">KCNK 5</td><td rowspan="1" colspan="1">Potassium channel, subfamily K, member 5</td><td rowspan="1" colspan="1">NM_003740</td><td rowspan="1" colspan="1">FLJ11035, K2p5.1, TASK-2, TASK2</td><td rowspan="1" colspan="1">18 682, 18 670</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">44</td><td rowspan="1" colspan="1">0.66 &#177; 0.07</td><td rowspan="1" colspan="1">0.85 &#177; 0.14</td><td rowspan="1" colspan="1">1.29</td></tr><tr><td rowspan="1" colspan="1">SULT 1B1</td><td rowspan="1" colspan="1">Sulfotransferase family, cytosolic, 1B, member 1</td><td rowspan="1" colspan="1">NM_014465</td><td rowspan="1" colspan="1">ST1B2; SULT1B2; MGC13356</td><td rowspan="1" colspan="1">&#8722;271</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.41 &#177; 0.16</td><td rowspan="1" colspan="1">0.34 &#177; 0.03</td><td rowspan="1" colspan="1">0.82</td></tr><tr><td rowspan="1" colspan="1">AKR1C1/2 (gene)</td><td rowspan="1" colspan="1">Aldo-keto reductase family 1, member C1</td><td rowspan="1" colspan="1">NM_001354</td><td rowspan="1" colspan="1">2-ALPHA-HSD, 20-ALPHA-HSD, C9, DD1, DDH, DDH1, H-37, HAKRC, MBAB, MGC8954</td><td rowspan="1" colspan="1">4088</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.39 &#177; 0.13</td><td rowspan="1" colspan="1">0.40 &#177; 0.22</td><td rowspan="1" colspan="1">1.03</td></tr><tr><td rowspan="1" colspan="1">AKR1C1/2 (downstream)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">NM_001354</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">18 979</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.45 &#177; 0.13</td><td rowspan="1" colspan="1">0.40 &#177; 0.07</td><td rowspan="1" colspan="1">0.90</td></tr><tr><td rowspan="1" colspan="1">EIF5</td><td rowspan="1" colspan="1">Eukaryotic translation initiation factor 5</td><td rowspan="1" colspan="1">NM_001969</td><td rowspan="1" colspan="1">EIF-5A</td><td rowspan="1" colspan="1">&#8722;1198</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.50 &#177; 0.05</td><td rowspan="1" colspan="1">0.47 &#177; 0.01</td><td rowspan="1" colspan="1">0.93</td></tr><tr><td rowspan="1" colspan="1">CYP2C8 (gene)</td><td rowspan="1" colspan="1">Cytochrome P450, family 2, subfamily C, polypeptide 8</td><td rowspan="1" colspan="1">NM_000770</td><td rowspan="1" colspan="1">CPC8, P450 MP-12/MP-20</td><td rowspan="1" colspan="1">18 489</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.30 &#177; 0.10</td><td rowspan="1" colspan="1">0.25 &#177; 0.01</td><td rowspan="1" colspan="1">0.86</td></tr><tr><td rowspan="1" colspan="1">CD59</td><td rowspan="1" colspan="1">CD59 molecule, complement regulatory protein</td><td rowspan="1" colspan="1">NM_000611</td><td rowspan="1" colspan="1">16.3A5, EJ16, EJ30, EL32, G344, MGC2354, MIC11, MIN1, MIN2, MIN3, MSK21, PROTECTIN, p18-20</td><td rowspan="1" colspan="1">36 417</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.89 &#177; 0.14</td><td rowspan="1" colspan="1">1.08 &#177; 0.30</td><td rowspan="1" colspan="1">1.21</td></tr><tr><td rowspan="1" colspan="1">CYP4F12<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">Cytochrome P450, family 4, subfamily F, polypeptide 12</td><td rowspan="1" colspan="1">NM_023944</td><td rowspan="1" colspan="1">F22329_1</td><td rowspan="1" colspan="1">8204, 8197</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">46</td><td rowspan="1" colspan="1">1.99 &#177; 0.29</td><td rowspan="1" colspan="1">3.49 &#177; 0.41</td><td rowspan="1" colspan="1">1.75</td></tr><tr><td rowspan="1" colspan="1">ABCC4<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">ATP-binding cassette, sub-family C (CFTR/MRP), member 4</td><td rowspan="1" colspan="1">NM_005845</td><td rowspan="1" colspan="1">RP11-74A12.1, EST170205, MOAT-B, MOATB, MRP4</td><td rowspan="1" colspan="1">90 518</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.20 &#177; 0.06</td><td rowspan="1" colspan="1">0.34 &#177; 0.02</td><td rowspan="1" colspan="1">1.69</td></tr><tr><td rowspan="1" colspan="1">UGT1A5<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">UDP glucuronosyltransferase 1 family, polypeptide A5</td><td rowspan="1" colspan="1">NM_019078</td><td rowspan="1" colspan="1">UDPGT, UGT1*5, UGT1E</td><td rowspan="1" colspan="1">&#8722;3758</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.41 &#177; 0.13</td><td rowspan="1" colspan="1">0.75 &#177; 0.18</td><td rowspan="1" colspan="1">1.84</td></tr><tr><td rowspan="1" colspan="1">CYP3A5<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">Cytochrome P450, family 3, subfamily A, polypeptide 5</td><td rowspan="1" colspan="1">NM_000777</td><td rowspan="1" colspan="1">CP35, P450PCN3, PCN3</td><td rowspan="1" colspan="1">7277</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.47 &#177; 0.08</td><td rowspan="1" colspan="1">0.79 &#177; 0.19</td><td rowspan="1" colspan="1">1.70</td></tr><tr><td rowspan="1" colspan="1">CARS<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">Cysteinyl-tRNA synthetase</td><td rowspan="1" colspan="1">NM_001751</td><td rowspan="1" colspan="1">CARS1, CYSRS, MGC:11246</td><td rowspan="1" colspan="1">15 820</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.48 &#177; 0.19</td><td rowspan="1" colspan="1">0.92 &#177; 0.23</td><td rowspan="1" colspan="1">1.92</td></tr><tr><td rowspan="1" colspan="1">BMP1<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">Bone morphogenetic protein 1</td><td rowspan="1" colspan="1">NM_006131</td><td rowspan="1" colspan="1">FLJ44432, PCOLC, PCP, TLD</td><td rowspan="1" colspan="1">4711</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.46 &#177; 0.08</td><td rowspan="1" colspan="1">0.69 &#177; 0.14</td><td rowspan="1" colspan="1">1.48</td></tr><tr><td rowspan="1" colspan="1">TGIF2<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">TGF-&#946;-induced factor homeobox 2</td><td rowspan="1" colspan="1">AF055012</td><td rowspan="1" colspan="1">5&#8242;-TG-3&#8242; interacting factor 2; TGF-&#946;-induced transcription factor 2; TGF-&#946;-induced factor 2 (TALE family homeobox); homeobox protein TGIF2; transcription growth factor-&#946;-induced factor 2</td><td rowspan="1" colspan="1">1373</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.72 &#177; 0.21</td><td rowspan="1" colspan="1">1.15 &#177; 0.41</td><td rowspan="1" colspan="1">1.61</td></tr><tr><td rowspan="1" colspan="1">BCL9L<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">B-cell CLL/lymphoma 9-like</td><td rowspan="1" colspan="1">NM_182557</td><td rowspan="1" colspan="1">BCL9-2, DLNB11</td><td rowspan="1" colspan="1">&#8722;23 391, &#8722;23 240, &#8722;23 141</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">291</td><td rowspan="1" colspan="1">1.20 &#177; 0.33</td><td rowspan="1" colspan="1">2.42 &#177; 1.14</td><td rowspan="1" colspan="1">2.01</td></tr><tr><td rowspan="1" colspan="1">CLG<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">Pleckstrin homology domain containing, family G (with RhoGef domain) member 2</td><td rowspan="1" colspan="1">NM_022835</td><td rowspan="1" colspan="1">PLEKHG2, FLJ00018, FLJ22458</td><td rowspan="1" colspan="1">&#8722;14 177, &#8722;15 081, &#8722;15 054</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">933</td><td rowspan="1" colspan="1">0.37 &#177; 0.11</td><td rowspan="1" colspan="1">0.81 &#177; 0.27</td><td rowspan="1" colspan="1">2.20</td></tr><tr><td rowspan="1" colspan="1">GLDC<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">Glycine dehydrogenase (decarboxylating)</td><td rowspan="1" colspan="1">NM_000170</td><td rowspan="1" colspan="1">GCE, GCSP, HYGN1, MGC138198, MGC138200, NKH</td><td rowspan="1" colspan="1">&#8722;109 084, &#8722;109 083, &#8722;109 566</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">524</td><td rowspan="1" colspan="1">0.37 &#177; 0.12</td><td rowspan="1" colspan="1">0.66 &#177; 0.27</td><td rowspan="1" colspan="1">1.77</td></tr><tr><td rowspan="1" colspan="1">ABCB4<sup>a</sup></td><td rowspan="1" colspan="1">ATP-binding cassette, sub-family B (MDR/TAP), member 4</td><td rowspan="1" colspan="1">NM_018849</td><td rowspan="1" colspan="1">MDR3; PGY3; ABC21; MDR2/3; PFIC-3</td><td rowspan="1" colspan="1">&#8722;3078</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.74 &#177; 0.05</td><td rowspan="1" colspan="1">1.19 &#177; 0.39</td><td rowspan="1" colspan="1">1.60</td></tr><tr><td rowspan="1" colspan="1">CFL1</td><td rowspan="1" colspan="1">Cofilin 1 (non-muscle)</td><td rowspan="1" colspan="1">NM_005507</td><td rowspan="1" colspan="1">CFL</td><td rowspan="1" colspan="1">&#8722;1874, &#8722;1879, &#8722;1882</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">47</td><td rowspan="1" colspan="1">0.44 &#177; 0.13</td><td rowspan="1" colspan="1">0.29 &#177; 0.16</td><td rowspan="1" colspan="1">0.66</td></tr><tr><td rowspan="1" colspan="1">CYP2C8 (downstream)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">NM_000770</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">33 678</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.51 &#177; 0.27</td><td rowspan="1" colspan="1">0.36 &#177; 0.15</td><td rowspan="1" colspan="1">0.71</td></tr><tr><td rowspan="1" colspan="1">GCKR</td><td rowspan="1" colspan="1">Glucokinase (hexokinase 4) regulator</td><td rowspan="1" colspan="1">NM_001486</td><td rowspan="1" colspan="1">GKRP</td><td rowspan="1" colspan="1">27 665</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.32 &#177; 0.05</td><td rowspan="1" colspan="1">0.19 &#177; 0.13</td><td rowspan="1" colspan="1">0.60</td></tr><tr><td rowspan="1" colspan="1">GSTT1</td><td rowspan="1" colspan="1">Glutathione S-transferase theta 1</td><td rowspan="1" colspan="1">NM_000853</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8722;567</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.40 &#177; 0.20</td><td rowspan="1" colspan="1">0.25 &#177; 0.11</td><td rowspan="1" colspan="1">0.63</td></tr></tbody></table>
###xml 16718 16719 16585 16586 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 16718 16826 16585 16693 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="34"><sup>a</sup>Trend towards increased PXR binding in the presence of rifampicin compared to vehicle (Control; 0.1% DMSO).</p>
###xml 16718 16826 16585 16693 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="TF1"><p textid="34"><sup>a</sup>Trend towards increased PXR binding in the presence of rifampicin compared to vehicle (Control; 0.1% DMSO).</p></fn>
###xml 16826 16933 16693 16800 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="35">Binding strength was determined by q-PCR signal &gt;5-fold above the background signal obtained for the Untr5.</p>
###xml 16826 16933 16693 16800 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="35">Binding strength was determined by q-PCR signal &gt;5-fold above the background signal obtained for the Untr5.</p></fn>
###xml 16933 17025 16800 16892 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="36">&gt;5-fold binding relative to the negative control region was defined as &#8216;strong PXR binding&#8217;.</p>
###xml 16933 17025 16800 16892 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="36">&gt;5-fold binding relative to the negative control region was defined as &#8216;strong PXR binding&#8217;.</p></fn>
###xml 16718 17025 16585 16892 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><fn id="TF1"><p textid="34"><sup>a</sup>Trend towards increased PXR binding in the presence of rifampicin compared to vehicle (Control; 0.1% DMSO).</p></fn><fn><p textid="35">Binding strength was determined by q-PCR signal &gt;5-fold above the background signal obtained for the Untr5.</p></fn><fn><p textid="36">&gt;5-fold binding relative to the negative control region was defined as &#8216;strong PXR binding&#8217;.</p></fn></table-wrap-foot>
###xml 13456 17025 13431 16892 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T2" position="float"><label>Table 2.</label><caption><p textid="33">List of identified strong PXR binding sites</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Binding site ID</th><th rowspan="1" colspan="1">Nearest gene, mRNA, EST, or genomic location</th><th rowspan="1" colspan="1">GenBank ID</th><th rowspan="1" colspan="1">Also known as</th><th rowspan="1" colspan="1">Distance to start of gene</th><th colspan="2" align="center" rowspan="1">Cluster information<hr/></th><th colspan="2" align="center" rowspan="1">Normalized binding<hr/></th><th rowspan="1" colspan="1">Binding ratios</th></tr><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">No. of tags</th><th rowspan="1" colspan="1">Length, nt</th><th rowspan="1" colspan="1">Control &#177; SD</th><th rowspan="1" colspan="1">Rifampicin &#177; SD</th><th rowspan="1" colspan="1">Rifampicin/ control</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">SLC40A1</td><td rowspan="1" colspan="1">Solute carrier family 40 (iron-regulated transporter), member 1</td><td rowspan="1" colspan="1">NM_014585</td><td rowspan="1" colspan="1">FPN1; HFE4; MTP1; IREG1; MST079; MSTP079; SLC11A3</td><td rowspan="1" colspan="1">&#8722;2914, &#8722;3986</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">1113</td><td rowspan="1" colspan="1">0.30 &#177; 0.10</td><td rowspan="1" colspan="1">0.39 &#177; 0.17</td><td rowspan="1" colspan="1">1.29</td></tr><tr><td rowspan="1" colspan="1">KCNK 5</td><td rowspan="1" colspan="1">Potassium channel, subfamily K, member 5</td><td rowspan="1" colspan="1">NM_003740</td><td rowspan="1" colspan="1">FLJ11035, K2p5.1, TASK-2, TASK2</td><td rowspan="1" colspan="1">18 682, 18 670</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">44</td><td rowspan="1" colspan="1">0.66 &#177; 0.07</td><td rowspan="1" colspan="1">0.85 &#177; 0.14</td><td rowspan="1" colspan="1">1.29</td></tr><tr><td rowspan="1" colspan="1">SULT 1B1</td><td rowspan="1" colspan="1">Sulfotransferase family, cytosolic, 1B, member 1</td><td rowspan="1" colspan="1">NM_014465</td><td rowspan="1" colspan="1">ST1B2; SULT1B2; MGC13356</td><td rowspan="1" colspan="1">&#8722;271</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.41 &#177; 0.16</td><td rowspan="1" colspan="1">0.34 &#177; 0.03</td><td rowspan="1" colspan="1">0.82</td></tr><tr><td rowspan="1" colspan="1">AKR1C1/2 (gene)</td><td rowspan="1" colspan="1">Aldo-keto reductase family 1, member C1</td><td rowspan="1" colspan="1">NM_001354</td><td rowspan="1" colspan="1">2-ALPHA-HSD, 20-ALPHA-HSD, C9, DD1, DDH, DDH1, H-37, HAKRC, MBAB, MGC8954</td><td rowspan="1" colspan="1">4088</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.39 &#177; 0.13</td><td rowspan="1" colspan="1">0.40 &#177; 0.22</td><td rowspan="1" colspan="1">1.03</td></tr><tr><td rowspan="1" colspan="1">AKR1C1/2 (downstream)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">NM_001354</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">18 979</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.45 &#177; 0.13</td><td rowspan="1" colspan="1">0.40 &#177; 0.07</td><td rowspan="1" colspan="1">0.90</td></tr><tr><td rowspan="1" colspan="1">EIF5</td><td rowspan="1" colspan="1">Eukaryotic translation initiation factor 5</td><td rowspan="1" colspan="1">NM_001969</td><td rowspan="1" colspan="1">EIF-5A</td><td rowspan="1" colspan="1">&#8722;1198</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.50 &#177; 0.05</td><td rowspan="1" colspan="1">0.47 &#177; 0.01</td><td rowspan="1" colspan="1">0.93</td></tr><tr><td rowspan="1" colspan="1">CYP2C8 (gene)</td><td rowspan="1" colspan="1">Cytochrome P450, family 2, subfamily C, polypeptide 8</td><td rowspan="1" colspan="1">NM_000770</td><td rowspan="1" colspan="1">CPC8, P450 MP-12/MP-20</td><td rowspan="1" colspan="1">18 489</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.30 &#177; 0.10</td><td rowspan="1" colspan="1">0.25 &#177; 0.01</td><td rowspan="1" colspan="1">0.86</td></tr><tr><td rowspan="1" colspan="1">CD59</td><td rowspan="1" colspan="1">CD59 molecule, complement regulatory protein</td><td rowspan="1" colspan="1">NM_000611</td><td rowspan="1" colspan="1">16.3A5, EJ16, EJ30, EL32, G344, MGC2354, MIC11, MIN1, MIN2, MIN3, MSK21, PROTECTIN, p18-20</td><td rowspan="1" colspan="1">36 417</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.89 &#177; 0.14</td><td rowspan="1" colspan="1">1.08 &#177; 0.30</td><td rowspan="1" colspan="1">1.21</td></tr><tr><td rowspan="1" colspan="1">CYP4F12<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">Cytochrome P450, family 4, subfamily F, polypeptide 12</td><td rowspan="1" colspan="1">NM_023944</td><td rowspan="1" colspan="1">F22329_1</td><td rowspan="1" colspan="1">8204, 8197</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">46</td><td rowspan="1" colspan="1">1.99 &#177; 0.29</td><td rowspan="1" colspan="1">3.49 &#177; 0.41</td><td rowspan="1" colspan="1">1.75</td></tr><tr><td rowspan="1" colspan="1">ABCC4<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">ATP-binding cassette, sub-family C (CFTR/MRP), member 4</td><td rowspan="1" colspan="1">NM_005845</td><td rowspan="1" colspan="1">RP11-74A12.1, EST170205, MOAT-B, MOATB, MRP4</td><td rowspan="1" colspan="1">90 518</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.20 &#177; 0.06</td><td rowspan="1" colspan="1">0.34 &#177; 0.02</td><td rowspan="1" colspan="1">1.69</td></tr><tr><td rowspan="1" colspan="1">UGT1A5<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">UDP glucuronosyltransferase 1 family, polypeptide A5</td><td rowspan="1" colspan="1">NM_019078</td><td rowspan="1" colspan="1">UDPGT, UGT1*5, UGT1E</td><td rowspan="1" colspan="1">&#8722;3758</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.41 &#177; 0.13</td><td rowspan="1" colspan="1">0.75 &#177; 0.18</td><td rowspan="1" colspan="1">1.84</td></tr><tr><td rowspan="1" colspan="1">CYP3A5<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">Cytochrome P450, family 3, subfamily A, polypeptide 5</td><td rowspan="1" colspan="1">NM_000777</td><td rowspan="1" colspan="1">CP35, P450PCN3, PCN3</td><td rowspan="1" colspan="1">7277</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.47 &#177; 0.08</td><td rowspan="1" colspan="1">0.79 &#177; 0.19</td><td rowspan="1" colspan="1">1.70</td></tr><tr><td rowspan="1" colspan="1">CARS<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">Cysteinyl-tRNA synthetase</td><td rowspan="1" colspan="1">NM_001751</td><td rowspan="1" colspan="1">CARS1, CYSRS, MGC:11246</td><td rowspan="1" colspan="1">15 820</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.48 &#177; 0.19</td><td rowspan="1" colspan="1">0.92 &#177; 0.23</td><td rowspan="1" colspan="1">1.92</td></tr><tr><td rowspan="1" colspan="1">BMP1<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">Bone morphogenetic protein 1</td><td rowspan="1" colspan="1">NM_006131</td><td rowspan="1" colspan="1">FLJ44432, PCOLC, PCP, TLD</td><td rowspan="1" colspan="1">4711</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.46 &#177; 0.08</td><td rowspan="1" colspan="1">0.69 &#177; 0.14</td><td rowspan="1" colspan="1">1.48</td></tr><tr><td rowspan="1" colspan="1">TGIF2<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">TGF-&#946;-induced factor homeobox 2</td><td rowspan="1" colspan="1">AF055012</td><td rowspan="1" colspan="1">5&#8242;-TG-3&#8242; interacting factor 2; TGF-&#946;-induced transcription factor 2; TGF-&#946;-induced factor 2 (TALE family homeobox); homeobox protein TGIF2; transcription growth factor-&#946;-induced factor 2</td><td rowspan="1" colspan="1">1373</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.72 &#177; 0.21</td><td rowspan="1" colspan="1">1.15 &#177; 0.41</td><td rowspan="1" colspan="1">1.61</td></tr><tr><td rowspan="1" colspan="1">BCL9L<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">B-cell CLL/lymphoma 9-like</td><td rowspan="1" colspan="1">NM_182557</td><td rowspan="1" colspan="1">BCL9-2, DLNB11</td><td rowspan="1" colspan="1">&#8722;23 391, &#8722;23 240, &#8722;23 141</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">291</td><td rowspan="1" colspan="1">1.20 &#177; 0.33</td><td rowspan="1" colspan="1">2.42 &#177; 1.14</td><td rowspan="1" colspan="1">2.01</td></tr><tr><td rowspan="1" colspan="1">CLG<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">Pleckstrin homology domain containing, family G (with RhoGef domain) member 2</td><td rowspan="1" colspan="1">NM_022835</td><td rowspan="1" colspan="1">PLEKHG2, FLJ00018, FLJ22458</td><td rowspan="1" colspan="1">&#8722;14 177, &#8722;15 081, &#8722;15 054</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">933</td><td rowspan="1" colspan="1">0.37 &#177; 0.11</td><td rowspan="1" colspan="1">0.81 &#177; 0.27</td><td rowspan="1" colspan="1">2.20</td></tr><tr><td rowspan="1" colspan="1">GLDC<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">Glycine dehydrogenase (decarboxylating)</td><td rowspan="1" colspan="1">NM_000170</td><td rowspan="1" colspan="1">GCE, GCSP, HYGN1, MGC138198, MGC138200, NKH</td><td rowspan="1" colspan="1">&#8722;109 084, &#8722;109 083, &#8722;109 566</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">524</td><td rowspan="1" colspan="1">0.37 &#177; 0.12</td><td rowspan="1" colspan="1">0.66 &#177; 0.27</td><td rowspan="1" colspan="1">1.77</td></tr><tr><td rowspan="1" colspan="1">ABCB4<sup>a</sup></td><td rowspan="1" colspan="1">ATP-binding cassette, sub-family B (MDR/TAP), member 4</td><td rowspan="1" colspan="1">NM_018849</td><td rowspan="1" colspan="1">MDR3; PGY3; ABC21; MDR2/3; PFIC-3</td><td rowspan="1" colspan="1">&#8722;3078</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.74 &#177; 0.05</td><td rowspan="1" colspan="1">1.19 &#177; 0.39</td><td rowspan="1" colspan="1">1.60</td></tr><tr><td rowspan="1" colspan="1">CFL1</td><td rowspan="1" colspan="1">Cofilin 1 (non-muscle)</td><td rowspan="1" colspan="1">NM_005507</td><td rowspan="1" colspan="1">CFL</td><td rowspan="1" colspan="1">&#8722;1874, &#8722;1879, &#8722;1882</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">47</td><td rowspan="1" colspan="1">0.44 &#177; 0.13</td><td rowspan="1" colspan="1">0.29 &#177; 0.16</td><td rowspan="1" colspan="1">0.66</td></tr><tr><td rowspan="1" colspan="1">CYP2C8 (downstream)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">NM_000770</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">33 678</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.51 &#177; 0.27</td><td rowspan="1" colspan="1">0.36 &#177; 0.15</td><td rowspan="1" colspan="1">0.71</td></tr><tr><td rowspan="1" colspan="1">GCKR</td><td rowspan="1" colspan="1">Glucokinase (hexokinase 4) regulator</td><td rowspan="1" colspan="1">NM_001486</td><td rowspan="1" colspan="1">GKRP</td><td rowspan="1" colspan="1">27 665</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.32 &#177; 0.05</td><td rowspan="1" colspan="1">0.19 &#177; 0.13</td><td rowspan="1" colspan="1">0.60</td></tr><tr><td rowspan="1" colspan="1">GSTT1</td><td rowspan="1" colspan="1">Glutathione S-transferase theta 1</td><td rowspan="1" colspan="1">NM_000853</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#8722;567</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.40 &#177; 0.20</td><td rowspan="1" colspan="1">0.25 &#177; 0.11</td><td rowspan="1" colspan="1">0.63</td></tr></tbody></table><table-wrap-foot><fn id="TF1"><p textid="34"><sup>a</sup>Trend towards increased PXR binding in the presence of rifampicin compared to vehicle (Control; 0.1% DMSO).</p></fn><fn><p textid="35">Binding strength was determined by q-PCR signal &gt;5-fold above the background signal obtained for the Untr5.</p></fn><fn><p textid="36">&gt;5-fold binding relative to the negative control region was defined as &#8216;strong PXR binding&#8217;.</p></fn></table-wrap-foot></table-wrap>
###xml 1602 1607 <span type="species:ncbi:9606">human</span>
###xml 7906 7911 <span type="species:ncbi:10090">mouse</span>
###xml 8224 8229 <span type="species:ncbi:10090">mouse</span>
###xml 11840 11845 <span type="species:ncbi:9606">human</span>
###xml 12965 12970 <span type="species:ncbi:10090">mouse</span>
The binding of PXR to identified genomic locations in cryopreserved hepatocytes treated with either vehicle or rifampicin was confirmed by q-PCR using PXR primers encompassing approximately200 nt of the putative PXR binding sites (). Of the 182 clusters, 12 clusters with strong PXR binding (>5-fold binding relative to the negative control region) were selected for further testing (Table 1). Several of these were not in the proximity of genes known to be involved in drug metabolism or transport but were involved in apoptosis, electron transport, hormone catabolic processes, response to chemical stimuli and steroid, estradiol, linoleic acid, retinol, tryptophan, arachidonic acid, fatty acid and lipid metabolism. In addition, 29 tags were selected which were in the proximity of genes known to be involved in different metabolic processes including drug metabolism, or recently identified as PXR target genes by gene profiling in studies with the colon carcinoma cell line LS180 (Table 1) (2). Of the 41 tags/clusters selected, 23 showed elevated PXR binding (>5-fold increased binding compared to the negative control regions) (Table 2). Interestingly, of the 23 identified PXR-binding sites only 11 showed a trend towards increased PXR-binding in the presence of rifampicin compared to the vehicle (Table 2 and Figure 3A). However, statistically significant differences were only observed for CYP4F12 and ABCC4. Figure 3.PXR (A) and SRC-1 (B) binding to 11 of 23 genes identified as PXRE-containing promoters with a trend towards increased binding in the presence of rifampicin. Cryopreserved human hepatocytes were treated with vehicle (Control; 0.1% DMSO) or rifampicin (10 microM) for 3 h and processed for ChIP assays as described in the Materials and methods section. The error bars represent the SD from the mean of triplicate assays of an individual experiment, n = 3, *P < 0.05. PXR-binding to CLG and SRC-1-binding to ABCB4 in rifampicin-treated cells are based upon n = 2.Table 1.Tags/Clusters from discovery approach selected for further analysisGenomic regionTag/Cluster nameGene/Proteome descriptionCYP3A4 (PXRE)Control (literature)CYP2B6Control (literature)UGT1A1Control (literature)MDR1Control (literature)CARSGP0059_02_B04-frag008Encodes a class 1 aminoacyl-tRNA synthetase, cysteinyl-tRNA synthetase. Each of the 20 aminoacyl-tRNA synthetases catalyzes the aminoacylation of a specific tRNA or tRNA isoaccepting family with the cognate amino acid. Alterations in this region have been associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and lung, ovarian and breast cancer.OSBP2GP0059_06_B06-frag009Oxysterols are byproducts of cholesterol that can have cytotoxic effects on many cell types. The membrane-bound protein encoded by this gene contains a pleckstrin homology domain and an oxysterol-binding region. It binds oxysterols such as 7-ketocholesterol and may inhibit their cytotoxicity.PFASGP0059_03_A11-frag004The enzyme encoded by this gene catalyzes the fourth step of inosine monophosphate biosynthesis.CD59GP0059_06_C01-frag008This gene encodes a cell surface glycoprotein that regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. This protein also plays a role in signal transduction pathways in the activation of T cells. Mutations in this gene cause CD59 deficiency, a disease resulting in hemolytic anemia and thrombosis, and which causes cerebral infarction.CEACAM6GP0059_05_C06-frag011Carcinoembryonic antigen is one of the most widely used tumor markers in serum immunoassay determinations of carcinoma. An apparent lack of absolute cancer specificity for CEA probably results in part from the presence in normal and neoplastic tissues of antigens that share antigenic determinants with the 180 kDa form of CEA.DOCK1GP0059_08_D04-frag004Dedicator of cytokinesis 1, member of the CDM family, contains an SH3 domain, binds phosphatidylinositol-3,4,5-triphosphate, integrin receptor-mediated complex formation with BCAR1 and CRK leads to RAC1 activation and phagocytosis of apoptotic cells.FLJ10986GP0059_06_D06-frag004CYP4F12Cluster 19 153 (GP0059_07_F05-frag007; GP0059_06_D09-frag005)Cytochrome P450 family 4 subfamily F polypeptide 12, metabolizes arachidonic acid by omega 3-hydroxylation, metabolizes docosahexanoic acid, docosapentaenoic acid, leukotrienes and the antihistamine drug ebastine.CYP3A5GP0059_02_H05-frag007This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. The enzyme metabolizes drugs such as nifedipine and cyclosporine as well as the steroid hormones testosterone, progesterone and androstenedione. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. This cluster includes a pseudogene, CYP3A5P1, which is very similar to CYP3A5. This similarity has caused some difficulty in determining whether cloned sequences represent the gene or the pseudogene.CYP3A5P2/CYP3A4Cluster 7 170 (GP0059_04_A01-frag006; GP0059_01_D05-frag007)ABCC4GP0059_10_C11-frag004The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. This protein is a member of the MRP subfamily which is involved in multi-drug resistance. The specific function of this protein has not yet been determined; however, this protein may play a role in cellular detoxification as a pump for its substrate, organic anions.SULT1B1GP0059_01_B02-frag007Sulfotransferase enzymes catalyze the sulfate conjugation of many hormones, neurotransmitters, drugs and xenobiotic compounds. These cytosolic enzymes are different in their tissue distributions and substrate specificities. The gene structure (number and length of exons) is similar among family members.SLC40A1Cluster 2 215 (GP0059_10_F11-frag006; GP0059_01_C04-frag005)Solute carrier family 40 (iron-regulated transporter) member 1, an iron transporter involved in iron homeostasis and regulation of translation initiation, possibly involved in development; gene mutations are a cause of autosomal dominant hemochromatosis.KCNK5Cluster 6 129 (GP0059_03_F09-frag006; GP0059_10_A04-frag005)Potassium channel subfamily K member 5, mediates a pH and acid sensitive, noninactivating, outwardly rectifying K+ conductance, involved in potassium ion transport, inhibited by amide anesthetics.UGT1A5GP0059_07_C01-frag002Encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones and drugs, into water-soluble, excretable metabolites.AKR1C1GP0059_01_B10-frag003Aldo-keto reductase family 1 member C1 acts in xenobiotic and progesterone metabolism, increased expression is observed in lung cancer, glaucoma and polycystic ovary syndrome.AKR1C2GP0059_02_C12-frag007Aldo-keto reductase family 1 member C2 (dihydrodiol dehydrogenase), functions in bile transport, steroid metabolism and xenobiotic metabolism, expression is decreased in prostate and breast cancer but upregulated in esophageal squamous cell carcinoma.CYP2C8 (gene)GP0059_03_D11-frag004Cytochrome P450 family 2 subfamily C polypeptide 8, a member of heme-binding mono-oxygenase superfamily, metabolizes steroids, fatty acids and xenobiotics, altered expression may contribute to colon cancer development.CYP2C8 (downstream)GP0059_05_C04-frag010PAPSS2GP0059_01_A08-frag0023'-phosphoadenosine 5'-phosphosulfate synthase 2, involved in skeletal development; mutation in the corresponding gene correlates with spondyloepimetaphyseal dysplasia, mouse Papss2 gene is associated with brachymorphism.HDAC7AGP0059_06_H02-frag002Histone acetylation/deacetylation alters chromosome structure and affects transcription factor access to DNA. The protein encoded by this gene has sequence homology to members of the histone deacetylase family. This gene is orthologous to mouse HDAC7 gene whose protein promotes repression mediated via the transcriptional corepressor SMRT.TEAD2GP0059_01_B06-frag007TEA domain family member 2, a member of the TEA DNA-binding domain family of transcription factors, regulates transcription, may be involved in organ morphogenesis and central nervous system development.HIST1H1EGP0059_06_E12-frag008The linker histone, H1, interacts with linker DNA between nucleosomes and functions in the compaction of chromatin into higher order structures. This gene is intronless and encodes a member of the histone H1 family. Transcripts from this gene lack polyA tails but instead contain a palindromic termination element. This gene is found in the large histone gene cluster on chromosome 6.BMP1GP0059_06_G08-frag002Encodes a protein that is capable of inducing formation of cartilage in vivo. Although other bone morphogenetic proteins are members of the TGF-beta superfamily, this gene encodes a protein that is not closely related to other known growth factors.CFL1GP0059_09_F09-frag0005Cofilin 1 (non-muscle), plays a role in actin filament depolymerization and lymphocyte chemotaxis, involved in the G protein-coupled receptor protein and Rho protein signaling pathways.EIF5GP0059_05_G08-frag003TGIF2GP0059_03_G06-frag003This gene is a DNA-binding homeobox protein and a transcriptional repressor. The encoded protein appears to repress transcription by recruiting histone deacetylases to TGF-beta-responsive genes. This gene is amplified and overexpressed in some ovarian cancers, and mutations in this gene can cause holoprosencephaly.BBC3Cluster 19-76Bcl-2 binding component 3, regulates p53 (TP53)-dependent and independent apoptosis, increased expression of BBC3 plays a role in chronic lymphocytic leukemia and lung neoplasms and is used in the treatment of glioma and colorectal neoplasms.CLGCluster 19-185GLDCCluster 9-228Glycine decarboxylase (glycine dehydrogenase, P-protein), part of the glycine cleavage system that catalyzes the decarboxylation of glycine; mutation of the corresponding gene causes nonketotic hyperglycinemia.ABCB4GP0059_06_D02-frag005This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance as well as antigen presentation. This gene encodes a full transporter and member of the P-glycoprotein family of membrane proteins with phosphatidylcholine as its substrate. The function of this protein has not yet been determined; however, it may involve transport of phospholipids from liver hepatocytes into bile.CENTD2Cluster 11-186Centaurin delta 2, functions as a GTPase activating protein (GAP) for both Arf and Rho family proteins, mediates PIP3 phosphoinositide-dependent Golgi apparatus membrane changes, filopodia formation and cell spreading.ZNF281Cluster 1-52Zinc finger protein 281, a transcriptional repressor, member of the ZBP family, contains four Kruppel-type zinc fingers.BCL9LCluster 11-267B-cell CLL/lymphoma 9-like, a BCL9-related protein that acts as a transcriptional regulator, induces beta-catenin (CTNNB1) nuclear translocation epithelial to mesenchymal transition, enhances cell migration, expression is upregulated in colorectal tumors.ARNT2Cluster 15-179Aryl-hydrocarbon receptor nuclear translocator 2, a protein that heterodimerizes with HIF-1alpha (HIF1A) and is involved in hypoxia-induced erythropoietin (EPO) expression.ASS1Cluster 9-86The protein encoded by this gene catalyzes the penultimate step of the arginine biosynthetic pathway. There are approximately 10-14 copies of this gene including the pseudogenes scattered across the human genome, among which the one located on chromosome 9 appears to be the only functional gene for argininosuccinate synthetase. Mutations in the chromosome 9 copy of ASS cause citrullinemia. Two transcript variants encoding the same protein have been found for this gene.CTNNA1GF0059_10_B02-frag003ELK1GP0059_02_G12-frag003This gene is a member of the Ets family of transcription factors and of the ternary complex factor (TCF) subfamily. Proteins of the TCF subfamily form a ternary complex by binding to the the serum response factor and the serum reponse element in the promoter of the c-fos proto-oncogene. The protein encoded by this gene is a nuclear target for the ras-raf-MAPK signaling cascade.MTL5GP0059_04_G12-frag010Metallothionein proteins are highly conserved low-molecular-weight cysteine-rich proteins that are induced by and bind to heavy metal ions and have no enzymatic activity. They may play a central role in the regulation of cell growth and differentiation and are involved in spermatogenesis. This gene encodes a metallothionein-like protein which has been shown to be expressed differentially in mouse testes and ovary.WTGP0059_05_B10-frag005XRCC5GP0059_01_D07-frag005The protein encoded by this gene is the 80 kDa subunit of the Ku heterodimer protein which is also known as ATP-dependant DNA helicase II or DNA repair protein XRCC5. Ku is the DNA-binding component of the DNA-dependent protein kinase, and it functions together with the DNA ligase IV-XRCC4 complex in the repair of DNA double-strand break by non-homologous end joining and the completion of V(D)J recombination events.Table 2.List of identified strong PXR binding sitesBinding site IDNearest gene, mRNA, EST, or genomic locationGenBank IDAlso known asDistance to start of geneCluster informationNormalized bindingBinding ratiosNo. of tagsLength, ntControl +/- SDRifampicin +/- SDRifampicin/ controlSLC40A1Solute carrier family 40 (iron-regulated transporter), member 1NM_014585FPN1; HFE4; MTP1; IREG1; MST079; MSTP079; SLC11A3-2914, -3986211130.30 +/- 0.100.39 +/- 0.171.29KCNK 5Potassium channel, subfamily K, member 5NM_003740FLJ11035, K2p5.1, TASK-2, TASK218 682, 18 6702440.66 +/- 0.070.85 +/- 0.141.29SULT 1B1Sulfotransferase family, cytosolic, 1B, member 1NM_014465ST1B2; SULT1B2; MGC13356-2710.41 +/- 0.160.34 +/- 0.030.82AKR1C1/2 (gene)Aldo-keto reductase family 1, member C1NM_0013542-ALPHA-HSD, 20-ALPHA-HSD, C9, DD1, DDH, DDH1, H-37, HAKRC, MBAB, MGC895440880.39 +/- 0.130.40 +/- 0.221.03AKR1C1/2 (downstream)NM_00135418 9790.45 +/- 0.130.40 +/- 0.070.90EIF5Eukaryotic translation initiation factor 5NM_001969EIF-5A-11980.50 +/- 0.050.47 +/- 0.010.93CYP2C8 (gene)Cytochrome P450, family 2, subfamily C, polypeptide 8NM_000770CPC8, P450 MP-12/MP-2018 4890.30 +/- 0.100.25 +/- 0.010.86CD59CD59 molecule, complement regulatory proteinNM_00061116.3A5, EJ16, EJ30, EL32, G344, MGC2354, MIC11, MIN1, MIN2, MIN3, MSK21, PROTECTIN, p18-2036 4170.89 +/- 0.141.08 +/- 0.301.21CYP4F12aCytochrome P450, family 4, subfamily F, polypeptide 12NM_023944F22329_18204, 81972461.99 +/- 0.293.49 +/- 0.411.75ABCC4aATP-binding cassette, sub-family C (CFTR/MRP), member 4NM_005845RP11-74A12.1, EST170205, MOAT-B, MOATB, MRP490 5180.20 +/- 0.060.34 +/- 0.021.69UGT1A5aUDP glucuronosyltransferase 1 family, polypeptide A5NM_019078UDPGT, UGT1*5, UGT1E-37580.41 +/- 0.130.75 +/- 0.181.84CYP3A5aCytochrome P450, family 3, subfamily A, polypeptide 5NM_000777CP35, P450PCN3, PCN372770.47 +/- 0.080.79 +/- 0.191.70CARSaCysteinyl-tRNA synthetaseNM_001751CARS1, CYSRS, MGC:1124615 8200.48 +/- 0.190.92 +/- 0.231.92BMP1aBone morphogenetic protein 1NM_006131FLJ44432, PCOLC, PCP, TLD47110.46 +/- 0.080.69 +/- 0.141.48TGIF2aTGF-beta-induced factor homeobox 2AF0550125'-TG-3' interacting factor 2; TGF-beta-induced transcription factor 2; TGF-beta-induced factor 2 (TALE family homeobox); homeobox protein TGIF2; transcription growth factor-beta-induced factor 213730.72 +/- 0.211.15 +/- 0.411.61BCL9LaB-cell CLL/lymphoma 9-likeNM_182557BCL9-2, DLNB11-23 391, -23 240, -23 14132911.20 +/- 0.332.42 +/- 1.142.01CLGaPleckstrin homology domain containing, family G (with RhoGef domain) member 2NM_022835PLEKHG2, FLJ00018, FLJ22458-14 177, -15 081, -15 05439330.37 +/- 0.110.81 +/- 0.272.20GLDCaGlycine dehydrogenase (decarboxylating)NM_000170GCE, GCSP, HYGN1, MGC138198, MGC138200, NKH-109 084, -109 083, -109 56635240.37 +/- 0.120.66 +/- 0.271.77ABCB4aATP-binding cassette, sub-family B (MDR/TAP), member 4NM_018849MDR3; PGY3; ABC21; MDR2/3; PFIC-3-30780.74 +/- 0.051.19 +/- 0.391.60CFL1Cofilin 1 (non-muscle)NM_005507CFL-1874, -1879, -18823470.44 +/- 0.130.29 +/- 0.160.66CYP2C8 (downstream)NM_00077033 6780.51 +/- 0.270.36 +/- 0.150.71GCKRGlucokinase (hexokinase 4) regulatorNM_001486GKRP27 6650.32 +/- 0.050.19 +/- 0.130.60GSTT1Glutathione S-transferase theta 1NM_000853-5670.40 +/- 0.200.25 +/- 0.110.63aTrend towards increased PXR binding in the presence of rifampicin compared to vehicle (Control; 0.1% DMSO).Binding strength was determined by q-PCR signal >5-fold above the background signal obtained for the Untr5.>5-fold binding relative to the negative control region was defined as 'strong PXR binding'.
###end p 30
###begin p 31
###xml 5 6 5 6 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 19 20 19 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 448 449 444 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 456 457 452 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 555 556 551 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 172 177 <span type="species:ncbi:9606">human</span>
PXR (A) and SRC-1 (B) binding to 11 of 23 genes identified as PXRE-containing promoters with a trend towards increased binding in the presence of rifampicin. Cryopreserved human hepatocytes were treated with vehicle (Control; 0.1% DMSO) or rifampicin (10 microM) for 3 h and processed for ChIP assays as described in the Materials and methods section. The error bars represent the SD from the mean of triplicate assays of an individual experiment, n = 3, *P < 0.05. PXR-binding to CLG and SRC-1-binding to ABCB4 in rifampicin-treated cells are based upon n = 2.
###end p 31
###begin p 32
Tags/Clusters from discovery approach selected for further analysis
###end p 32
###begin p 33
List of identified strong PXR binding sites
###end p 33
###begin p 34
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
aTrend towards increased PXR binding in the presence of rifampicin compared to vehicle (Control; 0.1% DMSO).
###end p 34
###begin p 35
Binding strength was determined by q-PCR signal >5-fold above the background signal obtained for the Untr5.
###end p 35
###begin p 36
>5-fold binding relative to the negative control region was defined as 'strong PXR binding'.
###end p 36
###begin p 37
###xml 262 270 262 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 638 646 626 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 712 721 700 709 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4.</label>
###xml 1249 1250 1230 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1257 1258 1238 1239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 721 1266 709 1247 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="38">RNA Pol II binding at or near previously known and unknown PXR binding sites. Chromatin from vehicle or 10 &#181;M rifampicin-treated hepatocytes (3 h) were immunoprecipitated with anti-Pol II antibodies, and binding of Pol II to the candidate PXR-binding sites or nearby gene sequences were determined by q-PCR. Sequences amplified by PCR were the same as for Figure 3. Signals were normalized for the &#946;-actin housekeeping gene. The error bars represent the SD from the mean of triplicate assays of an individual experiment, <italic>n</italic> = 3, *<italic>P</italic> &lt; 0.05.</p>
###xml 721 1266 709 1247 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="38">RNA Pol II binding at or near previously known and unknown PXR binding sites. Chromatin from vehicle or 10 &#181;M rifampicin-treated hepatocytes (3 h) were immunoprecipitated with anti-Pol II antibodies, and binding of Pol II to the candidate PXR-binding sites or nearby gene sequences were determined by q-PCR. Sequences amplified by PCR were the same as for Figure 3. Signals were normalized for the &#946;-actin housekeeping gene. The error bars represent the SD from the mean of triplicate assays of an individual experiment, <italic>n</italic> = 3, *<italic>P</italic> &lt; 0.05.</p></caption>
###xml 1266 1266 1247 1247 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn1047f4"/>
###xml 712 1266 700 1247 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F4" position="float"><label>Figure 4.</label><caption><p textid="38">RNA Pol II binding at or near previously known and unknown PXR binding sites. Chromatin from vehicle or 10 &#181;M rifampicin-treated hepatocytes (3 h) were immunoprecipitated with anti-Pol II antibodies, and binding of Pol II to the candidate PXR-binding sites or nearby gene sequences were determined by q-PCR. Sequences amplified by PCR were the same as for Figure 3. Signals were normalized for the &#946;-actin housekeeping gene. The error bars represent the SD from the mean of triplicate assays of an individual experiment, <italic>n</italic> = 3, *<italic>P</italic> &lt; 0.05.</p></caption><graphic xlink:href="gkn1047f4"/></fig>
In addition to assessing increased PXR-binding, we also determined whether increased PXR binding at the newly identified sites, as well as the previously identified literature controls, did result in increased binding of DNA-dependent RNA Pol II to these genes (Figure 4). Determinations were performed in a ChIP-type assay using an antibody against RNA Pol II (20). CYP4F12 showed a trend towards increased Pol II binding in the presence of rifampicin. However, ABCC4, UGT1A5, CARS, BMP1, TGIF2, BCL9L, CLG, GLDC and ABCB4 showed no change. As expected, both CYP3A4 and CYP2B6 showed a approximately2-fold increase in binding of Pol II (Figure 4). The increase observed for UGT1A1 and MDR1 was not significant. Figure 4.RNA Pol II binding at or near previously known and unknown PXR binding sites. Chromatin from vehicle or 10 microM rifampicin-treated hepatocytes (3 h) were immunoprecipitated with anti-Pol II antibodies, and binding of Pol II to the candidate PXR-binding sites or nearby gene sequences were determined by q-PCR. Sequences amplified by PCR were the same as for Figure 3. Signals were normalized for the beta-actin housekeeping gene. The error bars represent the SD from the mean of triplicate assays of an individual experiment, n = 3, *P < 0.05.
###end p 37
###begin p 38
###xml 528 529 521 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 536 537 529 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
RNA Pol II binding at or near previously known and unknown PXR binding sites. Chromatin from vehicle or 10 microM rifampicin-treated hepatocytes (3 h) were immunoprecipitated with anti-Pol II antibodies, and binding of Pol II to the candidate PXR-binding sites or nearby gene sequences were determined by q-PCR. Sequences amplified by PCR were the same as for Figure 3. Signals were normalized for the beta-actin housekeeping gene. The error bars represent the SD from the mean of triplicate assays of an individual experiment, n = 3, *P < 0.05.
###end p 38
###begin p 39
###xml 206 214 206 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 915 917 915 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1054 1063 1054 1063 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5.</label>
###xml 1514 1515 1498 1499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1515 1516 1499 1500 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 1677 1678 1661 1662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1685 1686 1669 1670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1063 1694 1063 1678 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="40">Comparison of CYP3A4-, CYP2B6-, CYP4F12-, MDR1- and UGT1A1-mRNA expression following 3 and 48 h treatment with rifampicin 10 &#181;M. Cryopreserved human hepatocytes were treated with vehicle (Control; 0.1% DMSO) or 10 &#181;M rifampicin for either 3 or 48 h. Thereafter, total RNA was isolated and subjected to TaqMan analysis as described in the Materials and methods section. Gene expression values were calculated based on the comparative &#916;&#916;<italic>C</italic><sub>t</sub> method and normalized to values obtained for 18S ribosomal RNA. The error bars represent the SD from the mean of triplicate assays of an individual experiment, <italic>n</italic> = 3, *<italic>P</italic> &lt; 0.05.</p>
###xml 1063 1694 1063 1678 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="40">Comparison of CYP3A4-, CYP2B6-, CYP4F12-, MDR1- and UGT1A1-mRNA expression following 3 and 48 h treatment with rifampicin 10 &#181;M. Cryopreserved human hepatocytes were treated with vehicle (Control; 0.1% DMSO) or 10 &#181;M rifampicin for either 3 or 48 h. Thereafter, total RNA was isolated and subjected to TaqMan analysis as described in the Materials and methods section. Gene expression values were calculated based on the comparative &#916;&#916;<italic>C</italic><sub>t</sub> method and normalized to values obtained for 18S ribosomal RNA. The error bars represent the SD from the mean of triplicate assays of an individual experiment, <italic>n</italic> = 3, *<italic>P</italic> &lt; 0.05.</p></caption>
###xml 1694 1694 1678 1678 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn1047f5"/>
###xml 1054 1694 1054 1678 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F5" position="float"><label>Figure 5.</label><caption><p textid="40">Comparison of CYP3A4-, CYP2B6-, CYP4F12-, MDR1- and UGT1A1-mRNA expression following 3 and 48 h treatment with rifampicin 10 &#181;M. Cryopreserved human hepatocytes were treated with vehicle (Control; 0.1% DMSO) or 10 &#181;M rifampicin for either 3 or 48 h. Thereafter, total RNA was isolated and subjected to TaqMan analysis as described in the Materials and methods section. Gene expression values were calculated based on the comparative &#916;&#916;<italic>C</italic><sub>t</sub> method and normalized to values obtained for 18S ribosomal RNA. The error bars represent the SD from the mean of triplicate assays of an individual experiment, <italic>n</italic> = 3, *<italic>P</italic> &lt; 0.05.</p></caption><graphic xlink:href="gkn1047f5"/></fig>
###xml 1210 1215 <span type="species:ncbi:9606">human</span>
In order to study the correlation between Pol II binding by ChIP and mRNA levels, we also conducted quantitative mRNA analysis using TaqMan following treatment of hepatocytes with rifampicin for 3 or 48 h (Figure 5). While increases in mRNA expression were observed as early as 3 h, the expression was significantly higher after 48 h of drug treatment. CYP3A4, CYP2B6, CYP4F12, MDR1 and UGT1A1 demonstrated 4.8-, 5.6-, 1.9-, 2.7- and 2.1-fold higher levels of mRNA expression after 48 h compared to 3 h drug treatment. Differences in mRNA levels between genes did not correlate with the Pol II ChIP experiments. The antibody used in these analyses is against phospho-Ser 2 in the C-terminal domain of Pol II, which is the elongating form of the polymerase. The analysis was not done at the transcription start site of the genes of interest as it is known that Pol II may be bound at that area but not transcribing (22). Interestingly, the relative difference in mRNA accumulation after 3 and 48 h of treatment were most pronounced for CYP3A4 and CYP2B6. Figure 5.Comparison of CYP3A4-, CYP2B6-, CYP4F12-, MDR1- and UGT1A1-mRNA expression following 3 and 48 h treatment with rifampicin 10 microM. Cryopreserved human hepatocytes were treated with vehicle (Control; 0.1% DMSO) or 10 microM rifampicin for either 3 or 48 h. Thereafter, total RNA was isolated and subjected to TaqMan analysis as described in the Materials and methods section. Gene expression values were calculated based on the comparative DeltaDeltaCt method and normalized to values obtained for 18S ribosomal RNA. The error bars represent the SD from the mean of triplicate assays of an individual experiment, n = 3, *P < 0.05.
###end p 39
###begin p 40
###xml 451 452 435 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 452 453 436 437 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 614 615 598 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 622 623 606 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 147 152 <span type="species:ncbi:9606">human</span>
Comparison of CYP3A4-, CYP2B6-, CYP4F12-, MDR1- and UGT1A1-mRNA expression following 3 and 48 h treatment with rifampicin 10 microM. Cryopreserved human hepatocytes were treated with vehicle (Control; 0.1% DMSO) or 10 microM rifampicin for either 3 or 48 h. Thereafter, total RNA was isolated and subjected to TaqMan analysis as described in the Materials and methods section. Gene expression values were calculated based on the comparative DeltaDeltaCt method and normalized to values obtained for 18S ribosomal RNA. The error bars represent the SD from the mean of triplicate assays of an individual experiment, n = 3, *P < 0.05.
###end p 40
###begin title 41
###xml 17 22 <span type="species:ncbi:9606">human</span>
PXR knockdown in human hepatocytes
###end title 41
###begin p 42
###xml 439 445 439 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP3A4</italic>
###xml 447 453 447 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2B6</italic>
###xml 455 459 455 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1</italic>
###xml 464 470 464 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UGT1A1</italic>
###xml 602 610 602 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 661 662 649 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1048 1051 1024 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18S</italic>
###xml 1056 1061 1032 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 1217 1226 1193 1202 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6.</label>
###xml 1585 1586 1561 1562 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1729 1730 1705 1706 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2000 2001 1972 1973 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 2008 2009 1980 1981 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1226 2017 1202 1989 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="43">Effect of PXR knockdown on the basal expression and inductive response of CYP4F12, CYP3A4, CYP2B6, MDR1 and UGT1A1 in human hepatocytes. Hepatocytes were transfected with ON-TARGETplus SMARTpool human NR1I2 siRNA (PXR-siRNA) or the non-specific ON-TARGETplus Non-Targeting Pool siRNA (scrambled, SCR-siRNA) as described in the Materials and methods section. (<bold>A</bold>) The effect of PXR silencing on basal expression of genes was determined relative to hepatocytes transfected with non-specific or SCR-siRNA. (<bold>B</bold>) The effect of PXR silencing on the inductive response was determined in hepatocytes transfected with PXR-siRNA or non-specific SCR-siRNA treated with rifampicin 10 &#181;M. The error bars represent the SD from the mean of triplicate assays of an individual experiment, <italic>n</italic> = 3, *<italic>P</italic> &lt; 0.05.</p>
###xml 1226 2017 1202 1989 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="43">Effect of PXR knockdown on the basal expression and inductive response of CYP4F12, CYP3A4, CYP2B6, MDR1 and UGT1A1 in human hepatocytes. Hepatocytes were transfected with ON-TARGETplus SMARTpool human NR1I2 siRNA (PXR-siRNA) or the non-specific ON-TARGETplus Non-Targeting Pool siRNA (scrambled, SCR-siRNA) as described in the Materials and methods section. (<bold>A</bold>) The effect of PXR silencing on basal expression of genes was determined relative to hepatocytes transfected with non-specific or SCR-siRNA. (<bold>B</bold>) The effect of PXR silencing on the inductive response was determined in hepatocytes transfected with PXR-siRNA or non-specific SCR-siRNA treated with rifampicin 10 &#181;M. The error bars represent the SD from the mean of triplicate assays of an individual experiment, <italic>n</italic> = 3, *<italic>P</italic> &lt; 0.05.</p></caption>
###xml 2017 2017 1989 1989 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn1047f6"/>
###xml 1217 2017 1193 1989 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F6" position="float"><label>Figure 6.</label><caption><p textid="43">Effect of PXR knockdown on the basal expression and inductive response of CYP4F12, CYP3A4, CYP2B6, MDR1 and UGT1A1 in human hepatocytes. Hepatocytes were transfected with ON-TARGETplus SMARTpool human NR1I2 siRNA (PXR-siRNA) or the non-specific ON-TARGETplus Non-Targeting Pool siRNA (scrambled, SCR-siRNA) as described in the Materials and methods section. (<bold>A</bold>) The effect of PXR silencing on basal expression of genes was determined relative to hepatocytes transfected with non-specific or SCR-siRNA. (<bold>B</bold>) The effect of PXR silencing on the inductive response was determined in hepatocytes transfected with PXR-siRNA or non-specific SCR-siRNA treated with rifampicin 10 &#181;M. The error bars represent the SD from the mean of triplicate assays of an individual experiment, <italic>n</italic> = 3, *<italic>P</italic> &lt; 0.05.</p></caption><graphic xlink:href="gkn1047f6"/></fig>
###xml 1344 1349 <span type="species:ncbi:9606">human</span>
###xml 1421 1426 <span type="species:ncbi:9606">human</span>
We conducted siRNA studies to further discern the involvement of PXR in the regulation of CYP4F12, UGT1A5, ABCB4 and ABCC4 which were identified as having strong PXR binding sites using ChIP analysis. We observed 79% knockdown in PXR mRNA levels in hepatocytes transfected for 72 h with PXR-siRNA relative to hepatocytes that were transfected with SCR-siRNA (data not shown). The basal expression levels of known PXR target genes, such as CYP3A4, CYP2B6, MDR1 and UGT1A1 were significantly lower (54-97%) in hepatocytes in which PXR was knocked down using PXR-siRNA compared to non-specific SCR-siRNA (Figure 6A). A statistically significant (approximately80%, P < 0.05) decrease was also observed in the basal expression of CYP4F12. While approximately30% decrease was observed in the basal expression of UGT1A5, this was not statistically significant when compared to hepatocytes transfected with the non-specific SCR-siRNA. To confirm the specificity of the PXR-siRNA we also determined whether basal expression levels of the housekeeping genes 18S and GAPDH were affected. We did not observe a statistically significant decrease in the expression of these genes (data not shown) following PXR-siRNA transfection. Figure 6.Effect of PXR knockdown on the basal expression and inductive response of CYP4F12, CYP3A4, CYP2B6, MDR1 and UGT1A1 in human hepatocytes. Hepatocytes were transfected with ON-TARGETplus SMARTpool human NR1I2 siRNA (PXR-siRNA) or the non-specific ON-TARGETplus Non-Targeting Pool siRNA (scrambled, SCR-siRNA) as described in the Materials and methods section. (A) The effect of PXR silencing on basal expression of genes was determined relative to hepatocytes transfected with non-specific or SCR-siRNA. (B) The effect of PXR silencing on the inductive response was determined in hepatocytes transfected with PXR-siRNA or non-specific SCR-siRNA treated with rifampicin 10 microM. The error bars represent the SD from the mean of triplicate assays of an individual experiment, n = 3, *P < 0.05.
###end p 42
###begin p 43
###xml 359 360 359 360 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 503 504 503 504 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 774 775 770 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 782 783 778 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 118 123 <span type="species:ncbi:9606">human</span>
###xml 195 200 <span type="species:ncbi:9606">human</span>
Effect of PXR knockdown on the basal expression and inductive response of CYP4F12, CYP3A4, CYP2B6, MDR1 and UGT1A1 in human hepatocytes. Hepatocytes were transfected with ON-TARGETplus SMARTpool human NR1I2 siRNA (PXR-siRNA) or the non-specific ON-TARGETplus Non-Targeting Pool siRNA (scrambled, SCR-siRNA) as described in the Materials and methods section. (A) The effect of PXR silencing on basal expression of genes was determined relative to hepatocytes transfected with non-specific or SCR-siRNA. (B) The effect of PXR silencing on the inductive response was determined in hepatocytes transfected with PXR-siRNA or non-specific SCR-siRNA treated with rifampicin 10 microM. The error bars represent the SD from the mean of triplicate assays of an individual experiment, n = 3, *P < 0.05.
###end p 43
###begin p 44
###xml 268 276 268 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1001 1006 1001 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23 B24 B25">23&#8211;25</xref>
A comparison of fold changes in gene expression in hepatocytes transfected with either SCR-siRNA or PXR-siRNA demonstrated a statistically significant decrease in the inductive response of CYP3A4 and CYP2B6 when treated with the prototypical PXR activator rifampicin (Figure 6B). We also observed a statistically significant decrease in the inductive response of CYP4F12 in hepatocytes transfected with SCR-siRNA or PXR-siRNA following treatment with rifampicin. No significant difference was observed in the expression of UGT1A1, MDR1, UGT1A5, ABCB4 and ABCC4 in SCR- versus PXR-transfected siRNA. The inductive response that we observed for UGT1A5, ABCB4 and ABCC4 in rifampicin-treated hepatocytes transfected with SCR-siRNA relative to DMSO control without subsequent knockdown in PXR-siRNA-transfected hepatocytes may be related to the regulation of these genes by other transcription factors, such as the vitamin-D receptor (VDR), farsenoid-X receptor (FXR) and aryl hydrocarbon receptor (AHR) (23-25).
###end p 44
###begin title 45
Association of corepressors and coactivators with PXR binding sites
###end title 45
###begin p 46
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 469 477 469 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 621 628 621 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 697 705 697 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 820 827 820 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP4F12</italic>
It was previously demonstrated that the steroid receptor complex protein SRC1 associates with PXR after ligand binding (26). Using a similar approach as used to determine PXR-binding to PXR gene promoters, we assessed whether the level of binding of SRC1 was increased after the treatment of cells with rifampicin. A very similar binding pattern to that observed with the anti-PXR antibody was observed in which increased binding was found for all four genes analyzed (Figure 1B). In addition, we assessed the association of SRC1 with the 11 genes showing increased binding to PXR after exposing the cells to rifampicin (Table 2). Again, binding patterns were very similar to those found for PXR (Figure 3B). In most cases, lower binding was detectable in cells not treated with rifampicin. Of the 11 genes tested, only CYP4F12 demonstrated significantly increased binding for both PXR and SRC1 after rifampicin treatment in three batches of hepatocytes.
###end p 46
###begin p 47
We extended our studies to assess the involvement of other previously published coactivators and corepressors of PXR on the regulation of CYP3A4, CYP2B6, CYP4F12, UGT1A1 and MDR1. ChIP analysis was performed with antibodies specific for the coactivators GRIP1, SRC3, PGC1alpha, FKHR and RIP140, and the corepressors NCoR, SMRT and SHP. All antibodies used have been evaluated by others before (see Material and methods section) and specificity was confirmed using known target genes (data not shown).
###end p 47
###begin p 48
###xml 182 191 178 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figures 7</xref>
###xml 196 197 192 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">8</xref>
###xml 368 374 360 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP3A4</italic>
###xml 379 386 371 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP4F12</italic>
###xml 460 468 452 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 471 480 463 472 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 7.</label>
###xml 891 892 867 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 899 900 875 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 480 908 472 884 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="49">Identification of HNF4&#945; binding to CYP3A4, CYP2B6, MDR1, UGT1A1 and CYP4F12. Chromatin from cryopreserved human hepatocytes treated with vehicle (Control; 0.1% DMSO) or rifampicin (10 &#181;M) for 3 h were immunoprecipitated with anti-HNF4&#945; antibody, and the enrichment of HNF4&#945; was determined by q-PCR. The error bars represent the SD from the mean of triplicate assays of an individual experiment, <italic>n</italic> = 3, *<italic>P</italic> &lt; 0.05.</p>
###xml 480 908 472 884 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="49">Identification of HNF4&#945; binding to CYP3A4, CYP2B6, MDR1, UGT1A1 and CYP4F12. Chromatin from cryopreserved human hepatocytes treated with vehicle (Control; 0.1% DMSO) or rifampicin (10 &#181;M) for 3 h were immunoprecipitated with anti-HNF4&#945; antibody, and the enrichment of HNF4&#945; was determined by q-PCR. The error bars represent the SD from the mean of triplicate assays of an individual experiment, <italic>n</italic> = 3, *<italic>P</italic> &lt; 0.05.</p></caption>
###xml 908 908 884 884 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn1047f7"/>
###xml 471 908 463 884 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F7" position="float"><label>Figure 7.</label><caption><p textid="49">Identification of HNF4&#945; binding to CYP3A4, CYP2B6, MDR1, UGT1A1 and CYP4F12. Chromatin from cryopreserved human hepatocytes treated with vehicle (Control; 0.1% DMSO) or rifampicin (10 &#181;M) for 3 h were immunoprecipitated with anti-HNF4&#945; antibody, and the enrichment of HNF4&#945; was determined by q-PCR. The error bars represent the SD from the mean of triplicate assays of an individual experiment, <italic>n</italic> = 3, *<italic>P</italic> &lt; 0.05.</p></caption><graphic xlink:href="gkn1047f7"/></fig>
###xml 908 917 884 893 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 8.</label>
###xml 977 978 953 954 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 989 990 965 966 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1001 1002 977 978 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1011 1012 987 988 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1026 1027 1002 1003 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 1449 1450 1417 1418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1457 1458 1425 1426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1552 1553 1520 1521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 917 1558 893 1526 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="50">Identification of PXR coactivators/corepressors binding to (<bold>A</bold>) CYP3A4, (<bold>B</bold>) CYP2B6, (<bold>C</bold>) MDR1, (<bold>D</bold>) UGT1A1 and (<bold>E</bold>) CYP4F12. Chromatin from cryopreserved human hepatocytes treated with vehicle (Control; 0.1% DMSO) or rifampicin (10 &#181;M) for 3 h were immunoprecipitated with anti-GRIP1, -NCOR, -SRC3, -PGC1 &#945;, -FKHR, -RIP140, -SMRT or -SHP antibody, and the enrichment of candidate coactivators/corepressors were determined by q-PCR. The error bars represent the SD from the mean of triplicate assays of an individual experiment, <italic>n</italic> = 3, *<italic>P</italic> &lt; 0.05. RIP140-binding to CYP3A4 in vehicle (Control; 0.1% DMSO)-treated cells is based upon <italic>n</italic> = 2.</p>
###xml 917 1558 893 1526 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="50">Identification of PXR coactivators/corepressors binding to (<bold>A</bold>) CYP3A4, (<bold>B</bold>) CYP2B6, (<bold>C</bold>) MDR1, (<bold>D</bold>) UGT1A1 and (<bold>E</bold>) CYP4F12. Chromatin from cryopreserved human hepatocytes treated with vehicle (Control; 0.1% DMSO) or rifampicin (10 &#181;M) for 3 h were immunoprecipitated with anti-GRIP1, -NCOR, -SRC3, -PGC1 &#945;, -FKHR, -RIP140, -SMRT or -SHP antibody, and the enrichment of candidate coactivators/corepressors were determined by q-PCR. The error bars represent the SD from the mean of triplicate assays of an individual experiment, <italic>n</italic> = 3, *<italic>P</italic> &lt; 0.05. RIP140-binding to CYP3A4 in vehicle (Control; 0.1% DMSO)-treated cells is based upon <italic>n</italic> = 2.</p></caption>
###xml 1558 1558 1526 1526 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn1047f8"/>
###xml 908 1558 884 1526 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F8" position="float"><label>Figure 8.</label><caption><p textid="50">Identification of PXR coactivators/corepressors binding to (<bold>A</bold>) CYP3A4, (<bold>B</bold>) CYP2B6, (<bold>C</bold>) MDR1, (<bold>D</bold>) UGT1A1 and (<bold>E</bold>) CYP4F12. Chromatin from cryopreserved human hepatocytes treated with vehicle (Control; 0.1% DMSO) or rifampicin (10 &#181;M) for 3 h were immunoprecipitated with anti-GRIP1, -NCOR, -SRC3, -PGC1 &#945;, -FKHR, -RIP140, -SMRT or -SHP antibody, and the enrichment of candidate coactivators/corepressors were determined by q-PCR. The error bars represent the SD from the mean of triplicate assays of an individual experiment, <italic>n</italic> = 3, *<italic>P</italic> &lt; 0.05. RIP140-binding to CYP3A4 in vehicle (Control; 0.1% DMSO)-treated cells is based upon <italic>n</italic> = 2.</p></caption><graphic xlink:href="gkn1047f8"/></fig>
###xml 590 595 <span type="species:ncbi:9606">human</span>
###xml 1067 1072 <span type="species:ncbi:9606">human</span>
Compared to the coactivators and corepressors that we assessed, HNF4alpha showed a significantly higher binding to the promoter elements of CYP3A4, CYP2B6, CYP4F12, UGT1A1 and MDR1 (Figures 7 and 8), but no increased binding of HNF4alpha was detectable after treatment of cells with rifampicin. In fact, the converse was true in that of the five genes evaluated, two (CYP3A4 and CYP4F12) showed a significantly decreased binding in the presence of rifampicin (Figure 7). Figure 7.Identification of HNF4alpha binding to CYP3A4, CYP2B6, MDR1, UGT1A1 and CYP4F12. Chromatin from cryopreserved human hepatocytes treated with vehicle (Control; 0.1% DMSO) or rifampicin (10 microM) for 3 h were immunoprecipitated with anti-HNF4alpha antibody, and the enrichment of HNF4alpha was determined by q-PCR. The error bars represent the SD from the mean of triplicate assays of an individual experiment, n = 3, *P < 0.05.Figure 8.Identification of PXR coactivators/corepressors binding to (A) CYP3A4, (B) CYP2B6, (C) MDR1, (D) UGT1A1 and (E) CYP4F12. Chromatin from cryopreserved human hepatocytes treated with vehicle (Control; 0.1% DMSO) or rifampicin (10 microM) for 3 h were immunoprecipitated with anti-GRIP1, -NCOR, -SRC3, -PGC1 alpha, -FKHR, -RIP140, -SMRT or -SHP antibody, and the enrichment of candidate coactivators/corepressors were determined by q-PCR. The error bars represent the SD from the mean of triplicate assays of an individual experiment, n = 3, *P < 0.05. RIP140-binding to CYP3A4 in vehicle (Control; 0.1% DMSO)-treated cells is based upon n = 2.
###end p 48
###begin p 49
###xml 411 412 395 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 419 420 403 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 110 115 <span type="species:ncbi:9606">human</span>
Identification of HNF4alpha binding to CYP3A4, CYP2B6, MDR1, UGT1A1 and CYP4F12. Chromatin from cryopreserved human hepatocytes treated with vehicle (Control; 0.1% DMSO) or rifampicin (10 microM) for 3 h were immunoprecipitated with anti-HNF4alpha antibody, and the enrichment of HNF4alpha was determined by q-PCR. The error bars represent the SD from the mean of triplicate assays of an individual experiment, n = 3, *P < 0.05.
###end p 49
###begin p 50
###xml 60 61 60 61 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 72 73 72 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 84 85 84 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 94 95 94 95 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 109 110 109 110 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 532 533 524 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 540 541 532 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 635 636 627 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 150 155 <span type="species:ncbi:9606">human</span>
Identification of PXR coactivators/corepressors binding to (A) CYP3A4, (B) CYP2B6, (C) MDR1, (D) UGT1A1 and (E) CYP4F12. Chromatin from cryopreserved human hepatocytes treated with vehicle (Control; 0.1% DMSO) or rifampicin (10 microM) for 3 h were immunoprecipitated with anti-GRIP1, -NCOR, -SRC3, -PGC1 alpha, -FKHR, -RIP140, -SMRT or -SHP antibody, and the enrichment of candidate coactivators/corepressors were determined by q-PCR. The error bars represent the SD from the mean of triplicate assays of an individual experiment, n = 3, *P < 0.05. RIP140-binding to CYP3A4 in vehicle (Control; 0.1% DMSO)-treated cells is based upon n = 2.
###end p 50
###begin p 51
###xml 352 360 352 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Figure 8</xref>
###xml 372 380 372 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Figure 8</xref>
###xml 395 403 395 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Figure 8</xref>
###xml 471 479 471 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Figure 8</xref>
None of the other coactivators that we assessed showed a statistically significant increase in binding in cells treated with rifampicin versus vehicle control. Interestingly, GRIP1 showed a decrease in binding to CYP4F12 in the presence of rifampicin. Of the corepressors tested, while a trend towards decreased binding of SHP was observed for CYP3A4 (Figure 8A), CYP2B6 (Figure 8B) and UGT1A1 (Figure 8D), we observed a statistically significant decrease only for MDR1 (Figure 8C).
###end p 51
###begin title 52
DISCUSSION
###end title 52
###begin p 53
###xml 738 745 738 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP4F12</italic>
###xml 125 130 <span type="species:ncbi:9606">human</span>
Here we report the identification of new genes containing PXR binding sites using ChIP-based assays in cryopreserved primary human hepatocytes. The use of ChIP can detect the direct association of PXR and coactivators/corepressors with promoter elements. This is different from gene profiling experiments with cells treated with PXR-activators where it cannot be excluded that the induction of genes is a secondary effect of PXR activation. Our studies indicate that PXR binds to PXREs in the presence and absence of rifampicin, and that binding of PXR to many of the newly identified genes does not increase after treatment with rifampicin. The ability of PXR to regulate the basal expression and inducibility of one of these new genes, CYP4F12, was confirmed by hepatocytes depleted of PXR by siRNA. Finally, we extended our studies and also found that binding of SRC1 correlates with transcriptional activation of PXR target genes, whereas this was not found for other coactivators or corepressors studied.
###end p 53
###begin p 54
###xml 626 628 626 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 773 779 773 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 781 783 781 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 985 990 985 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACC-1</italic>
###xml 136 141 <span type="species:ncbi:9606">human</span>
###xml 896 900 <span type="species:ncbi:10090">mice</span>
###xml 916 920 <span type="species:ncbi:10090">mice</span>
Using a ChIP-based discovery approach, we were able to identify genes containing PXR binding sites which were mapped against the entire human genome (). Tags were identified which were localized large distances upstream from, within or downstream of their potentially associated genes. The identified tags were located on all 23 chromosomes and included drug metabolizing and transporter genes as well as genes not involved in drug disposition. The presence of PXR-binding sites on genes not involved in drug disposition is not unexpected given that recent evidence suggests that PXR plays a role in hepatic lipid metabolism (27). For instance, PXR binds to FOXA2 () and represses its' activity and the genes encoding the key enzymes in energy metabolism. Furthermore, Dai et al. (28) observed that ACC1 (Acetyl CoA carboxylase 1), which is a lipogenic enzyme, was consistently lower in PXR-null mice than wild-type mice. Their data indicated that PXR is involved in the regulation of ACC-1 gene expression during liver regeneration.
###end p 54
###begin p 55
###xml 160 167 160 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 384 390 384 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP3A5</italic>
###xml 392 398 392 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2C8</italic>
###xml 403 408 403 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 432 439 432 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 442 443 442 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 444 445 444 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 523 531 523 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 584 592 584 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
Using the data obtained in the ChIP-based discovery approach we were able to confirm that several previously unidentified drug disposition genes contain PXREs (Table 2). These included phase I (CYP4F12) and phase II (SULT1B1 and UGT1A5) drug metabolizing enzymes, as well as transporters (SLC40A1 and ABCB4). In addition, our data also confirmed previous studies which indicated that CYP3A5, CYP2C8 and GSTT1 were PXR-target genes (Table 2) (1,2,29). Similar to what we observed for the genes with known PXR-binding sites (Figure 1A), PXR binding to the PXREs on 11 genes analyzed in Figure 3A also occurred in the absence of rifampicin. To ensure that our findings were not due to the high inducibility of PXR in the cells we used in our experiments, we have looked at binding to several targets in two to three batches of hepatocytes. The data indicated that results were consistently in agreement. While our discovery approach identified many new genes binding to PXR, the number of tags sequenced likely did not reach saturation, and therefore more PXR target genes may be identified in the future.
###end p 55
###begin p 56
###xml 180 188 180 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 609 617 609 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 661 667 661 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 669 671 669 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 893 899 893 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 901 903 901 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 712 717 <span type="species:ncbi:10090">mouse</span>
###xml 787 792 <span type="species:ncbi:9606">human</span>
As expected, in our PXR antibody validation studies with known PXR-binding sites, all four genes showed significantly higher PXR binding than was observed for the control regions (Figure 1A). Similar to what we observed during the discovery approach, binding of PXR to these PXREs was also detected in the absence of rifampicin in which the binding to MDR1 was much higher than that to UGT1A1, CYP2B6 and CYP3A4. Our PXR knockdown studies add additional evidence of PXR binding to PXREs in the absence of ligand and the subsequent reduction in the basal expression of CYP3A4, CYP2B6, UGT1A1, Pgp and CYP4F12 (Figure 6). This is in line with findings by Squires et al. (30) that PXR was present in the nucleus of mouse liver cells prior to the addition of a ligand. Similarly, in primary human hepatocytes in which PXR was knocked down using the hPXR-siRNA-adenovirus expression system, Kojima et al. (31) observed a reduction in the basal expression of CYP3A4 and CYP2B6 mRNA levels.
###end p 56
###begin p 57
###xml 263 271 263 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 387 395 387 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 526 534 526 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 608 616 608 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 813 815 813 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 986 988 986 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
Our studies did confirm that addition of rifampicin significantly increased the binding of PXR to the PXREs of CYP3A4, MDR1, UGT1A1 and CYP2B6. Interestingly, the fold increase of PXR binding to PXRE was several-fold higher for CYP3A4 than was observed for MDR1 (Figure 1A). This may explain why minimal induction of MDR1 was observed after treatment with rifampicin compared to CYP3A4 (Figure 5). Also of interest was the finding that PXR binding to PXREs did not always significantly increase in the presence of rifampicin (Figure 3) which subsequently did not result in an increase in gene transcription (Figure 4). This phenomenon is difficult to explain and could be related to the fact that PXR binding to PXREs occurs in the absence of the ligand which could lead to saturation of PXREs on specific genes (30). It should also be noted that PXR binding to PXREs is not the only determinant of an increase in gene transcription but involves numerous corepressors and coactivators (12).
###end p 57
###begin p 58
###xml 365 367 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 592 594 592 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 595 597 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 598 600 598 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 725 726 725 726 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 737 739 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 740 742 740 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 182 187 <span type="species:ncbi:9606">human</span>
Using ChIP we identified CYP4F12 as having PXR-binding sites. We confirmed the involvement of PXR in the regulation of CYP4F12 by assessing its' basal expression and inducibility in human hepatocytes in which PXR was knocked down. CYP4F12 mRNA has been detected in several major tissues involved in drug disposition including the liver, kidney and small intestine (32,33). It is the only member of the CYP4F family involved in xenobiotic metabolism. In particular, CYP4F12 has been shown to be highly efficient toward metabolism of antihistaminic compounds, such as ebastine and terfenadine (32,34,35). In addition to xenobiotics, CYP4F12 is also involved in the oxidation of arachadonic acid and stable prostaglandin H2 (PGH2) analogs (32,34).
###end p 58
###begin p 59
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 233 242 233 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figures 1</xref>
###xml 248 249 248 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
###xml 550 552 550 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
Previous studies have highlighted the importance of the coactivator SRC-1 in PXR activation and the subsequent increase in gene transcription (36). Our studies confirmed that the SRC-1 binding pattern mirrors that observed with PXR (Figures 1B and 3B). Similar to PXR, SRC-1 binding was increased after treatment of hepatocytes with rifampicin. This is in line with crystallographic studies which demonstrated that SRC-1 binds to PXR and stabilizes the PXR-LBD and together with the ligand exerts an additive effect on the stability of the receptor (36). Binding of SRC-1 to the surface of PXR limits the ability of the receptor to continuously change its conformation and helps trap a single, active conformation of the ligand.
###end p 59
###begin p 60
###xml 226 228 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 428 436 424 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Figure 8</xref>
###xml 714 722 710 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 884 889 880 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13 B14 B15 B16">13&#8211;16</xref>
###xml 671 676 <span type="species:ncbi:9606">human</span>
In addition to SRC-1, several other PXR-coactivators and -corepressors have been implicated in PXR-mediated gene regulation. These include the coactivators GRIP1, PGC1alpha, FKHR and RIP140, and the corepressors SMRT and SHP (12). Analysis of these coactivators and corepressors did, in most cases, show significant binding to the promoter elements of the target genes in the absence of rifampicin compared to the control Untr (Figure 8). Treatment of the hepatocytes with rifampicin did not result in a consistent increase in binding in the case of coactivators or decreased binding in the presence of corepressors. This may be related to our studies being conducted in human hepatocytes and not in a recombinant in vitro system. In comparison, studies by others were conducted in cell lines in which proteins were overexpressed and were outside their natural chromatin environment (13-16). Overall, however, our data suggests that binding of the coactivators and corepressors studied were involved in the regulation of gene expression as binding was higher than to the negative control and, with few exceptions, the overall pattern of binding to the various promoter elements studied were similar. An important point to consider is that all our analyses were done after treatment of hepatocytes with rifampicin and we cannot exclude that different binding behavior could be found in the presence of other PXR activators.
###end p 60
###begin p 61
###xml 111 113 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 305 313 293 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 401 403 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 416 422 400 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 424 426 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 591 597 571 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 599 601 579 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 1027 1029 995 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 1030 1032 998 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 680 685 <span type="species:ncbi:9606">human</span>
HNF4alpha has been shown to cooperate at the -7.8 kb XREM in the PXR-dependent induction of CYP3A4 expression (17). Even though HNF4alpha binding was detectable in the presence and absence of rifampicin, it was unexpected that we observed a decrease in binding of HNF4alpha in the presence of rifampicin (Figure 7). The role of HNF4alpha in PXR-mediated gene activation is not clear as Li and Chiang (18) and Tegude et al. (37) have shown that binding of HNF4alpha to the XREM-DR1 element is not required for gene activation of the CYP3A4 promoter. This was confirmed in a study by Kamiyama et al. (38) in which HNF4alpha was knocked down using an adenovirus expressing system in human hepatocytes. They observed that hHNF4alpha-siRNA did not significantly affect the fold-induction of CYP2B6, CYP2C8, CYP2C9 or CYP3A4 mRNA levels following treatment with CYP inducers, such as phenobarbital, rifampicin and dexamethasone. There is strong evidence, however, that HNF4alpha is involved in regulating basal expression of CYP3A4 (37,38).
###end p 61
###begin p 62
###xml 40 45 <span type="species:ncbi:9606">human</span>
In conclusion, in cryopreserved primary human hepatocytes we identified several new genes containing PXR binding sites. We confirmed the involvement of PXR in the regulation of CYP4F12 using siRNA. We also found that the SRC-1 binding pattern is very similar to PXR and that both bind to promoter elements in the absence of ligand. Finally, we did not observe a pattern correlating with rifampicin treatment with respect to other PXR coactivators/corepressors involved in gene regulation in the presence of rifampicin.
###end p 62
###begin title 63
FUNDING
###end title 63
###begin p 64
Funding for open access charge: Merck & Co., Inc.
###end p 64
###begin p 65
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 65
###begin title 66
Supplementary Material
###end title 66
###begin title 67
[Supplementary Data]
###end title 67
###begin title 68
REFERENCES
###end title 68
###begin article-title 69
Nuclear pregnane X receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification
###end article-title 69
###begin article-title 70
Identification of potential pharmacological and toxicological targets differentiating structural analogs by a combination of transcriptional profiling and promoter analysis in LS-180 and Caco-2 adenocarcinoma cell lines
###end article-title 70
###begin article-title 71
Genetic profiling defines the xenobiotic gene network controlled by the nuclear receptor pregnane X receptor
###end article-title 71
###begin article-title 72
Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor
###end article-title 72
###begin article-title 73
The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity
###end article-title 73
###begin article-title 74
###xml 62 67 <span type="species:ncbi:9606">human</span>
Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7 alpha-hydroxylase gene transcription
###end article-title 74
###begin article-title 75
The mycoestrogen zearalenone induces CYP3A through activation of the pregnane X receptor
###end article-title 75
###begin article-title 76
Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin
###end article-title 76
###begin article-title 77
CYP induction-mediated drug interactions: in vitro assessment and clinical implications
###end article-title 77
###begin article-title 78
An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway
###end article-title 78
###begin article-title 79
The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux
###end article-title 79
###begin article-title 80
International Union of Pharmacology. LXII. The NR1H and NR1I receptors: constitutive androstane receptor, pregnene X receptor, farnesoid X receptor alpha, farnesoid X receptor beta, liver X receptor alpha, liver X receptor beta, and vitamin D receptor
###end article-title 80
###begin article-title 81
The small heterodimer partner interacts with the pregnane X receptor and represses its transcriptional activity
###end article-title 81
###begin article-title 82
The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux
###end article-title 82
###begin article-title 83
Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR)
###end article-title 83
###begin article-title 84
###xml 54 59 <span type="species:ncbi:9606">human</span>
Bisphenol-A, an environmental estrogen, activates the human orphan nuclear receptor, steroid and xenobiotic receptor-mediated transcription
###end article-title 84
###begin article-title 85
The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4
###end article-title 85
###begin article-title 86
Rifampicin induction of CYP3A4 requires pregnane X receptor cross talk with hepatocyte nuclear factor 4alpha and coactivators, and suppression of small heterodimer partner gene expression
###end article-title 86
###begin article-title 87
Dissecting long-range transcriptional mechanisms by chromatin immunoprecipitation
###end article-title 87
###begin article-title 88
Identification of target genes in breast cancer cells directly regulated by the SRC-3/AIB1 coactivator
###end article-title 88
###begin article-title 89
###xml 11 16 <span type="species:ncbi:9606">human</span>
The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module
###end article-title 89
###begin article-title 90
RNA polymerase II stalling: loading at the start prepares genes for a sprint
###end article-title 90
###begin article-title 91
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human UDP-glucuronosyltransferase 1A5: identification, expression, and activity
###end article-title 91
###begin article-title 92
Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein)
###end article-title 92
###begin article-title 93
Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450
###end article-title 93
###begin article-title 94
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity
###end article-title 94
###begin article-title 95
The roles of nuclear receptors CAR and PXR in hepatic energy metabolism
###end article-title 95
###begin article-title 96
Pregnane X receptor is essential for normal progression of liver regeneration
###end article-title 96
###begin article-title 97
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human CYP2C8 is transcriptionally regulated by the nuclear receptors constitutive androstane receptor, pregnane X receptor, glucocorticoid receptor, and hepatic nuclear factor 4alpha
###end article-title 97
###begin article-title 98
###xml 94 99 <span type="species:ncbi:10090">mouse</span>
Cytoplasmic localization of pregnane X receptor and ligand-dependent nuclear translocation in mouse liver
###end article-title 98
###begin article-title 99
###xml 99 104 <span type="species:ncbi:9606">human</span>
Broad but distinct role of pregnane X receptor on the expression of individual cytochrome p450s in human hepatocytes
###end article-title 99
###begin article-title 100
###xml 48 53 <span type="species:ncbi:9606">human</span>
cDna cloning and expression of CYP4F12, a novel human cytochrome P450
###end article-title 100
###begin article-title 101
Expression of CYP4F12 in gastrointestinal and urogenital epithelia
###end article-title 101
###begin article-title 102
###xml 70 75 <span type="species:ncbi:9606">human</span>
cDNA cloning and expression of a novel cytochrome p450 (cyp4f12) from human small intestine
###end article-title 102
###begin article-title 103
###xml 67 72 <span type="species:ncbi:9606">human</span>
Involvement of CYP2J2 and CYP4F12 in the metabolism of ebastine in human intestinal microsomes
###end article-title 103
###begin article-title 104
Coactivator binding promotes the specific interaction between ligand and the pregnane X receptor
###end article-title 104
###begin article-title 105
Molecular mechanism of basal CYP3A4 regulation by hepatocyte nuclear factor 4 alpha: evidence for direct regulation in the intestine
###end article-title 105
###begin article-title 106
###xml 8 13 <span type="species:ncbi:9606">human</span>
###xml 114 119 <span type="species:ncbi:9606">human</span>
Role of human hepatocyte nuclear factor 4alpha in the expression of drug-metabolizing enzymes and transporters in human hepatocytes assessed by use of small interfering RNA
###end article-title 106

